CPT_id	rootSource	name	obsolete	atomCount	concepts
0001U	CPT	Red blood cell antigen typing, DNA, human erythrocyte antigen gene analysis of 35 antigens from 11 blood groups, utilizing whole blood, common RBC alleles reported	False	5	C4521667;C5414375;C4301946
0002M	CPT	Liver disease, ten biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, haptoglobin, AST, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and alcoholic steatohepatitis (ASH)	False	4	C3869480;C5697505
0002U	CPT	Oncology (colorectal), quantitative assessment of three urine metabolites (ascorbic acid, succinic acid and carnitine) by liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring acquisition, algorithm reported as likelihood of adenomatous polyps	False	5	C5414376;C4521656
0003M	CPT	Liver disease, ten biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, haptoglobin, AST, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and nonalcoholic steatohepatitis (NASH)	False	4	C3869479;C5697506
0003U	CPT	Oncology (ovarian) biochemical assays of five proteins (apolipoprotein A-1, CA 125 II, follicle stimulating hormone, human epididymis protein 4, transferrin), utilizing serum, algorithm reported as a likelihood score	False	5	C4301944;C4523576
0004M	CPT	Scoliosis, DNA analysis of 53 single nucleotide polymorphisms (SNPs), using saliva, prognostic algorithm reported as a risk score	False	4	C3869478;C5697507
0005U	CPT	Oncology (prostate) gene expression profile by real-time RT-PCR of 3 genes (ERG, PCA3, and SPDEF), urine, algorithm reported as risk score	False	5	C4521662;C5414377
0006M	CPT	Oncology (hepatic), mRNA expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier	False	4	C3869477;C5697508
0007M	CPT	Oncology (gastrointestinal neuroendocrine tumors), real-time PCR expression analysis of 51 genes, utilizing whole peripheral blood, algorithm reported as a nomogram of tumor disease index	False	4	C3869476;C5697509
0007U	CPT	Drug test(s), presumptive, with definitive confirmation of positive results, any number of drug classes, urine, includes specimen verification including DNA authentication in comparison to buccal DNA, per date of service	False	5	C4521675;C4523580
0008U	CPT	Helicobacter pylori detection and antibiotic resistance, DNA, 16S and 23S rRNA, gyrA, pbp1, rdxA and rpoB, next generation sequencing, formalin-fixed paraffin-embedded or fresh tissue or fecal sample, predictive, reported as positive or negative for resistance to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline, and rifabutin	False	7	C4521495;C5414378;C5414379;C5414380
0009U	CPT	Oncology (breast cancer), ERBB2 (HER2) copy number by FISH, tumor cells from formalin-fixed paraffin-embedded tissue isolated using image-based dielectrophoresis (DEP) sorting, reported as ERBB2 gene amplified or non-amplified	False	5	C4521499;C4521655;C5414381
0010U	CPT	Infectious disease (bacterial), strain typing by whole genome sequencing, phylogenetic-based report of strain relatedness, per submitted isolate	False	5	C0201216;C4521498;C5414382
0011M	CPT	Oncology, prostate cancer, mRNA expression assay of 12 genes (10 content and 2 housekeeping), RT-PCR test utilizing blood plasma and urine, algorithms to predict high-grade prostate cancer risk	False	4	C5697510;C4732724
0011U	CPT	Prescription drug monitoring, evaluation of drugs present by LC-MS/MS, using oral fluid, reported as a comparison to an estimated steady-state range, per date of service including all drug compounds and metabolites	False	5	C4521672;C5414383
0012M	CPT	Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having urothelial carcinoma	False	4	C5697511;C4732725
0013M	CPT	Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having recurrent urothelial carcinoma	False	4	C4732726;C5697512
0015M	CPT	Adrenal cortical tumor, biochemical assay of 25 steroid markers, utilizing 24-hour urine specimen and clinical parameters, prognostic algorithm reported as a clinical risk and integrated clinical steroid risk for adrenal cortical carcinoma, adenoma, or other adrenal malignancy	False	4	C5697514;C5416726
0016M	CPT	Oncology (bladder), mRNA, microarray gene expression profiling of 219 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as molecular subtype (luminal, luminal infiltrated, basal, basal claudin-low, neuroendocrine-like)	False	4	C5416727;C5697515
0016U	CPT	Oncology (hematolymphoid neoplasia), RNA, BCR/ABL1 major and minor breakpoint fusion transcripts, quantitative PCR amplification, blood or bone marrow, report of fusion not detected or detected with quantitation	False	6	C5414389;C4521658;C5414388;C5414387
0017M	CPT	Oncology (diffuse large B-cell lymphoma [DLBCL]), mRNA, gene expression profiling by fluorescent probe hybridization of 20 genes, formalin-fixed paraffin-embedded tissue, algorithm reported as cell of origin	False	4	C5697516;C5691641
0017U	CPT	Oncology (hematolymphoid neoplasia), JAK2 mutation, DNA, PCR amplification of exons 12-14 and sequence analysis, blood or bone marrow, report of JAK2 mutation not detected or detected	False	6	C4521657;C5414390;C5414391;C5414392
0018M	CPT	Transplantation medicine (allograft rejection, renal), measurement of donor and third-party-induced CD154+T-cytotoxic memory cells, utilizing whole peripheral blood, algorithm reported as a rejection risk score	False	4	C5691642;C5697517
0018U	CPT	Oncology (thyroid), microRNA profiling by RT-PCR of 10 microRNA sequences, utilizing fine needle aspirate, algorithm reported as a positive or negative result for moderate to high risk of malignancy	False	5	C4542814;C5414393;C4732273
0019M	CPT	Cardiovascular disease, plasma, analysis of protein biomarkers by aptamer-based microarray and algorithm reported as 4-year likelihood of coronary event in high-risk populations	False	4	C5852380;C5852381
0019U	CPT	Oncology, RNA, gene expression by whole transcriptome sequencing, formalin-fixed paraffin-embedded tissue or fresh frozen tissue, predictive algorithm reported as potential targets for therapeutic agents	False	6	C4732275;C4732276;C4732277;C4542815
0020M	CPT	Oncology (central nervous system), analysis of 30000 DNA methylation loci by methylation array, utilizing DNA extracted from tumor tissue, diagnostic algorithm reported as probability of matching a reference tumor subclass	False	4	C5945047;C5945048
0021U	CPT	Oncology (prostate), detection of 8 autoantibodies (ARF 6, NKX3-1, 5'-UTR-BMI1, CEP 164, 3'-UTR-Ropporin, Desmocollin, AURKAIP-1, CSNK2A2), multiplexed immunoassay and flow cytometry serum, algorithm reported as risk score	False	5	C4542816;C4732279;C4732280
0022U	CPT	Targeted genomic sequence analysis panel, non-small cell lung neoplasia, DNA and RNA analysis, 23 genes, interrogation for sequence variants and rearrangements, reported as presence or absence of variants and associated therapy(ies) to consider	False	5	C4542817;C5851832;C5851833
0023U	CPT	Oncology (acute myelogenous leukemia), DNA, genotyping of internal tandem duplication, p.D835, p.I836, using mononuclear cells, reported as detection or non-detection of FLT3 mutation and indication for or against the use of midostaurin	False	5	C5414395;C4732283;C4542818
0024U	CPT	Glycosylated acute phase proteins (GlycA), nuclear magnetic resonance spectroscopy, quantitative	False	5	C5414396;C4732285;C4732286
0025U	CPT	Tenofovir, by liquid chromatography with tandem mass spectrometry (LC-MS/MS), urine, quantitative	False	5	C4732289;C5414397;C4732288
0026U	CPT	Oncology (thyroid), DNA and mRNA of 112 genes, next-generation sequencing, fine needle aspirate of thyroid nodule, algorithmic analysis reported as a categorical result ("Positive, high probability of malignancy" or "Negative, low probability of malignancy")	False	5	C5414398;C4732291;C4732292
0027U	CPT	JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, targeted sequence analysis exons 12-15	False	5	C4732294;C5414399;C4732295
0029U	CPT	Drug metabolism (adverse drug reactions and drug response), targeted sequence analysis (ie, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP4F2, SLCO1B1, VKORC1 and rs12777823)	False	5	C5414400;C4732298;C4732299
0030U	CPT	Drug metabolism (warfarin drug response), targeted sequence analysis (ie, CYP2C9, CYP4F2, VKORC1, rs12777823)	False	5	C4732302;C5414401;C4732301
0031U	CPT	CYP1A2 (cytochrome P450 family 1, subfamily A, member 2) (eg, drug metabolism) gene analysis, common variants (ie, *1F, *1K, *6, *7)	False	5	C4722651;C4732305;C4732304
0032U	CPT	COMT (catechol-O-methyltransferase) (eg, drug metabolism) gene analysis, c.472G>A (rs4680) variant	False	5	C4724362;C4732307;C4732306
0034U	CPT	TPMT (thiopurine S-methyltransferase), NUDT15 (nudix hydroxylase 15) (eg, thiopurine metabolism) gene analysis, common variants (ie, TPMT *2, *3A, *3B, *3C, *4, *5, *6, *8, *12; NUDT15 *3, *4, *5)	False	5	C3708795;C4732311;C4732312
0035U	CPT	Neurology (prion disease), cerebrospinal fluid, detection of prion protein by quaking-induced conformational conversion, qualitative	False	5	C4732313;C4732315;C4732314
0036U	CPT	Exome (ie, somatic mutations), paired formalin-fixed paraffin-embedded tumor tissue and normal specimen, sequence analyses	False	5	C4732316;C4732317;C4732318
0037U	CPT	Targeted genomic sequence analysis, solid organ neoplasm, DNA analysis of 324 genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden	False	5	C4732321;C4732319;C4732320
0038U	CPT	Vitamin D, 25 hydroxy D2 and D3, by LC-MS/MS, serum microsample, quantitative	False	5	C5414402;C4732322;C0428586
0039U	CPT	Deoxyribonucleic acid (DNA) antibody, double stranded, high avidity	False	5	C0236300;C4732324;C4732325
0040U	CPT	BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis, major breakpoint, quantitative	False	5	C4732326;C4732327;C5414403
0041U	CPT	Borrelia burgdorferi, antibody detection of 5 recombinant protein groups, by immunoblot, IgM	False	5	C4732330;C4732331;C4732329
0042U	CPT	Borrelia burgdorferi, antibody detection of 12 recombinant protein groups, by immunoblot, IgG	False	5	C4732334;C4732332;C4732333
0043U	CPT	Tick-borne relapsing fever Borrelia group, antibody detection to 4 recombinant protein groups, by immunoblot, IgM	False	5	C5414405;C5414404;C4732335
0044U	CPT	Tick-borne relapsing fever Borrelia group, antibody detection to 4 recombinant protein groups, by immunoblot, IgG	False	5	C4732338;C5414406;C4732336
0045U	CPT	Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence score	False	5	C5414407;C4732341;C4732340
0046U	CPT	FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia) internal tandem duplication (ITD) variants, quantitative	False	5	C5414408;C4732343;C3516223
0047U	CPT	Oncology (prostate), mRNA, gene expression profiling by real-time RT-PCR of 17 genes (12 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a risk score	False	5	C5414409;C4732346;C4732345
0048U	CPT	Oncology (solid organ neoplasia), DNA, targeted sequencing of protein-coding exons of 468 cancer-associated genes, including interrogation for somatic mutations and microsatellite instability, matched with normal specimens, utilizing formalin-fixed paraffin-embedded tumor tissue, report of clinically significant mutation(s)	False	5	C4732349;C5414410;C4732348
0049U	CPT	NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative	False	5	C4732351;C4732352;C4732353
0050U	CPT	Targeted genomic sequence analysis panel, acute myelogenous leukemia, DNA analysis, 194 genes, interrogation for sequence variants, copy number variants or rearrangements	False	5	C4732355;C4732354;C4732356
0051U	CPT	Prescription drug monitoring, evaluation of drugs present by liquid chromatography tandem mass spectrometry (LC-MS/MS), urine or blood, 31 drug panel, reported as quantitative results, detected or not detected, per date of service	False	6	C5696560;C5698178;C5698179;C4732357
0052U	CPT	Lipoprotein, blood, high resolution fractionation and quantitation of lipoproteins, including all five major lipoprotein classes and subclasses of HDL, LDL, and VLDL by vertical auto profile ultracentrifugation	False	5	C5414412;C4732360;C4732361
0054U	CPT	Prescription drug monitoring, 14 or more classes of drugs and substances, definitive tandem mass spectrometry with chromatography, capillary blood, quantitative report with therapeutic and toxic ranges, including steady-state range for the prescribed dose when detected, per date of service	False	5	C4732367;C4732369;C4732366
0055U	CPT	Cardiology (heart transplant), cell-free DNA, PCR assay of 96 DNA target sequences (94 single nucleotide polymorphism targets and two control targets), plasma	False	5	C5414414;C4732371;C4732370
0058U	CPT	Oncology (Merkel cell carcinoma), detection of antibodies to the Merkel cell polyoma virus oncoprotein (small T antigen), serum, quantitative	False	5	C4722652;C5414415;C4732380
0059U	CPT	Oncology (Merkel cell carcinoma), detection of antibodies to the Merkel cell polyoma virus capsid protein (VP1), serum, reported as positive or negative	False	5	C5414416;C4732381;C4732382
0060U	CPT	Twin zygosity, genomic-targeted sequence analysis of chromosome 2, using circulating cell-free fetal DNA in maternal blood	False	5	C4732384;C5414417;C4732385
0061U	CPT	Transcutaneous measurement of five biomarkers (tissue oxygenation [StO2], oxyhemoglobin [ctHbO2], deoxyhemoglobin [ctHbR], papillary and reticular dermal hemoglobin concentrations [ctHb1 and ctHb2]), using spatial frequency domain imaging (SFDI) and multi-spectral analysis	False	5	C4732387;C4732388;C5414418
0062U	CPT	Autoimmune (systemic lupus erythematosus), IgG and IgM analysis of 80 biomarkers, utilizing serum, algorithm reported with a risk score	False	5	C5202015;C4746523;C5202014
0063U	CPT	Neurology (autism), 32 amines by LC-MS/MS, using plasma, algorithm reported as metabolic signature associated with autism spectrum disorder	False	5	C5414419;C4746524;C5202016
0064U	CPT	Antibody, Treponema pallidum, total and rapid plasma reagin (RPR), immunoassay, qualitative	False	5	C4746525;C5202018;C5414420
0065U	CPT	Syphilis test, non-treponemal antibody, immunoassay, qualitative (RPR)	False	5	C4722653;C5202020;C5414421
0066U					
0067U	CPT	Oncology (breast), immunohistochemistry, protein expression profiling of 4 biomarkers (matrix metalloproteinase-1 [MMP-1], carcinoembryonic antigen-related cell adhesion molecule 6 [CEACAM6], hyaluronoglucosaminidase [HYAL1], highly expressed in cancer protein [HEC1]), formalin-fixed paraffin-embedded precancerous breast tissue, algorithm reported as carcinoma risk score	False	5	C5202024;C4746527;C5202025
0068U	CPT	Candida species panel (C. albicans, C. glabrata, C. parapsilosis, C. kruseii, C. tropicalis, and C. auris), amplified probe technique with qualitative report of the presence or absence of each species	False	5	C5202026;C4746528;C5202027
0069U	CPT	Oncology (colorectal), microRNA, RT-PCR expression profiling of miR-31-3p, formalin-fixed paraffin-embedded tissue, algorithm reported as an expression score	False	5	C5414423;C4746529;C5202028
0070U	CPT	CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, common and select rare variants (ie, *2, *3, *4, *4N, *5, *6, *7, *8, *9, *10, *11, *12, *13, *14A, *14B, *15, *17, *29, *35, *36, *41, *57, *61, *63, *68, *83, *xN)	False	5	C4746530;C5202030;C5202031
0071U	CPT	CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, full gene sequence (List separately in addition to code for primary procedure)	False	5	C5201275;C5202033;C5202032
0072U	CPT	CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D6-2D7 hybrid gene) (List separately in addition to code for primary procedure)	False	5	C4746531;C5202034;C5414424
0073U	CPT	CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D7-2D6 hybrid gene) (List separately in addition to code for primary procedure)	False	5	C4746532;C5202036;C5414425
0074U	CPT	CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, non-duplicated gene when duplication/multiplication is trans) (List separately in addition to code for primary procedure)	False	5	C4746533;C5202038;C5414426
0075U	CPT	CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 5' gene duplication/multiplication) (List separately in addition to code for primary procedure)	False	5	C4746534;C5202040;C5414427
0076U	CPT	CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 3' gene duplication/multiplication) (List separately in addition to code for primary procedure)	False	5	C4746535;C5202042;C5202041
0077U	CPT	Immunoglobulin paraprotein (M-protein), qualitative, immunoprecipitation and mass spectrometry, blood or urine, including isotype	False	6	C5202045;C4746536;C5202044;C5202043
0078U					
0080U	CPT	Oncology (lung), mass spectrometric analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130, with five clinical risk factors (age, smoking status, nodule diameter, nodule-spiculation status and nodule location), utilizing plasma, algorithm reported as a categorical probability of malignancy	False	5	C4746539;C5202050;C5414430
0082U	CPT	Drug test(s), definitive, 90 or more drugs or substances, definitive chromatography with mass spectrometry, and presumptive, any number of drug classes, by instrument chemistry analyzer (utilizing immunoassay), urine, report of presence or absence of each drug, drug metabolite or substance with description and severity of significant interactions per date of service	False	6	C5414432;C5414431;C4746541;C5202053
0083U	CPT	Oncology, response to chemotherapy drugs using motility contrast tomography, fresh or frozen tissue, reported as likelihood of sensitivity or resistance to drugs or drug combinations	False	6	C4746542;C5202056;C5202057;C5202055
0084U	CPT	Red blood cell antigen typing, DNA, genotyping of 10 blood groups with phenotype prediction of 37 red blood cell antigens	False	5	C5202059;C5202058;C5202060
0086U	CPT	Infectious disease (bacterial and fungal), organism identification, blood culture, using rRNA FISH, 6 or more organism targets, reported as positive or negative with phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility	False	5	C5202065;C5202067;C5202066
0087U	CPT	Cardiology (heart transplant), mRNA gene expression profiling by microarray of 1283 genes, transplant biopsy tissue, allograft rejection and injury algorithm reported as a probability score	False	5	C5202070;C5202071;C5202072
0088U	CPT	Transplantation medicine (kidney allograft rejection), microarray gene expression profiling of 1494 genes, utilizing transplant biopsy tissue, algorithm reported as a probability score for rejection	False	5	C5202073;C5202075;C5202074
0089U	CPT	Oncology (melanoma), gene expression profiling by RTqPCR, PRAME and LINC00518, superficial collection using adhesive patch(es)	False	5	C5414433;C5202077;C5202076
0090U	CPT	Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 23 genes (14 content and 9 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)	False	5	C5202080;C5202081
0092U	CPT	Oncology (lung), three protein biomarkers, immunoassay using magnetic nanosensor technology, plasma, algorithm reported as risk score for likelihood of malignancy	False	5	C5202086;C5202088;C5202087
0093U	CPT	Prescription drug monitoring, evaluation of 65 common drugs by LC-MS/MS, urine, each drug reported detected or not detected	False	5	C5202089;C5202090;C5414436
0094U	CPT	Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis	False	7	C5202092;C5202095;C5202093;C5202094
0095U	CPT	Eosinophilic esophagitis (Eotaxin-3 [CCL26 {C-C motif chemokine ligand 26}] and major basic protein [PRG2 {proteoglycan 2, pro eosinophil major basic protein}]), enzyme-linked immunosorbent assays (ELISA), specimen obtained by esophageal string test device, algorithm reported as probability of active or inactive eosinophilic esophagitis	False	5	C5202096;C5202097
0096U	CPT	Human papillomavirus (HPV), high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), male urine	False	5	C5202099;C5202100;C5202101
0101U	CPT	Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (15 genes [sequencing and deletion/duplication], EPCAM and GREM1 [deletion/duplication only])	False	5	C5202114;C5202115;C5414441
0102U	CPT	Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (17 genes [sequencing and deletion/duplication])	False	5	C5202117;C5202118;C5414442
0103U	CPT	Hereditary ovarian cancer (eg, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (24 genes [sequencing and deletion/duplication], EPCAM [deletion/duplication only])	False	5	C5202121;C5202120;C5414443
0105U	CPT	Nephrology (chronic kidney disease), multiplex electrochemiluminescent immunoassay (ECLIA) of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) combined with longitudinal clinical data, including APOL1 genotype if available, and plasma (isolated fresh or frozen), algorithm reported as probability score for rapid kidney function decline (RKFD)	False	8	C5414447;C5414444;C5202123;C5202124;C5414446;C5414445
0106U	CPT	Gastric emptying, serial collection of 7 timed breath specimens, non-radioisotope carbon-13 (13C) spirulina substrate, analysis of each specimen by gas isotope ratio mass spectrometry, reported as rate of 13CO2 excretion	False	5	C5202129;C5702108;C5414448
0107U	CPT	Clostridium difficile toxin(s) antigen detection by immunoassay technique, stool, qualitative, multiple-step method	False	5	C5414449;C5202132;C5202133
0108U	CPT	Gastroenterology (Barrett's esophagus), whole slide-digital imaging, including morphometric analysis, computer-assisted quantitative immunolabeling of 9 protein biomarkers (p16, AMACR, p53, CD68, COX-2, CD45RO, HIF1a, HER-2, K20) and morphology, formalin-fixed paraffin-embedded tissue, algorithm reported as risk of progression to high-grade dysplasia or cancer	False	5	C5414450;C5202135;C5202136
0109U	CPT	Infectious disease (Aspergillus species), real-time PCR for detection of DNA from 4 species (A. fumigatus, A. terreus, A. niger, and A. flavus), blood, lavage fluid, or tissue, qualitative reporting of presence or absence of each species	False	7	C5414453;C5414451;C5202139;C5202138;C5414452
0110U	CPT	Prescription drug monitoring, one or more oral oncology drug(s) and substances, definitive tandem mass spectrometry with chromatography, serum or plasma from capillary blood or venous blood, quantitative report with steady-state range for the prescribed drug(s) when detected	False	20	C5414458;C5414461;C5414466;C5414454;C5414455;C5414456;C5414467;C5414469;C5202144;C5202143;C5414460;C5414463;C5414464;C5414465;C5414468;C5414457;C5414459;C5414462
0111U	CPT	Oncology (colon cancer), targeted KRAS (codons 12, 13, and 61) and NRAS (codons 12, 13, and 61) gene analysis, utilizing formalin-fixed paraffin-embedded tissue	False	5	C5202153;C5202154;C5414470
0112U	CPT	Infectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance gene	False	5	C5202157;C5202156;C5414471
0113U	CPT	Oncology (prostate), measurement of PCA3 and TMPRSS2-ERG in urine and PSA in serum following prostatic massage, by RNA amplification and fluorescence-based detection, algorithm reported as risk score	False	5	C5202159;C5202160;C5202161
0114U	CPT	Gastroenterology (Barrett's esophagus), VIM and CCNA1 methylation analysis, esophageal cells, algorithm reported as likelihood for Barrett's esophagus	False	5	C5202162;C5202163;C5202164
0115U	CPT	Respiratory infectious agent detection by nucleic acid (DNA and RNA), 18 viral types and subtypes and 2 bacterial targets, amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected	False	5	C5202165;C5202166;C5202167
0116U	CPT	Prescription drug monitoring, enzyme immunoassay of 35 or more drugs confirmed with LC-MS/MS, oral fluid, algorithm results reported as a patient-compliance measurement with risk of drug to drug interactions for prescribed medications	False	5	C5202168;C5202169;C5414472
0117U	CPT	Pain management, analysis of 11 endogenous analytes (methylmalonic acid, xanthurenic acid, homocysteine, pyroglutamic acid, vanilmandelate, 5-hydroxyindoleacetic acid, hydroxymethylglutarate, ethylmalonate, 3-hydroxypropyl mercapturic acid (3-HPMA), quinolinic acid, kynurenic acid), LC-MS/MS, urine, algorithm reported as a pain-index score with likelihood of atypical biochemical function associated with pain	False	5	C5202171;C5202172;C5414473
0118U	CPT	Transplantation medicine, quantification of donor-derived cell-free DNA using whole genome next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA in the total cell-free DNA	False	5	C5202174;C5202175;C5202176
0119U	CPT	Cardiology, ceramides by liquid chromatography-tandem mass spectrometry, plasma, quantitative report with risk score for major cardiovascular events	False	5	C5414474;C5202177;C5202178
0120U	CPT	Oncology (B-cell lymphoma classification), mRNA, gene expression profiling by fluorescent probe hybridization of 58 genes (45 content and 13 housekeeping genes), formalin-fixed paraffin-embedded tissue, algorithm reported as likelihood for primary mediastinal B-cell lymphoma (PMBCL) and diffuse large B-cell lymphoma (DLBCL) with cell of origin subtyping in the latter	False	5	C5202180;C5202182;C5202181
0121U	CPT	Sickle cell disease, microfluidic flow adhesion (VCAM-1), whole blood	False	5	C5202183;C5202184;C5414475
0122U	CPT	Sickle cell disease, microfluidic flow adhesion (P-Selectin), whole blood	False	5	C5202188;C5202186;C5202187
0123U	CPT	Mechanical fragility, RBC, shear stress and spectral analysis profiling	False	5	C5202189;C5202190;C5414476
0129U	CPT	Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis and deletion/duplication analysis panel (ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, and TP53)	False	5	C5202207;C5202208;C5414477
0130U	CPT	Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), targeted mRNA sequence analysis panel (APC, CDH1, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, and TP53) (List separately in addition to code for primary procedure)	False	5	C5414478;C5202210;C5202211
0133U	CPT	Hereditary prostate cancer-related disorders, targeted mRNA sequence analysis panel (11 genes) (List separately in addition to code for primary procedure)	False	5	C5202220;C5202219;C5414480
0134U	CPT	Hereditary pan cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (18 genes) (List separately in addition to code for primary procedure)	False	5	C5202222;C5202223;C5414481
0136U	CPT	ATM (ataxia telangiectasia mutated) (eg, ataxia telangiectasia) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5202229;C5202228;C5202230
0137U	CPT	PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5202231;C5202232;C5414483
0138U	CPT	BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5202234;C5202235;C5414484
0140U	CPT	Infectious disease (fungi), fungal pathogen identification, DNA (15 fungal targets), blood culture, amplified probe technique, each target reported as detected or not detected	False	5	C5229224;C5414487;C5414488
0141U	CPT	Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected	False	5	C5414489;C5229225;C5414490
0142U	CPT	Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected	False	5	C5414491;C5414492;C5229226
0152U	CPT	Infectious disease (bacteria, fungi, parasites, and DNA viruses), microbial cell-free DNA, plasma, untargeted next-generation sequencing, report for significant positive pathogens	False	5	C5229235;C5698180;C5696561
0153U	CPT	Oncology (breast), mRNA, gene expression profiling by next-generation sequencing of 101 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a triple negative breast cancer clinical subtype(s) with information on immune cell involvement	False	5	C5414514;C5229236;C5414513
0154U	CPT	Oncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G], p.G370C [c.1108G>T], p.Y373C [c.1118A>G], FGFR3-TACC3v1, and FGFR3-TACC3v3), utilizing formalin-fixed paraffin-embedded urothelial cancer tumor tissue, reported as FGFR gene alteration status	False	5	C5414517;C5414515;C5414516
0155U	CPT	Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, breast cancer) gene analysis (ie, p.C420R, p.E542K, p.E545A, p.E545D [g.1635G>T only], p.E545G, p.E545K, p.Q546E, p.Q546R, p.H1047L, p.H1047R, p.H1047Y), utilizing formalin-fixed paraffin-embedded breast tumor tissue, reported as PIK3CA gene mutation status	False	5	C5414518;C5414519;C5414520
0156U	CPT	Copy number (eg, intellectual disability, dysmorphology), sequence analysis	False	5	C5229239;C5414521;C5414522
0157U	CPT	APC (APC regulator of WNT signaling pathway) (eg, familial adenomatosis polyposis [FAP]) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5414524;C5225015;C5414523
0158U	CPT	MLH1 (mutL homolog 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5414525;C5225017;C5414526
0159U	CPT	MSH2 (mutS homolog 2) (eg, hereditary colon cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5414527;C5414528;C5225018
0160U	CPT	MSH6 (mutS homolog 6) (eg, hereditary colon cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5225019;C5414529;C5414530
0161U	CPT	PMS2 (PMS1 homolog 2, mismatch repair system component) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)	False	5	C5229244;C5414532;C5414531
0162U	CPT	Hereditary colon cancer (Lynch syndrome), targeted mRNA sequence analysis panel (MLH1, MSH2, MSH6, PMS2) (List separately in addition to code for primary procedure)	False	5	C5414533;C5229245;C5414534
0163U	CPT	Oncology (colorectal) screening, biochemical enzyme-linked immunosorbent assay (ELISA) of 3 plasma or serum proteins (teratocarcinoma derived growth factor-1 [TDGF-1, Cripto-1], carcinoembryonic antigen [CEA], extracellular matrix protein [ECM]), with demographic data (age, gender, CRC-screening compliance) using a proprietary algorithm and reported as likelihood of CRC or advanced adenomas	False	5	C5414537;C5414535;C5414536
0164U	CPT	Gastroenterology (irritable bowel syndrome [IBS]), immunoassay for anti-CdtB and anti-vinculin antibodies, utilizing plasma, algorithm for elevated or not elevated qualitative results	False	5	C5414538;C5414539;C5414540
0165U	CPT	Peanut allergen-specific quantitative assessment of multiple epitopes using enzyme-linked immunosorbent assay (ELISA), blood, individual epitope results and probability of peanut allergy	False	5	C5414541;C5414542;C5414543
0166U	CPT	Liver disease, 10 biochemical assays (ä¼ª2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, GGT, ALT, AST, triglycerides, cholesterol, fasting glucose) and biometric and demographic data, utilizing serum, algorithm reported as scores for fibrosis, necroinflammatory activity, and steatosis with a summary interpretation	False	5	C5414544;C5414545;C5414546
0169U	CPT	NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants	False	5	C5414553;C5414555;C5414554
0170U	CPT	Neurology (autism spectrum disorder [ASD]), RNA, next-generation sequencing, saliva, algorithmic analysis, and results reported as predictive probability of ASD diagnosis	False	5	C5414556;C5414558;C5414557
0171U	CPT	Targeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms, DNA analysis, 23 genes, interrogation for sequence variants, rearrangements and minimal residual disease, reported as presence/absence	False	5	C5414559;C5414560;C5414561
0172U	CPT	Oncology (solid tumor as indicated by the label), somatic mutation analysis of BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) and analysis of homologous recombination deficiency pathways, DNA, formalin-fixed paraffin-embedded tissue, algorithm quantifying tumor genomic instability score	False	5	C5414562;C5414563;C5414564
0173U	CPT	Psychiatry (ie, depression, anxiety), genomic analysis panel, includes variant analysis of 14 genes	False	5	C5414566;C5414567;C5414565
0174T	CPT	Computer-aided detection (CAD) (computer algorithm analysis of digital image data for lesion detection) with further physician review for interpretation and report, with or without digitization of film radiographic images, chest radiograph(s), performed concurrent with primary interpretation (List separately in addition to code for primary procedure)	False	4	C1742232;C3517548
0174U	CPT	Oncology (solid tumor), mass spectrometric 30 protein targets, formalin-fixed paraffin-embedded tissue, prognostic and predictive algorithm reported as likely, unlikely, or uncertain benefit of 39 chemotherapy and targeted therapeutic oncology agents	False	5	C5414568;C5414569;C5414570
0175T	CPT	Computer-aided detection (CAD) (computer algorithm analysis of digital image data for lesion detection) with further physician review for interpretation and report, with or without digitization of film radiographic images, chest radiograph(s), performed remote from primary interpretation	False	4	C1741964;C3517549
0175U	CPT	Psychiatry (eg, depression, anxiety), genomic analysis panel, variant analysis of 15 genes	False	5	C5414571;C5414572;C5414573
0176U	CPT	Cytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)	False	6	C5414574;C5202063;C5202064;C5202061
0177U	CPT	Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) gene analysis of 11 gene variants utilizing plasma, reported as PIK3CA gene mutation status	False	5	C5414577;C5414575;C5414576
0178U	CPT	Peanut allergen-specific quantitative assessment of multiple epitopes using enzyme-linked immunosorbent assay (ELISA), blood, report of minimum eliciting exposure for a clinical reaction	False	5	C5414580;C5414578;C5414579
0179U	CPT	Oncology (non-small cell lung cancer), cell-free DNA, targeted sequence analysis of 23 genes (single nucleotide variations, insertions and deletions, fusions without prior knowledge of partner/breakpoint, copy number variations), with report of significant mutation(s)	False	5	C5414582;C5414581;C5414583
0180U	CPT	Red cell antigen (ABO blood group) genotyping (ABO), gene analysis Sanger/chain termination/conventional sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene, including subtyping, 7 exons	False	5	C5414586;C5414584;C5414585
0181U	CPT	Red cell antigen (Colton blood group) genotyping (CO), gene analysis, AQP1 (aquaporin 1 [Colton blood group]) exon 1	False	5	C5414587;C5414588;C5414589
0182U	CPT	Red cell antigen (Cromer blood group) genotyping (CROM), gene analysis, CD55 (CD55 molecule [Cromer blood group]) exons 1-10	False	5	C5414590;C5414591;C5414592
0183U	CPT	Red cell antigen (Diego blood group) genotyping (DI), gene analysis, SLC4A1 (solute carrier family 4 member 1 [Diego blood group]) exon 19	False	5	C5414593;C5414594;C5414595
0184U	CPT	Red cell antigen (Dombrock blood group) genotyping (DO), gene analysis, ART4 (ADP-ribosyltransferase 4 [Dombrock blood group]) exon 2	False	5	C5414596;C5414598;C5414597
0185U	CPT	Red cell antigen (H blood group) genotyping (FUT1), gene analysis, FUT1 (fucosyltransferase 1 [H blood group]) exon 4	False	5	C5414599;C5414600;C5414601
0186U	CPT	Red cell antigen (H blood group) genotyping (FUT2), gene analysis, FUT2 (fucosyltransferase 2) exon 2	False	5	C5414602;C5414603;C5414604
0187U	CPT	Red cell antigen (Duffy blood group) genotyping (FY), gene analysis, ACKR1 (atypical chemokine receptor 1 [Duffy blood group]) exons 1-2	False	5	C5414605;C5414606;C5414607
0188U	CPT	Red cell antigen (Gerbich blood group) genotyping (GE), gene analysis, GYPC (glycophorin C [Gerbich blood group]) exons 1-4	False	5	C5414610;C5414609;C5414608
0189U	CPT	Red cell antigen (MNS blood group) genotyping (GYPA), gene analysis, GYPA (glycophorin A [MNS blood group]) introns 1, 5, exon 2	False	5	C5414612;C5414613;C5414611
0190U	CPT	Red cell antigen (MNS blood group) genotyping (GYPB), gene analysis, GYPB (glycophorin B [MNS blood group]) introns 1, 5, pseudoexon 3	False	5	C5414614;C5414616;C5414615
0191U	CPT	Red cell antigen (Indian blood group) genotyping (IN), gene analysis, CD44 (CD44 molecule [Indian blood group]) exons 2, 3, 6	False	5	C5414618;C5414619;C5414617
0192U	CPT	Red cell antigen (Kidd blood group) genotyping (JK), gene analysis, SLC14A1 (solute carrier family 14 member 1 [Kidd blood group]) gene promoter, exon 9	False	5	C5414620;C5414622;C5414621
0193U	CPT	Red cell antigen (JR blood group) genotyping (JR), gene analysis, ABCG2 (ATP binding cassette subfamily G member 2 [Junior blood group]) exons 2-26	False	5	C5414625;C5414623;C5414624
0194U	CPT	Red cell antigen (Kell blood group) genotyping (KEL), gene analysis, KEL (Kell metallo-endopeptidase [Kell blood group]) exon 8	False	5	C5414627;C5414626;C5414628
0195U	CPT	KLF1 (Kruppel-like factor 1), targeted sequencing (ie, exon 13)	False	6	C5414632;C5414629;C5414630;C5414631
0196U	CPT	Red cell antigen (Lutheran blood group) genotyping (LU), gene analysis, BCAM (basal cell adhesion molecule [Lutheran blood group]) exon 3	False	5	C5414633;C5414635;C5414634
0197U	CPT	Red cell antigen (Landsteiner-Wiener blood group) genotyping (LW), gene analysis, ICAM4 (intercellular adhesion molecule 4 [Landsteiner-Wiener blood group]) exon 1	False	5	C5414637;C5414636;C5414638
0198U	CPT	Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis Sanger/chain termination/conventional sequencing, RHD (Rh blood group D antigen) exons 1-10 and RHCE (Rh blood group CcEe antigens) exon 5	False	5	C5414639;C5414641;C5414640
0199U	CPT	Red cell antigen (Scianna blood group) genotyping (SC), gene analysis, ERMAP (erythroblast membrane associated protein [Scianna blood group]) exons 4, 12	False	5	C5414642;C5414643;C5414644
0200U	CPT	Red cell antigen (Kx blood group) genotyping (XK), gene analysis, XK (X-linked Kx blood group) exons 1-3	False	5	C5414645;C5414646;C5414647
0201U	CPT	Red cell antigen (Yt blood group) genotyping (YT), gene analysis, ACHE (acetylcholinesterase [Cartwright blood group]) exon 2	False	5	C5414650;C5414649;C5414648
0202U	CPT	Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected	False	5	C5414652;C5400851;C5414651
0203U	CPT	Autoimmune (inflammatory bowel disease), mRNA, gene expression profiling by quantitative RT-PCR, 17 genes (15 target and 2 reference genes), whole blood, reported as a continuous risk score and classification of inflammatory bowel disease aggressiveness	False	5	C5414655;C5414653;C5414654
0205U	CPT	Ophthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using PCR and MALDI-TOF, buccal swab, reported as positive or negative for neovascular age-related macular-degeneration risk associated with zinc supplements	False	5	C5414660;C5414661;C5414659
0206U	CPT	Neurology (Alzheimer disease); cell aggregation using morphometric imaging and protein kinase C-epsilon (PKCe) concentration in response to amylospheroid treatment by ELISA, cultured skin fibroblasts, each reported as positive or negative for Alzheimer disease	False	5	C5414662;C5414663;C5414664
0207U	CPT	Neurology (Alzheimer disease); quantitative imaging of phosphorylated ERK1 and ERK2 in response to bradykinin treatment by in situ immunofluorescence, using cultured skin fibroblasts, reported as a probability index for Alzheimer disease (List separately in addition to code for primary procedure)	False	5	C5414665;C5414666;C5414667
0209U	CPT	Cytogenomic constitutional (genome-wide) analysis, interrogation of genomic regions for copy number, structural changes and areas of homozygosity for chromosomal abnormalities	False	5	C5414671;C5414672;C5414673
0210U	CPT	Syphilis test, non-treponemal antibody, immunoassay, quantitative (RPR)	False	5	C5414674;C5414676;C5414675
0211U	CPT	Oncology (pan-tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association	False	5	C5414677;C5414678;C5414679
0212U	CPT	Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband	False	6	C5414680;C5414683;C5414681;C5414682
0213U	CPT	Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent, sibling)	False	8	C5414689;C5414685;C5414686;C5414684;C5414688;C5414687
0214U	CPT	Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband	False	6	C5414690;C5414692;C5414691;C5414693
0215U	CPT	Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator exome (eg, parent, sibling)	False	8	C5414699;C5414696;C5414694;C5414697;C5414698;C5414695
0216U	CPT	Neurology (inherited ataxias), genomic DNA sequence analysis of 12 common genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants	False	6	C5414700;C5414702;C5414703;C5414701
0217U	CPT	Neurology (inherited ataxias), genomic DNA sequence analysis of 51 genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants	False	6	C5414704;C5414705;C5414707;C5414706
0218U	CPT	Neurology (muscular dystrophy), DMD gene sequence analysis, including small sequence changes, deletions, duplications, and variants in non-uniquely mappable regions, blood or saliva, identification and characterization of genetic variants	False	6	C5414708;C5414711;C5414710;C5414709
0219U	CPT	Infectious agent (human immunodeficiency virus), targeted viral next-generation sequence analysis (ie, protease [PR], reverse transcriptase [RT], integrase [INT]), algorithm reported as prediction of antiviral drug susceptibility	False	5	C5414712;C5414714;C5414713
0220U	CPT	Oncology (breast cancer), image analysis with artificial intelligence assessment of 12 histologic and immunohistochemical features, reported as a recurrence score	False	5	C5414715;C5414717;C5414716
0221U	CPT	Red cell antigen (ABO blood group) genotyping (ABO), gene analysis, next-generation sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene	False	5	C5414718;C5414719;C5414720
0222U	CPT	Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis, next-generation sequencing, RH proximal promoter, exons 1-10, portions of introns 2-3	False	5	C5414722;C5414721;C5414723
0223U	CPT	Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected	False	5	C5414651;C5400850;C5414724
0224U	CPT	Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), includes titer(s), when performed	False	7	C5414727;C5413657;C5414725;C5414726
0225U	CPT	Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected	False	5	C5414728;C5414729;C5414730
0226U	CPT	Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), ELISA, plasma, serum	False	6	C5414731;C5414733;C5414734;C5414732
0227U	CPT	Drug assay, presumptive, 30 or more drugs or metabolites, urine, liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring (MRM), with drug or metabolite description, includes sample validation	False	5	C5439855;C5698181;C5696562
0228U	CPT	Oncology (prostate), multianalyte molecular profile by photometric detection of macromolecules adsorbed on nanosponge array slides with machine learning, utilizing first morning voided urine, algorithm reported as likelihood of prostate cancer	False	5	C5439856;C5698182;C5696563
0229U	CPT	BCAT1 (Branched chain amino acid transaminase 1) and IKZF1 (IKAROS family zinc finger 1) (eg, colorectal cancer) promoter methylation analysis	False	5	C5439857
0230U	CPT	AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation), full sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5439858;C5696565;C5698184
0231U	CPT	CACNA1A (calcium voltage-gated channel subunit alpha 1A) (eg, spinocerebellar ataxia), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) gene expansions, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5439859;C5696566;C5698185
0232U	CPT	CSTB (cystatin B) (eg, progressive myoclonic epilepsy type 1A, Unverricht-Lundborg disease), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5439860;C5696567;C5698186
0233U	CPT	FXN (frataxin) (eg, Friedreich ataxia), gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5575053;C5696568;C5698187
0234U	CPT	MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5696569;C5439861;C5698188
0235U	CPT	PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5439862;C5698189;C5696570
0236U	CPT	SMN1 (survival of motor neuron 1, telomeric) and SMN2 (survival of motor neuron 2, centromeric) (eg, spinal muscular atrophy) full gene analysis, including small sequence changes in exonic and intronic regions, duplications, deletions, and mobile element insertions	False	5	C5696571;C5439863;C5698190
0237U	CPT	Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia), genomic sequence analysis panel including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5696572;C5439864;C5698191
0238U	CPT	Oncology (Lynch syndrome), genomic DNA sequence analysis of MLH1, MSH2, MSH6, PMS2, and EPCAM, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions	False	5	C5696573;C5439865;C5698192
0239U	CPT	Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations	False	5	C5439866;C5696574;C5698193
0242U	CPT	Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 55-74 genes, interrogation for sequence variants, gene copy number amplifications, and gene rearrangements	False	5	C5696577;C5691504;C5698196
0243U	CPT	Obstetrics (preeclampsia), biochemical assay of placental-growth factor, time-resolved fluorescence immunoassay, maternal serum, predictive algorithm reported as a risk score for preeclampsia	False	5	C5691505;C5696578;C5698197
0244U	CPT	Oncology (solid organ), DNA, comprehensive genomic profiling, 257 genes, interrogation for single-nucleotide variants, insertions/deletions, copy number alterations, gene rearrangements, tumor-mutational burden and microsatellite instability, utilizing formalin-fixed paraffin-embedded tumor tissue	False	5	C5696579;C5691506;C5698198
0245U	CPT	Oncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes associated risk of malignancy expressed as a percentage	False	5	C5691507;C5696580;C5698199
0246U	CPT	Red blood cell antigen typing, DNA, genotyping of at least 16 blood groups with phenotype prediction of at least 51 red blood cell antigens	False	5	C5698200;C5691508;C5696581
0247U	CPT	Obstetrics (preterm birth), insulin-like growth factor-binding protein 4 (IBP4), sex hormone-binding globulin (SHBG), quantitative measurement by LC-MS/MS, utilizing maternal serum, combined with clinical data, reported as predictive-risk stratification for spontaneous preterm birth	False	5	C5696582;C5698201;C5691509
0248U	CPT	Oncology, spheroid cell culture in 3D microenvironment, 12-drug panel, brain- or brain metastasis-response prediction for each drug	False	6	C5691510;C5944586;C5696583;C5944587
0249U	CPT	Oncology (breast), semiquantitative analysis of 32 phosphoproteins and protein analytes, includes laser capture microdissection, with algorithmic analysis and interpretative report	False	5	C5696584;C5691511;C5698203
0250U	CPT	Oncology (solid organ neoplasm), targeted genomic sequence DNA analysis of 505 genes, interrogation for somatic alterations (SNVs [single nucleotide variant], small insertions and deletions, one amplification, and four translocations), microsatellite instability and tumor-mutation burden	False	5	C5691512;C5696585;C5698204
0251U	CPT	Hepcidin-25, enzyme-linked immunosorbent assay (ELISA), serum or plasma	False	6	C5541207;C5696586;C5698205;C5698206
0252U	CPT	Fetal aneuploidy short tandem-repeat comparative analysis, fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy	False	5	C5698207;C5691513;C5696587
0253U	CPT	Reproductive medicine (endometrial receptivity analysis), RNA gene expression profile, 238 genes by next-generation sequencing, endometrial tissue, predictive algorithm reported as endometrial window of implantation (eg, pre-receptive, receptive, post-receptive)	False	5	C5696588;C5698208;C5691514
0254U	CPT	Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using embryonic DNA genomic sequence analysis for aneuploidy, and a mitochondrial DNA score in euploid embryos, results reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy, per embryo tested	False	5	C5691515;C5698209;C5696589
0255U	CPT	Andrology (infertility), sperm-capacitation assessment of ganglioside GM1 distribution patterns, fluorescence microscopy, fresh or frozen specimen, reported as percentage of capacitated sperm and probability of generating a pregnancy score	False	6	C5698211;C5691516;C5696590;C5698210
0256U	CPT	Trimethylamine/trimethylamine N-oxide (TMA/TMAO) profile, tandem mass spectrometry (MS/MS), urine, with algorithmic analysis and interpretive report	False	5	C5696591;C5698212;C5691517
0257U	CPT	Very long chain acyl-coenzyme A (CoA) dehydrogenase (VLCAD), leukocyte enzyme activity, whole blood	False	5	C5696592;C5691518;C5698213
0258U	CPT	Autoimmune (psoriasis), mRNA, next-generation sequencing, gene expression profiling of 50-100 genes, skin-surface collection using adhesive patch, algorithm reported as likelihood of response to psoriasis biologics	False	5	C5698214;C5691519;C5696593
0259U	CPT	Nephrology (chronic kidney disease), nuclear magnetic resonance spectroscopy measurement of myo-inositol, valine, and creatinine, algorithmically combined with cystatin C (by immunoassay) and demographic data to determine estimated glomerular filtration rate (GFR), serum, quantitative	False	5	C5698215;C5691520;C5696594
0260U	CPT	Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping	False	5	C5970180;C5696595;C5698216
0261U	CPT	Oncology (colorectal cancer), image analysis with artificial intelligence assessment of 4 histologic and immunohistochemical features (CD3 and CD8 within tumor-stroma border and tumor core), tissue, reported as immune response and recurrence-risk score	False	5	C5698217;C5691521;C5696596
0262U	CPT	Oncology (solid tumor), gene expression profiling by real-time RT-PCR of 7 gene pathways (ER, AR, PI3K, MAPK, HH, TGFB, Notch), formalin-fixed paraffin-embedded (FFPE), algorithm reported as gene pathway activity score	False	5	C5698218;C5691522;C5696597
0263U	CPT	Neurology (autism spectrum disorder [ASD]), quantitative measurements of 16 central carbon metabolites (ie, ä¼ª-ketoglutarate, alanine, lactate, phenylalanine, pyruvate, succinate, carnitine, citrate, fumarate, hypoxanthine, inosine, malate, S-sulfocysteine, taurine, urate, and xanthine), liquid chromatography tandem mass spectrometry (LC-MS/MS), plasma, algorithmic analysis with result reported as negative or positive (with metabolic subtypes of ASD)	False	5	C5691523;C5696598;C5698219
0264U	CPT	Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping	False	5	C5696595;C5698220;C5671325
0265U	CPT	Rare constitutional and other heritable disorders, whole genome and mitochondrial DNA sequence analysis, blood, frozen and formalin-fixed paraffin-embedded (FFPE) tissue, saliva, buccal swabs or cell lines, identification of single nucleotide and copy number variants	False	9	C5698222;C5698225;C5691524;C5696599;C5698221;C5698223;C5698224
0266U	CPT	Unexplained constitutional or other heritable disorders or syndromes, tissue-specific gene expression by whole-transcriptome and next-generation sequencing, blood, formalin-fixed paraffin-embedded (FFPE) tissue or fresh frozen tissue, reported as presence or absence of splicing or expression changes	False	7	C5691525;C5696600;C5698227;C5698228;C5698226
0267U	CPT	Rare constitutional and other heritable disorders, identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping and whole genome sequencing	False	5	C5691526;C5696601;C5698229
0268U	CPT	Hematology (atypical hemolytic uremic syndrome [aHUS]), genomic sequence analysis of 15 genes, blood, buccal swab, or amniotic fluid	False	7	C5691527;C5696602;C5698230;C5698231;C5698232
0269U	CPT	Hematology (autosomal dominant congenital thrombocytopenia), genomic sequence analysis of 22 genes, blood, buccal swab, or amniotic fluid	False	7	C5851834;C5851837;C5851836;C5851835;C5691528
0270U	CPT	Hematology (congenital coagulation disorders), genomic sequence analysis of 20 genes, blood, buccal swab, or amniotic fluid	False	7	C5698238;C5691529;C5696604;C5698237;C5698236
0271U	CPT	Hematology (congenital neutropenia), genomic sequence analysis of 24 genes, blood, buccal swab, or amniotic fluid	False	7	C5851838;C5851839;C5851841;C5851840;C5691530
0272U	CPT	Hematology (genetic bleeding disorders), genomic sequence analysis of 60 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid, comprehensive	False	20	C5851843;C5851844;C5851852;C5851856;C5851842;C5851849;C5851851;C5851853;C5851847;C5851854;C5851857;C5851845;C5851846;C5851848;C5851850;C5851855;C5691531
0273U	CPT	Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2 by next-generation sequencing, and PLAU by array comparative genomic hybridization), blood, buccal swab, or amniotic fluid	False	7	C5691532;C5698247;C5698245;C5698246
0274U	CPT	Hematology (genetic platelet disorders), genomic sequence analysis of 62 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid	False	20	C5851867;C5851872;C5851874;C5851860;C5851861;C5851873;C5851858;C5851859;C5851863;C5851864;C5851868;C5851870;C5851862;C5851865;C5851866;C5851869;C5851871;C5691533
0275U	CPT	Hematology (heparin-induced thrombocytopenia), platelet antibody reactivity by flow cytometry, serum	False	5	C5696609;C5691534;C5698251
0276U	CPT	Hematology (inherited thrombocytopenia), genomic sequence analysis of 42 genes, blood, buccal swab, or amniotic fluid	False	7	C5702110;C5691535;C5702111;C5702112;C5702109
0277U	CPT	Hematology (genetic platelet function disorder), genomic sequence analysis of 40 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid	False	31	C5851877;C5851879;C5851880;C5851883;C5851885;C5851886;C5851887;C5851890;C5851893;C5851898;C5851899;C5851900;C5851878;C5851889;C5851896;C5851884;C5851891;C5851894;C5851875;C5851881;C5851882;C5851888;C5851895;C5851876;C5851892
0278U	CPT	Hematology (genetic thrombosis), genomic sequence analysis of 14 genes, blood, buccal swab, or amniotic fluid	False	8	C5691537;C5851901;C5851903;C5851904;C5851902
0279U	CPT	Hematology (von Willebrand disease [VWD]), von Willebrand factor (VWF) and collagen III binding by enzyme-linked immunosorbent assays (ELISA), plasma, report of collagen III binding	False	5	C5691538;C5696613;C5698261
0280U	CPT	Hematology (von Willebrand disease [VWD]), von Willebrand factor (VWF) and collagen IV binding by enzyme-linked immunosorbent assays (ELISA), plasma, report of collagen IV binding	False	5	C5691539;C5696614;C5698262
0281U	CPT	Hematology (von Willebrand disease [VWD]), von Willebrand propeptide, enzyme-linked immunosorbent assays (ELISA), plasma, diagnostic report of von Willebrand factor (VWF) propeptide antigen level	False	5	C5691540;C5698263;C5696615
0282U	CPT	Red blood cell antigen typing, DNA, genotyping of 12 blood group system genes to predict 44 red blood cell antigen phenotypes	False	5	C5691541;C5696616;C5698264
0283U	CPT	von Willebrand factor (VWF), type 2B, platelet-binding evaluation, radioimmunoassay, plasma	False	5	C5696617;C5698265;C5691542
0284U	CPT	von Willebrand factor (VWF), type 2N, factor VIII and VWF binding evaluation, enzyme-linked immunosorbent assays (ELISA), plasma	False	5	C5691543;C5696618;C5698266
0285U	CPT	Oncology, response to radiation, cell-free DNA, quantitative branched chain DNA amplification, plasma, reported as a radiation toxicity score	False	5	C5702113;C5702114
0286U	CPT	CEP72 (centrosomal protein, 72-KDa), NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants	False	5	C5702115
0287U	CPT	Oncology (thyroid), DNA and mRNA, next-generation sequencing analysis of 112 genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithmic prediction of cancer recurrence, reported as a categorical risk result (low, intermediate, high)	False	6	C5702116;C5702117;C5702118;C5702119
0288U	CPT	Oncology (lung), mRNA, quantitative PCR analysis of 11 genes (BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, WNT3A) and 3 reference genes (ESD, TBP, YAP1), formalin-fixed paraffin-embedded (FFPE) tumor tissue, algorithmic interpretation reported as a recurrence risk score	False	5	C5702120;C5702121
0289U	CPT	Neurology (Alzheimer disease), mRNA, gene expression profiling by RNA sequencing of 24 genes, whole blood, algorithm reported as predictive risk score	False	5	C5702122
0290U	CPT	Pain management, mRNA, gene expression profiling by RNA sequencing of 36 genes, whole blood, algorithm reported as predictive risk score	False	5	C5702123
0291U	CPT	Psychiatry (mood disorders), mRNA, gene expression profiling by RNA sequencing of 144 genes, whole blood, algorithm reported as predictive risk score	False	5	C5702124
0292U	CPT	Psychiatry (stress disorders), mRNA, gene expression profiling by RNA sequencing of 72 genes, whole blood, algorithm reported as predictive risk score	False	5	C5702125
0293U	CPT	Psychiatry (suicidal ideation), mRNA, gene expression profiling by RNA sequencing of 54 genes, whole blood, algorithm reported as predictive risk score	False	5	C5702126
0294U	CPT	Longevity and mortality risk, mRNA, gene expression profiling by RNA sequencing of 18 genes, whole blood, algorithm reported as predictive risk score	False	5	C5702127;C5702128
0295U	CPT	Oncology (breast ductal carcinoma in situ), protein expression profiling by immunohistochemistry of 7 proteins (COX2, FOXA1, HER2, Ki-67, p16, PR, SIAH2), with 4 clinicopathologic factors (size, age, margin status, palpability), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a recurrence risk score	False	5	C5702130;C5702129
0296U	CPT	Oncology (oral and/or oropharyngeal cancer), gene expression profiling by RNA sequencing of at least 20 molecular features (eg, human and/or microbial mRNA), saliva, algorithm reported as positive or negative for signature associated with malignancy	False	5	C5702131;C5702132
0297U	CPT	Oncology (pan tumor), whole genome sequencing of paired malignant and normal DNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and variant identification	False	8	C5702135;C5702137;C5702138;C5702133;C5702134;C5702136
0298U	CPT	Oncology (pan tumor), whole transcriptome sequencing of paired malignant and normal RNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and expression level and chimeric transcript identification	False	8	C5702139;C5702141;C5702140;C5702144;C5702142;C5702143
0299U	CPT	Oncology (pan tumor), whole genome optical genome mapping of paired malignant and normal DNA specimens, fresh frozen tissue, blood, or bone marrow, comparative structural variant identification	False	7	C5702146;C5702147;C5702148;C5702149;C5702145
0300U	CPT	Oncology (pan tumor), whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens, fresh tissue, blood, or bone marrow, comparative sequence analyses and variant identification	False	7	C5702152;C5702153;C5702150;C5702151
0301U	CPT	Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR)	False	5	C5702154;C5702155
0302U	CPT	Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR); following liquid enrichment	False	5	C5702156;C5702157
0303U	CPT	Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood, with algorithmic analysis and result reported as an RBC adhesion index; hypoxic	False	6	C5702159;C5702161;C5702160
0304U	CPT	Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood, with algorithmic analysis and result reported as an RBC adhesion index; normoxic	False	6	C5702162;C5702164;C5702163
0305U	CPT	Hematology, red blood cell (RBC) functionality and deformity as a function of shear stress, whole blood, reported as a maximum elongation index	False	5	C5702165
0306U	CPT	Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient-specific panel for future comparisons to evaluate for MRD	False	5	C5702166
0307U	CPT	Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis of a patient-specific panel, cell-free DNA, subsequent assessment with comparison to previously analyzed patient specimens to evaluate for MRD	False	5	C5702167
0308U	CPT	Cardiology (coronary artery disease [CAD]), analysis of 3 proteins (high sensitivity [hs] troponin, adiponectin, and kidney injury molecule-1 [KIM-1]) with 3 clinical parameters (age, sex, history of cardiac intervention), plasma, algorithm reported as a risk score for obstructive CAD	False	5	C5702168;C5851905
0309U	CPT	Cardiology (cardiovascular disease), analysis of 4 proteins (NT-proBNP, osteopontin, tissue inhibitor of metalloproteinase-1 [TIMP-1], and kidney injury molecule-1 [KIM-1]), plasma, algorithm reported as a risk score for major adverse cardiac event	False	5	C5702169
0310U	CPT	Pediatrics (vasculitis, Kawasaki disease [KD]), analysis of 3 biomarkers (NT-proBNP, C-reactive protein, and T-uptake), plasma, algorithm reported as a risk score for KD	False	5	C5702170;C5702171
0311U	CPT	Infectious disease (bacterial), quantitative antimicrobial susceptibility reported as phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility for each organism identified	False	5	C5702172
0312U	CPT	Autoimmune diseases (eg, systemic lupus erythematosus [SLE]), analysis of 8 IgG autoantibodies and 2 cell-bound complement activation products using enzyme-linked immunosorbent immunoassay (ELISA), flow cytometry and indirect immunofluorescence, serum, or plasma and whole blood, individual components reported along with an algorithmic SLE-likelihood assessment	False	6	C5702173;C5702175;C5702174
0313U	CPT	Oncology (pancreas), DNA and mRNA next-generation sequencing analysis of 74 genes and analysis of CEA (CEACAM5) gene expression, pancreatic cyst fluid, algorithm reported as a categorical result (ie, negative, low probability of neoplasia or positive, high probability of neoplasia)	False	5	C5702176
0314U	CPT	Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 35 genes (32 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)	False	5	C5702178;C5702177
0315U	CPT	Oncology (cutaneous squamous cell carcinoma), mRNA gene expression profiling by RT-PCR of 40 genes (34 content and 6 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical risk result (ie, Class 1, Class 2A, Class 2B)	False	5	C5702179
0316U	CPT	Borrelia burgdorferi (Lyme disease), OspA protein evaluation, urine	False	5	C5702180
0317U	CPT	Oncology (lung cancer), four-probe FISH (3q29, 3p22.1, 10q22.3, 10cen) assay, whole blood, predictive algorithm-generated evaluation reported as decreased or increased risk for lung cancer	False	5	C5702181
0318U	CPT	Pediatrics (congenital epigenetic disorders), whole genome methylation analysis by microarray for 50 or more genes, blood	False	5	C5702183;C5702182
0319U	CPT	Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using pretransplant peripheral blood, algorithm reported as a risk score for early acute rejection	False	5	C5702184
0320U	CPT	Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using posttransplant peripheral blood, algorithm reported as a risk score for acute cellular rejection	False	5	C5702185
0321U	CPT	Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique	False	6	C5702186;C5702187
0322U	CPT	Neurology (autism spectrum disorder [ASD]), quantitative measurements of 14 acyl carnitines and microbiome-derived metabolites, liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma, results reported as negative or positive for risk of metabolic subtypes associated with ASD	False	5	C5702188
0323U	CPT	Infectious agent detection by nucleic acid (DNA and RNA), central nervous system pathogen, metagenomic next-generation sequencing, cerebrospinal fluid (CSF), identification of pathogenic bacteria, viruses, parasites, or fungi	False	8	C5702193;C5702190;C5702189;C5702191;C5702192
0326U	CPT	Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 83 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden	False	5	C5702196;C5702197
0327U	CPT	Fetal aneuploidy (trisomy 13, 18, and 21), DNA sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy, includes sex reporting, if performed	False	6	C5702198;C5702200;C5702199
0328U	CPT	Drug assay, definitive, 120 or more drugs and metabolites, urine, quantitative liquid chromatography with tandem mass spectrometry (LC-MS/MS), includes specimen validity and algorithmic analysis describing drug or metabolite and presence or absence of risks for a significant patient-adverse event, per date of service	False	5	C5702202;C5702201
0329U	CPT	Oncology (neoplasia), exome and transcriptome sequence analysis for sequence variants, gene copy number amplifications and deletions, gene rearrangements, microsatellite instability and tumor mutational burden utilizing DNA and RNA from tumor with DNA from normal blood or saliva for subtraction, report of clinically significant mutation(s) with therapy associations	False	6	C5702204;C5702205;C5702203;C5702206
0330T	CPT	Tear film imaging, unilateral or bilateral, with interpretation and report	False	4	C3704187;C3702532
0330U	CPT	Infectious agent detection by nucleic acid (DNA or RNA), vaginal pathogen panel, identification of 27 organisms, amplified probe technique, vaginal swab	False	5	C5702207;C5702208
0331T	CPT	Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment	False	4	C3704188;C3702533
0331U	CPT	Oncology (hematolymphoid neoplasia), optical genome mapping for copy number alterations and gene rearrangements utilizing DNA from blood or bone marrow, report of clinically significant alterations	False	6	C5702209;C5702212;C5702211;C5702210
0332T	CPT	Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment; with tomographic SPECT	False	4	C3704189;C3702534
0332U	CPT	Oncology (pan-tumor), genetic profiling of 8 DNA-regulatory (epigenetic) markers by quantitative polymerase chain reaction (qPCR), whole blood, reported as a high or low probability of responding to immune checkpoint-inhibitor therapy	False	5	C5702213;C5702214
0333U	CPT	Oncology (liver), surveillance for hepatocellular carcinoma (HCC) in high-risk patients, analysis of methylation patterns on circulating cell-free DNA (cfDNA) plus measurement of serum of AFP/AFP-L3 and oncoprotein des-gamma-carboxy-prothrombin (DCP), algorithm reported as normal or abnormal result	False	5	C5702215;C5702216
0334U	CPT	Oncology (solid organ), targeted genomic sequence analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis, 84 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden	False	5	C5702217;C5702218
0335U	CPT	Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, fetal sample, identification and categorization of genetic variants	False	5	C5702219
0336U	CPT	Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent)	False	8	C5702223;C5702224;C5702220;C5702222;C5702225;C5702221
0337U	CPT	Oncology (plasma cell disorders and myeloma), circulating plasma cell immunologic selection, identification, morphological characterization, and enumeration of plasma cells based on differential CD138, CD38, CD19, and CD45 protein biomarker expression, peripheral blood	False	5	C5702226;C5702227
0338U	CPT	Oncology (solid tumor), circulating tumor cell selection, identification, morphological characterization, detection and enumeration based on differential EpCAM, cytokeratins 8, 18, and 19, and CD45 protein biomarkers, and quantification of HER2 protein biomarker-expressing cells, peripheral blood	False	5	C5702228;C5702229
0339U	CPT	Oncology (prostate), mRNA expression profiling of HOXC6 and DLX1, reverse transcription polymerase chain reaction (RT-PCR), first-void urine following digital rectal examination, algorithm reported as probability of high-grade cancer	False	5	C5702230;C5702231
0340U	CPT	Oncology (pan-cancer), analysis of minimal residual disease (MRD) from plasma, with assays personalized to each patient based on prior next-generation sequencing of the patient's tumor and germline DNA, reported as absence or presence of MRD, with disease-burden correlation, if appropriate	False	6	C5702232;C5702233;C5702234
0341U	CPT	Fetal aneuploidy DNA sequencing comparative analysis, fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploid	False	5	C5702235;C5702236
0342U	CPT	Oncology (pancreatic cancer), multiplex immunoassay of C5, C4, cystatin C, factor B, osteoprotegerin (OPG), gelsolin, IGFBP3, CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9, serum, diagnostic algorithm reported qualitatively as positive, negative, or borderline	False	5	C5702238;C5702237
0343U	CPT	Oncology (prostate), exosome-based analysis of 442 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as molecular evidence of no-, low-, intermediate- or high-risk of prostate cancer	False	5	C5702239;C5702240
0344U	CPT	Hepatology (nonalcoholic fatty liver disease [NAFLD]), semiquantitative evaluation of 28 lipid markers by liquid chromatography with tandem mass spectrometry (LC-MS/MS), serum, reported as at-risk for nonalcoholic steatohepatitis (NASH) or not NASH	False	5	C5702242;C5702241
0345U	CPT	Psychiatry (eg, depression, anxiety, attention deficit hyperactivity disorder [ADHD]), genomic analysis panel, variant analysis of 15 genes, including deletion/duplication analysis of CYP2D6	False	5	C5702243;C5702245;C5702244
0347U	CPT	Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 16 gene report, with variant analysis and reported phenotypes	False	6	C5702247;C5702250;C5702248;C5702249
0348U	CPT	Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 25 gene report, with variant analysis and reported phenotypes	False	6	C5702251;C5702253;C5702254;C5702252
0349U	CPT	Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 27 gene report, with variant analysis, including reported phenotypes and impacted gene-drug interactions	False	6	C5702255;C5702257;C5702256;C5702258
0350U	CPT	Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 27 gene report, with variant analysis and reported phenotypes	False	6	C5702259;C5702261;C5702260;C5702262
0351U	CPT	Infectious disease (bacterial or viral), biochemical assays, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), interferon gamma-induced protein-10 (IP-10), and C-reactive protein, serum, or venous whole blood, algorithm reported as likelihood of bacterial infection	False	5	C5702264;C5702265;C5702263
0355U	CPT	APOL1 (apolipoprotein L1) (eg, chronic kidney disease), risk variants (G1, G2)	False	6	C5702960
0356U	CPT	Oncology (oropharyngeal or anal), evaluation of 17 DNA biomarkers using droplet digital PCR (ddPCR), cell-free DNA, algorithm reported as a prognostic risk score for cancer recurrence	False	5	C5944589;C5771752;C5944588
0358U	CPT	Neurology (mild cognitive impairment), analysis of å°¾-amyloid 1-42 and 1-40, chemiluminescence enzyme immunoassay, cerebral spinal fluid, reported as positive, likely positive, or negative	False	5	C5771754;C5851907
0359U	CPT	Oncology (prostate cancer), analysis of all prostate-specific antigen (PSA) structural isoforms by phase separation and immunoassay, plasma, algorithm reports risk of cancer	False	5	C5771755;C5851908
0360U	CPT	Oncology (lung), enzyme-linked immunosorbent assay (ELISA) of 7 autoantibodies (p53, NY-ESO-1, CAGE, GBU4-5, SOX2, MAGE A4, and HuD), plasma, algorithm reported as a categorical result for risk of malignancy	False	5	C5771756;C5851909
0362U	CPT	Oncology (papillary thyroid cancer), gene-expression profiling via targeted hybrid capture-enrichment RNA sequencing of 82 content genes and 10 housekeeping genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as one of three molecular subtypes	False	7	C5771758;C5851911;C5851912;C5851910
0363U	CPT	Oncology (urothelial), mRNA, gene-expression profiling by real-time quantitative PCR of 5 genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm incorporates age, sex, smoking history, and macrohematuria frequency, reported as a risk score for having urothelial carcinoma	False	5	C5771759;C5851913
0364U	CPT	Oncology (hematolymphoid neoplasm), genomic sequence analysis using multiplex (PCR) and next-generation sequencing with algorithm, quantification of dominant clonal sequence(s), reported as presence or absence of minimal residual disease (MRD) with quantitation of disease burden, when appropriate	False	5	C5851914;C5851915;C5851916
0365U	CPT	Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA) by immunoassays, urine, algorithm reported as a probability of bladder cancer	False	5	C5851918;C5851917
0366U	CPT	Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA) by immunoassays, urine, algorithm reported as a probability of recurrent bladder cancer	False	5	C5851919;C5851920
0367U	CPT	Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA) by immunoassays, urine, diagnostic algorithm reported as a risk score for probability of rapid recurrence of recurrent or persistent cancer following transurethral resection	False	7	C5851922;C5851924;C5851925;C5851921;C5851923
0368U	CPT	Oncology (colorectal cancer), evaluation for mutations of APC, BRAF, CTNNB1, KRAS, NRAS, PIK3CA, SMAD4, and TP53, and methylation markers (MYO1G, KCNQ5, C9ORF50, FLI1, CLIP4, ZNF132, and TWIST1), multiplex quantitative polymerase chain reaction (qPCR), circulating cell-free DNA (cfDNA), plasma, report of risk score for advanced adenoma or colorectal cancer	False	7	C5851926;C5851927;C5851929;C5851928
0371U	CPT	Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogen, semiquantitative identification, DNA from 16 bacterial organisms and 1 fungal organism, multiplex amplified probe technique via quantitative polymerase chain reaction (qPCR), urine	False	7	C5851943;C5851944;C5851940;C5851941;C5851942
0372U	CPT	Infectious disease (genitourinary pathogens), antibiotic-resistance gene detection, multiplex amplified probe technique, urine, reported as an antimicrobial stewardship risk score	False	5	C5851945;C5851946
0375U	CPT	Oncology (ovarian), biochemical assays of 7 proteins (follicle stimulating hormone, human epididymis protein 4, apolipoprotein A-1, transferrin, beta-2 macroglobulin, prealbumin [ie, transthyretin], and cancer antigen 125), algorithm reported as ovarian cancer risk score	False	5	C5851961;C5851962
0376U	CPT	Oncology (prostate cancer), image analysis of at least 128 histologic features and clinical factors, prognostic algorithm determining the risk of distant metastases, and prostate cancer-specific mortality, includes predictive algorithm to androgen deprivation-therapy response, if appropriate	False	5	C5851963;C5851965;C5851964
0377U	CPT	Cardiovascular disease, quantification of advanced serum or plasma lipoprotein profile, by nuclear magnetic resonance (NMR) spectrometry with report of a lipoprotein profile (including 23 variables)	False	5	C5851966;C5851967
0378U	CPT	RFC1 (replication factor C subunit 1), repeat expansion variant analysis by traditional and repeat-primed PCR, blood, saliva, or buccal swab	False	8	C5851968;C5851969;C5851972;C5851970;C5851971
0379U	CPT	Targeted genomic sequence analysis panel, solid organ neoplasm, DNA (523 genes) and RNA (55 genes) by next-generation sequencing, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutational burden	False	5	C5851973;C5851974
0381U	CPT	Maple syrup urine disease monitoring by patient-collected blood card sample, quantitative measurement of allo-isoleucine, leucine, isoleucine, and valine, liquid chromatography with tandem mass spectrometry (LC-MS/MS)	False	5	C5851979;C5851980
0382U	CPT	Hyperphenylalaninemia monitoring by patient-collected blood card sample, quantitative measurement of phenylalanine and tyrosine, liquid chromatography with tandem mass spectrometry (LC-MS/MS)	False	5	C5851981;C5851982
0383U	CPT	Tyrosinemia type I monitoring by patient-collected blood card sample, quantitative measurement of tyrosine, phenylalanine, methionine, succinylacetone, nitisinone, liquid chromatography with tandem mass spectrometry (LC-MS/MS)	False	5	C5851983;C5851984
0384U	CPT	Nephrology (chronic kidney disease), carboxymethyllysine, methylglyoxal hydroimidazolone, and carboxyethyl lysine by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and HbA1c and estimated glomerular filtration rate (GFR), with risk score reported for predictive progression to high-stage kidney disease	False	5	C5851985;C5851986
0385U	CPT	Nephrology (chronic kidney disease), apolipoprotein A4 (ApoA4), CD5 antigen-like (CD5L), and insulin-like growth factor binding protein 3 (IGFBP3) by enzyme-linked immunoassay (ELISA), plasma, algorithm combining results with HDL, estimated glomerular filtration rate (GFR) and clinical data reported as a risk score for developing diabetic kidney disease	False	5	C5851987;C5851988
0387U	CPT	Oncology (melanoma), autophagy and beclin 1 regulator 1 (AMBRA1) and loricrin (AMLo) by immunohistochemistry, formalin-fixed paraffin-embedded (FFPE) tissue, report for risk of progression	False	5	C5851989;C5851990
0388U	CPT	Oncology (non-small cell lung cancer), next-generation sequencing with identification of single nucleotide variants, copy number variants, insertions and deletions, and structural variants in 37 cancer-related genes, plasma, with report for alteration detection	False	5	C5851991;C5851992
0389U	CPT	Pediatric febrile illness (Kawasaki disease [KD]), interferon alpha-inducible protein 27 (IFI27) and mast cell-expressed membrane protein 1 (MCEMP1), RNA, using quantitative reverse transcription polymerase chain reaction (RT-qPCR), blood, reported as a risk score for KD	False	5	C5851993;C5851994
0390U	CPT	Obstetrics (preeclampsia), kinase insert domain receptor (KDR), Endoglin (ENG), and retinol-binding protein 4 (RBP4), by immunoassay, serum, algorithm reported as a risk score	False	5	C5851996;C5851995
0391U	CPT	Oncology (solid tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded (FFPE) tissue, 437 genes, interpretive report for single nucleotide variants, splice-site variants, insertions/deletions, copy number alterations, gene fusions, tumor mutational burden, and microsatellite instability, with algorithm quantifying immunotherapy response score	False	5	C5851997;C5851998
0392U	CPT	Drug metabolism (depression, anxiety, attention deficit hyperactivity disorder [ADHD]), gene-drug interactions, variant analysis of 16 genes, including deletion/duplication analysis of CYP2D6, reported as impact of gene-drug interaction for each drug	False	16	C5852007;C5852008;C5851999;C5852002;C5852006;C5852005;C5852009;C5852000;C5852001;C5852004;C5852010;C5852011;C5852003
0393U	CPT	Neurology (eg, Parkinson disease, dementia with Lewy bodies), cerebrospinal fluid (CSF), detection of misfolded ä¼ª-synuclein protein by seed amplification assay, qualitative	False	6	C5852012;C5852013;C5852014;C5852015
0394U	CPT	Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 16 PFAS compounds by liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma or serum, quantitative	False	13	C5852017;C5852020;C5852022;C5852021;C5852016;C5852024;C5852026;C5852018;C5852019;C5852025;C5852023
0395T	CPT	High dose rate electronic brachytherapy, interstitial or intracavitary treatment, per fraction, includes basic dosimetry, when performed	False	4	C5416616;C4051827
0395U	CPT	Oncology (lung), multi-omics (microbial DNA by shotgun next-generation sequencing and carcinoembryonic antigen and osteopontin by immunoassay), plasma, algorithm reported as malignancy risk for lung nodules in early-stage disease	False	5	C5852028;C5852027
0398U	CPT	Gastroenterology (Barrett's esophagus), P16, RUNX3, HPP1, and FBN1 DNA methylation analysis using PCR, formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as risk score for progression to high-grade dysplasia or cancer	False	5	C5852030;C5852031
0399U	CPT	Neurology (cerebral folate deficiency), serum, detection of anti-human folate receptor IgG-binding antibody and blocking autoantibodies by enzyme-linked immunoassay (ELISA), qualitative, and blocking autoantibodies, using a functional blocking assay for IgG or IgM, quantitative, reported as positive or not detected	False	5	C5852032;C5852033;C5852034
0400U	CPT	Obstetrics (expanded carrier screening), 145 genes by next-generation sequencing, fragment analysis and multiplex ligation-dependent probe amplification, DNA, reported as carrier positive or negative	False	5	C5852035;C5852036
0401U	CPT	Cardiology (coronary heart disease [CHD]), 9 genes (12 variants), targeted variant genotyping, blood, saliva, or buccal swab, algorithm reported as a genetic risk score for a coronary event	False	8	C5852038;C5852037;C5852041;C5852039;C5852040
0402U	CPT	Infectious agent (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, multiplex amplified probe technique, vaginal, endocervical, or male urine, each pathogen reported as detected or not detected	False	8	C5852042;C5852046;C5852044;C5852045;C5852043
0403U	CPT	Oncology (prostate), mRNA, gene expression profiling of 18 genes, first-catch urine, algorithm reported as percentage of likelihood of detecting clinically significant prostate cancer	False	5	C5852048;C5852047;C5944590
0404U	CPT	Oncology (breast), semiquantitative measurement of thymidine kinase activity by immunoassay, serum, results reported as risk of disease progression	False	5	C5852051;C5852052
0405U	CPT	Oncology (pancreatic), 59 methylation haplotype block markers, next-generation sequencing, plasma, reported as cancer signal detected or not detected	False	5	C5852054;C5852053
0406U	CPT	Oncology (lung), flow cytometry, sputum, 5 markers (meso-tetra [4-carboxyphenyl] porphyrin [TCPP], CD206, CD66b, CD3, CD19), algorithm reported as likelihood of lung cancer	False	5	C5852055;C5852056
0407U	CPT	Nephrology (diabetic chronic kidney disease [CKD]), multiplex electrochemiluminescent immunoassay (ECLIA) of soluble tumor necrosis factor receptor 1 (sTNFR1), soluble tumor necrosis receptor 2 (sTNFR2), and kidney injury molecule 1 (KIM-1) combined with clinical data, plasma, algorithm reported as risk for progressive decline in kidney function	False	5	C5852057;C5852058
0408U	CPT	Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])	False	5	C5852059
0409U	CPT	Oncology (solid tumor), DNA (80 genes) and RNA (36 genes), by next-generation sequencing from plasma, including single nucleotide variants, insertions/deletions, copy number alterations, microsatellite instability, and fusions, report showing identified mutations with clinical actionability	False	5	C5852061;C5852060
0410U	CPT	Oncology (pancreatic), DNA, whole genome sequencing with 5-hydroxymethylcytosine enrichment, whole blood or plasma, algorithm reported as cancer detected or not detected	False	7	C5852062;C5852063;C5852064;C5852065;C5852066
0411U	CPT	Psychiatry (eg, depression, anxiety, attention deficit hyperactivity disorder [ADHD]), genomic analysis panel, variant analysis of 15 genes, including deletion/duplication analysis of CYP2D6	False	8	C5852070;C5848697;C5852067;C5852069;C5852071;C5852068
0412U	CPT	Beta amyloid, Aå°¾42/40 ratio, immunoprecipitation with quantitation by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and qualitative ApoE isoform-specific proteotyping, plasma combined with age, algorithm reported as presence or absence of brain amyloid pathology	False	5	C5852072;C5852073
0413U	CPT	Oncology (hematolymphoid neoplasm), optical genome mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements, DNA from blood or bone marrow, report of clinically significant alterations	False	5	C5852074;C5852075
0414U	CPT	Oncology (lung), augmentative algorithmic analysis of digitized whole slide imaging for 8 genes (ALK, BRAF, EGFR, ERBB2, MET, NTRK1-3, RET, ROS1), and KRAS G12C and PD-L1, if performed, formalin-fixed paraffin-embedded (FFPE) tissue, reported as positive or negative for each biomarker	False	5	C5852078;C5852076;C5852077
0415U	CPT	Cardiovascular disease (acute coronary syndrome [ACS]), IL-16, FAS, FASLigand, HGF, CTACK, EOTAXIN, and MCP-3 by immunoassay combined with age, sex, family history, and personal history of diabetes, blood, algorithm reported as a 5-year (deleted risk) score for ACS	False	5	C5852079;C5852080
0417U	CPT	Rare diseases (constitutional/heritable disorders), whole mitochondrial genome sequence with heteroplasmy detection and deletion analysis, nuclear-encoded mitochondrial gene analysis of 335 nuclear genes, including sequence changes, deletions, insertions, and copy number variants analysis, blood or saliva, identification and categorization of mitochondrial disorder-associated genetic variants	False	7	C5852083;C5852087;C5852085;C5852086;C5852084
0418U	CPT	Oncology (breast), augmentative algorithmic analysis of digitized whole slide imaging of 8 histologic and immunohistochemical features, reported as a recurrence score	False	5	C5852088;C5852089;C5852090
0419U	CPT	Neuropsychiatry (eg, depression, anxiety), genomic sequence analysis panel, variant analysis of 13 genes, saliva or buccal swab, report of each gene phenotype	False	13	C5852091;C5852093;C5852098;C5852100;C5852101;C5852092;C5852097;C5852095;C5852096;C5852094;C5852099
0420U	CPT	Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) of genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma	False	5	C5884297;C5944591
0421U	CPT	Oncology (colorectal) screening, quantitative real-time target and signal amplification of 8 RNA markers (GAPDH, SMAD4, ACY1, AREG, CDH1, KRAS, TNFRSF10B, EGLN2) and fecal hemoglobin, algorithm reported as a positive or negative for colorectal cancer risk	False	5	C5884298;C5944592
0422T	CPT	Tactile breast imaging by computer-aided tactile sensors, unilateral or bilateral	False	4	C4067646
0422U	CPT	Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate	False	5	C5884299;C5944593;C5944594
0423U	CPT	Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition	False	5	C5884300;C5944595;C5944596
0424U	CPT	Oncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as no molecular evidence, low-, moderate-, or elevated-risk of prostate cancer	False	5	C5884301;C5944597
0425U	CPT	Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (eg, parents, siblings)	False	5	C5884302;C5944598
0426U	CPT	Genome (eg, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysis	False	5	C5878571;C5944599
0427U	CPT	Monocyte distribution width, whole blood (List separately in addition to code for primary procedure)	False	5	C5876644
0429U	CPT	Human papillomavirus (HPV), oropharyngeal swab, 14 high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68)	False	5	C5884306;C5944601
0430U	CPT	Gastroenterology, malabsorption evaluation of alpha-1-antitrypsin, calprotectin, pancreatic elastase and reducing substances, feces, quantitative	False	5	C5884307;C5944602
0431U	CPT	Glycine receptor alpha1 IgG, serum or cerebrospinal fluid (CSF), live cell-binding assay (LCBA), qualitative	False	6	C5884308;C5944603;C5944604;C5944605
0432U	CPT	Kelch-like protein 11 (KLHL11) antibody, serum or cerebrospinal fluid (CSF), cell-binding assay, qualitative	False	6	C5884309;C5944608;C5944606;C5944607
0433U	CPT	Oncology (prostate), 5 DNA regulatory markers by quantitative PCR, whole blood, algorithm, including prostate-specific antigen, reported as likelihood of cancer	False	5	C5884310;C5944609
0434U	CPT	Drug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypes	False	5	C5884311;C5944610
0435U	CPT	Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on cytotoxicity percentage observed, minimum of 14 drugs or drug combinations	False	5	C5884312;C5944611
0436U	CPT	Oncology (lung), plasma analysis of 388 proteins, using aptamer-based proteomics technology, predictive algorithm reported as clinical benefit from immune checkpoint inhibitor therapy	False	5	C5884313;C5944612
0437U	CPT	Psychiatry (anxiety disorders), mRNA, gene expression profiling by RNA sequencing of 15 biomarkers, whole blood, algorithm reported as predictive risk score	False	5	C5884314
0438U	CPT	Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of CYP2D6, including reported phenotypes and impacted gene-drug interactions	False	5	C5884315;C5944613
0439U	CPT	Cardiology (coronary heart disease [CHD]), DNA, analysis of 5 single-nucleotide polymorphisms (SNPs) (rs11716050 [LOC105376934], rs6560711 [WDR37], rs3735222 [SCIN/LOC107986769], rs6820447 [intergenic], and rs9638144 [ESYT2]) and 3 DNA methylation markers (cg00300879 [transcription start site {TSS200} of CNKSR1], cg09552548 [intergenic], and cg14789911 [body of SPATC1L]), qPCR and digital PCR, whole blood, algorithm reported as a 4-tiered risk score for a 3-year risk of symptomatic CHD	False	5	C5944614;C5944615
0440U	CPT	Cardiology (coronary heart disease [CHD]), DNA, analysis of 10 single-nucleotide polymorphisms (SNPs) (rs710987 [LINC010019], rs1333048 [CDKN2B-AS1], rs12129789 [KCND3], rs942317 [KTN1-AS1], rs1441433 [PPP3CA], rs2869675 [PREX1], rs4639796 [ZBTB41], rs4376434 [LINC00972], rs12714414 [TMEM18], and rs7585056 [TMEM18]) and 6 DNA methylation markers (cg03725309 [SARS1], cg12586707 [CXCL1], cg04988978 [MPO], cg17901584 [DHCR24-DT], cg21161138 [AHRR], and cg12655112 [EHD4]), qPCR and digital PCR, whole blood, algorithm reported as detected or not detected for CHD	False	5	C5944616;C5944617
0441U	CPT	Infectious disease (bacterial, fungal, or viral infection), semiquantitative biomechanical assessment (via deformability cytometry), whole blood, with algorithmic analysis and result reported as an index	False	7	C5944618;C5944619;C5944621;C5944620
0442U	CPT	Infectious disease (respiratory infection), Myxovirus resistance protein A (MxA) and C-reactive protein (CRP), fingerstick whole blood specimen, each biomarker reported as present or absent	False	5	C5944622;C5944623
0443U	CPT	Neurofilament light chain (NfL), ultra-sensitive immunoassay, serum or cerebrospinal fluid	False	6	C5944625;C5944624;C5944626
0444U	CPT	Oncology (solid organ neoplasia), targeted genomic sequence analysis panel of 361 genes, interrogation for gene fusions, translocations, or other rearrangements, using DNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue, report of clinically significant variant(s)	False	5	C5944627
0445U	CPT	å°¾-amyloid (Abeta42) and phospho tau (181P) (pTau181), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology	False	5	C5944628
0446U	CPT	Autoimmune diseases (systemic lupus erythematosus [SLE]), analysis of 10 cytokine soluble mediator biomarkers by immunoassay, plasma, individual components reported with an algorithmic risk score for current disease activity	False	5	C5944629
0447U	CPT	Autoimmune diseases (systemic lupus erythematosus [SLE]), analysis of 11 cytokine soluble mediator biomarkers by immunoassay, plasma, individual components reported with an algorithmic prognostic risk score for developing a clinical flare	False	5	C5944630
0449U	CPT	Carrier screening for severe inherited conditions (eg, cystic fibrosis, spinal muscular atrophy, beta hemoglobinopathies [including sickle cell disease], alpha thalassemia), regardless of race or self-identified ancestry, genomic sequence analysis panel, must include analysis of 5 genes (CFTR, SMN1, HBB, HBA1, HBA2)	False	5	C5944635;C5944634;C5944633
0452U	CPT	Oncology (bladder), methylated PENK DNA detection by linear target enrichment-quantitative methylation-specific real-time PCR (LTE-qMSP), urine, reported as likelihood of bladder cancer	False	5	C5944641;C5944640
0453U	CPT	Oncology (colorectal cancer), cell-free DNA (cfDNA), methylation-based quantitative PCR assay (SEPTIN9, IKZF1, BCAT1, Septin9-2, VAV3, BCAN), plasma, reported as presence or absence of circulating tumor DNA (ctDNA)	False	5	C5944642;C5944643
0454U	CPT	Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping	False	5	C5944645;C5944644;C5944646
0455U	CPT	Infectious agents (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, multiplex amplified probe technique, vaginal, endocervical, gynecological specimens, oropharyngeal swabs, rectal swabs, female or male urine, each pathogen reported as detected or not detected	False	11	C5944654;C5944648;C5944655;C5944649;C5944650;C5944653;C5944647;C5944651;C5944652
0457U	CPT	Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 9 PFAS compounds by LC-MS/MS, plasma or serum, quantitative	False	6	C5944658;C5944659;C5944661;C5944660
0458U	CPT	Oncology (breast cancer), S100A8 and S100A9, by enzyme-linked immunosorbent assay (ELISA), tear fluid with age, algorithm reported as a risk score	False	5	C5944663;C5944662
0459U	CPT	å°¾-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology	False	5	C5944664;C5944665
0460U	CPT	Oncology, whole blood or buccal, DNA single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, with variant analysis and reported phenotypes	False	6	C5944666;C5944669;C5944667;C5944668
0461U	CPT	Oncology, pharmacogenomic analysis of single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, whole blood or buccal swab, with variant analysis, including impacted gene-drug interactions and reported phenotypes	False	6	C5944670;C5944671;C5944673;C5944672
0462U	CPT	Melatonin levels test, sleep study, 7 or 9 sample melatonin profile (cortisol optional), enzyme-linked immunosorbent assay (ELISA), saliva, screening/preliminary	False	5	C5944674;C5944675
0463U	CPT	Oncology (cervix), mRNA gene expression profiling of 14 biomarkers (E6 and E7 of the highest-risk human papillomavirus [HPV] types 16, 18, 31, 33, 45, 52, 58), by real-time nucleic acid sequence-based amplification (NASBA), exo- or endocervical epithelial cells, algorithm reported as positive or negative for increased risk of cervical dysplasia or cancer for each biomarker	False	6	C5944676;C5944678;C5944677;C5944679
0464U	CPT	Oncology (colorectal) screening, quantitative real-time target and signal amplification, methylated DNA markers, including LASS4, LRRC4 and PPP2R5C, a reference marker ZDHHC1, and a protein marker (fecal hemoglobin), utilizing stool, algorithm reported as a positive or negative result	False	5	C5944680;C5944681
0465U	CPT	Oncology (urothelial carcinoma), DNA, quantitative methylation-specific PCR of 2 genes (ONECUT2, VIM), algorithmic analysis reported as positive or negative	False	5	C5944682;C5944683
0466U	CPT	Cardiology (coronary artery disease [CAD]), DNA, genome-wide association studies (564856 single-nucleotide polymorphisms [SNPs], targeted variant genotyping), patient lifestyle and clinical data, buccal swab, algorithm reported as polygenic risk to acquired heart disease	False	5	C5944685;C5944684;C5944686
0467U	CPT	Oncology (bladder), DNA, next-generation sequencing (NGS) of 60 genes and whole genome aneuploidy, urine, algorithms reported as minimal residual disease (MRD) status positive or negative and quantitative disease burden	False	5	C5944687;C5944688
0468U	CPT	Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a-5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis	False	6	C5944689;C5944690;C5944691;C5944692
0469U	CPT	Rare diseases (constitutional/heritable disorders), whole genome sequence analysis for chromosomal abnormalities, copy number variants, duplications/deletions, inversions, unbalanced translocations, regions of homozygosity (ROH), inheritance pattern that indicate uniparental disomy (UPD), and aneuploidy, fetal sample (amniotic fluid, chorionic villus sample, or products of conception), identification and categorization of genetic variants, diagnostic report of fetal results based on phenotype with maternal sample and paternal sample, if performed, as comparators and/or maternal cell contamination	False	7	C5944693;C5944694;C5944696;C5944695;C5944697
0470U	CPT	Oncology (oropharyngeal), detection of minimal residual disease by next-generation sequencing (NGS) based quantitative evaluation of 8 DNA targets, cell-free HPV 16 and 18 DNA from plasma	False	5	C5944698;C5944699
0471U	CPT	Oncology (colorectal cancer), qualitative real-time PCR of 35 variants of KRAS and NRAS genes (exons 2, 3, 4), formalin-fixed paraffin-embedded (FFPE), predictive, identification of detected mutations	False	5	C5944700;C5944701
0472U	CPT	Carbonic anhydrase VI (CA VI), parotid specific/secretory protein (PSP) and salivary protein (SP1) IgG, IgM, and IgA antibodies, enzyme-linked immunosorbent assay (ELISA), semiqualitative, blood, reported as predictive evidence of early Sjægren's syndrome	False	5	C5944702;C5944703
0473U	CPT	Oncology (solid tumor), next-generation sequencing (NGS) of DNA from formalin-fixed paraffin-embedded (FFPE) tissue with comparative sequence analysis from a matched normal specimen (blood or saliva), 648 genes, interrogation for sequence variants, insertion and deletion alterations, copy number variants, rearrangements, microsatellite instability, and tumor-mutation burden	False	5	C5944704;C5944705
0474U	CPT	Hereditary pan-cancer (eg, hereditary sarcomas, hereditary endocrine tumors, hereditary neuroendocrine tumors, hereditary cutaneous melanoma), genomic sequence analysis panel of 88 genes with 20 duplications/deletions using next-generation sequencing (NGS), Sanger sequencing, blood or saliva, reported as positive or negative for germline variants, each gene	False	5	C5944706;C5944707;C5944708
0475U	CPT	Hereditary prostate cancer-related disorders, genomic sequence analysis panel using next-generation sequencing (NGS), Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), and array comparative genomic hybridization (CGH), evaluation of 23 genes and duplications/deletions when indicated, pathologic mutations reported with a genetic risk score for prostate cancer	False	5	C5944710;C5944709;C5944711
0476U	CPT	Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia), whole blood, buccal swab, and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant analysis and reported phenotypes	False	6	C5944712;C5944713;C5944714;C5944715
0477U	CPT	Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia), whole blood, buccal swab, and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant analysis, including impacted gene-drug interactions and reported phenotypes	False	6	C5944717;C5944716;C5944718;C5944719
0478U	CPT	Oncology (non-small cell lung cancer), DNA and RNA, digital PCR analysis of 9 genes (EGFR, KRAS, BRAF, ALK, ROS1, RET, NTRK 1/2/3, ERBB2, and MET) in formalin-fixed paraffin-embedded (FFPE) tissue, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, and reported as actionable detected variants for therapy selection	False	6	C5944723;C5944720;C5944722;C5944721
0479U	CPT	Tau, phosphorylated, pTau217	False	5	C5944724;C5944725
0480U	CPT	Infectious disease (bacteria, viruses, fungi, and parasites), cerebrospinal fluid (CSF), metagenomic next-generation sequencing (DNA and RNA), bioinformatic analysis, with positive pathogen identification	False	6	C5944727;C5944726;C5944728;C5944729
0481U	CPT	IDH1 (isocitrate dehydrogenase 1 [NADP+]), IDH2 (isocitrate dehydrogenase 2 [NADP+]), and TERT (telomerase reverse transcriptase) promoter (eg, central nervous system [CNS] tumors), next-generation sequencing (single-nucleotide variants [SNV], deletions, and insertions)	False	5	C5944730;C5944731
0482U	CPT	Obstetrics (preeclampsia), biochemical assay of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF), serum, ratio reported for sFlt-1/PlGF, with risk of progression for preeclampsia with severe features within 2 weeks	False	5	C5944732;C5944733
0483U	CPT	Infectious disease (Neisseria gonorrhoeae), sensitivity, ciprofloxacin resistance (gyrA S91F point mutation), oral, rectal, or vaginal swab, algorithm reported as probability of fluoroquinolone resistance	False	7	C5944737;C5944734;C5944735;C5944736;C5944738
0484U	CPT	Infectious disease (Mycoplasma genitalium), macrolide sensitivity (23S rRNA point mutation), oral, rectal, or vaginal swab, algorithm reported as probability of macrolide resistance	False	7	C5944740;C5944743;C5944741;C5944739;C5944742
0485U	CPT	Oncology (solid tumor), cell-free DNA and RNA by next-generation sequencing, interpretative report for germline mutations, clonal hematopoiesis of indeterminate potential, and tumor-derived single-nucleotide variants, small insertions/deletions, copy number alterations, fusions, microsatellite instability, and tumor mutational burden	False	6	C5944747;C5944745;C5944746;C5944744
0486U	CPT	Oncology (pan-solid tumor), next-generation sequencing analysis of tumor methylation markers present in cell-free circulating tumor DNA, algorithm reported as quantitative measurement of methylation as a correlate of tumor fraction	False	5	C5944748;C5944749;C5944750
0487U	CPT	Oncology (solid tumor), cell-free circulating DNA, targeted genomic sequence analysis panel of 84 genes, interrogation for sequence variants, aneuploidy-corrected gene copy number amplifications and losses, gene rearrangements, and microsatellite instability	False	5	C5944751;C5944752
0488U	CPT	Obstetrics (fetal antigen noninvasive prenatal test), cell-free DNA sequence analysis for detection of fetal presence or absence of 1 or more of the Rh, C, c, D, E, Duffy (Fya), or Kell (K) antigen in alloimmunized pregnancies, reported as selected antigen(s) detected or not detected	False	5	C5944754;C5944753;C5944755
0489U	CPT	Obstetrics (single-gene noninvasive prenatal test), cell-free DNA sequence analysis of 1 or more targets (eg, CFTR, SMN1, HBB, HBA1, HBA2) to identify paternally inherited pathogenic variants, and relative mutation-dosage analysis based on molecular counts to determine fetal inheritance of maternal mutation, algorithm reported as a fetal risk score for the condition (eg, cystic fibrosis, spinal muscular atrophy, beta hemoglobinopathies [including sickle cell disease], alpha thalassemia)	False	5	C5944756;C5944757;C5944758
0490U	CPT	Oncology (cutaneous or uveal melanoma), circulating tumor cell selection, morphological characterization and enumeration based on differential CD146, high molecular-weight melanoma-associated antigen, CD34 and CD45 protein biomarkers, peripheral blood	False	5	C5944759;C5944760
0491U	CPT	Oncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM), cytokeratins 8, 18, and 19, CD45 protein biomarkers, and quantification of estrogen receptor (ER) protein biomarker-expressing cells, peripheral blood	False	5	C5944762;C5944761
0492U	CPT	Oncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM), cytokeratins 8, 18, and 19, CD45 protein biomarkers, and quantification of PD-L1 protein biomarker-expressing cells, peripheral blood	False	5	C5944763;C5944764
0493U	CPT	Transplantation medicine, quantification of donor-derived cell-free DNA (cfDNA) using next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA	False	5	C5944765;C5944766
0494U	CPT	Red blood cell antigen (fetal RhD gene analysis), next-generation sequencing of circulating cell-free DNA (cfDNA) of blood in pregnant individuals known to be RhD negative, reported as positive or negative	False	5	C5944767;C5944768;C5944769
0495U	CPT	Oncology (prostate), analysis of circulating plasma proteins (tPSA, fPSA, KLK2, PSP94, and GDF15), germline polygenic risk score (60 variants), clinical information (age, family history of prostate cancer, prior negative prostate biopsy), algorithm reported as risk of likelihood of detecting clinically significant prostate cancer	False	5	C5944770;C5944771
0496U	CPT	Oncology (colorectal), cell-free DNA, 8 genes for mutations, 7 genes for methylation by real-time RT-PCR, and 4 proteins by enzyme-linked immunosorbent assay, blood, reported positive or negative for colorectal cancer or advanced adenoma risk	False	5	C5944773;C5944772
0497U	CPT	Oncology (prostate), mRNA gene-expression profiling by real-time RT-PCR of 6 genes (FOXM1, MCM3, MTUS1, TTC21B, ALAS1, and PPP2CA), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a risk score for prostate cancer	False	5	C5944775;C5944774
0498U	CPT	Oncology (colorectal), next-generation sequencing for mutation detection in 43 genes and methylation pattern in 45 genes, blood, and formalin-fixed paraffin-embedded (FFPE) tissue, report of variants and methylation pattern with interpretation	False	6	C5944776;C5944777;C5944779;C5944778
0499U	CPT	Oncology (colorectal and lung), DNA from formalin-fixed paraffin-embedded (FFPE) tissue, next-generation sequencing of 8 genes (NRAS, EGFR, CTNNB1, PIK3CA, APC, BRAF, KRAS, and TP53), mutation detection	False	6	C5944781;C5944780;C5944782;C5944783
0500U	CPT	Autoinflammatory disease (VEXAS syndrome), DNA, UBA1 gene mutations, targeted variant analysis (M41T, M41V, M41L, c.118-2A>C, c.118-1G>C, c.118-9_118-2del, S56F, S621C)	False	5	C5944784;C5944785
0501U	CPT	Oncology (colorectal), blood, quantitative measurement of cell-free DNA (cfDNA)	False	5	C5944786;C5944787
0502U	CPT	Human papillomavirus (HPV), E6/E7 markers for high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), cervical cells, branched-chain capture hybridization, reported as negative or positive for high risk for HPV	False	5	C5944788;C5944789
0503U	CPT	Neurology (Alzheimer disease), beta amyloid (Aå°¾40, Aå°¾42, Aå°¾42/40 ratio) and tau-protein (ptau217, np-tau217, ptau217/np-tau217 ratio), blood, immunoprecipitation with quantitation by liquid chromatography with tandem mass spectrometry (LC-MS/MS), algorithm score reported as likelihood of positive or negative for amyloid plaques	False	5	C5944791;C5944790
0504U	CPT	Infectious disease (urinary tract infection), identification of 17 pathologic organisms, urine, real-time PCR, reported as positive or negative for each organism	False	5	C5944792;C5944793
0505U	CPT	Infectious disease (vaginal infection), identification of 32 pathogenic organisms, swab, real-time PCR, reported as positive or negative for each organism	False	5	C5944794;C5944795
0506U	CPT	Gastroenterology (Barrett's esophagus), esophageal cells, DNA methylation analysis by next-generation sequencing of at least 89 differentially methylated genomic regions, algorithm reported as likelihood for Barrett's esophagus	False	5	C5944796;C5944797
0507U	CPT	Oncology (ovarian), DNA, whole-genome sequencing with 5-hydroxymethylcytosine (5hmC) enrichment, using whole blood or plasma, algorithm reported as cancer detected or not detected	False	6	C5944801;C5944798;C5944799;C5944800
0510U	CPT	Oncology (pancreatic cancer), augmentative algorithmic analysis of 16 genes from previously sequenced RNA whole-transcriptome data, reported as probability of predicted molecular subtype	False	5	C5944808;C5944809
0511U	CPT	Oncology (solid tumor), tumor cell culture in 3D microenvironment, 36 or more drug panel, reported as tumor-response prediction for each drug	False	5	C5944810
0512U	CPT	Oncology (prostate), augmentative algorithmic analysis of digitized whole-slide imaging of histologic features for microsatellite instability (MSI) status, formalin-fixed paraffin-embedded (FFPE) tissue, reported as increased or decreased probability of MSI-high (MSI-H)	False	5	C5944811;C5944812
0513U	CPT	Oncology (prostate), augmentative algorithmic analysis of digitized whole-slide imaging of histologic features for microsatellite instability (MSI) and homologous recombination deficiency (HRD) status, formalin-fixed paraffin-embedded (FFPE) tissue, reported as increased or decreased probability of each biomarker	False	5	C5944814;C5944813
0514U	CPT	Gastroenterology (irritable bowel disease [IBD]), immunoassay for quantitative determination of adalimumab (ADL) levels in venous serum in patients undergoing adalimumab therapy, results reported as a numerical value as micrograms per milliliter (ç¢g/mL)	False	5	C5944815;C5944816
0515U	CPT	Gastroenterology (irritable bowel disease [IBD]), immunoassay for quantitative determination of infliximab (IFX) levels in venous serum in patients undergoing infliximab therapy, results reported as a numerical value as micrograms per milliliter (ç¢g/mL)	False	5	C5944817;C5944818
0516U	CPT	Drug metabolism, whole blood, pharmacogenomic genotyping of 40 genes and CYP2D6 copy number variant analysis, reported as metabolizer status	False	5	C5944820;C5944819
0517U	CPT	Therapeutic drug monitoring, 80 or more psychoactive drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic minimally and maximally effective dose of prescribed and non-prescribed medications	False	5	C5944822;C5944823;C5944821
0518U	CPT	Therapeutic drug monitoring, 90 or more pain and mental health drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic minimally effective range of prescribed and non-prescribed medications	False	5	C5944824;C5944825
0519U	CPT	Therapeutic drug monitoring, medications specific to pain, depression, and anxiety, LC-MS/MS, plasma, 110 or more drugs or substances, qualitative and quantitative therapeutic minimally effective range of prescribed, non-prescribed, and illicit medications in circulation	False	5	C5944826;C5944827;C5944828
0520U	CPT	Therapeutic drug monitoring, 200 or more drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic minimally effective range of prescribed and non-prescribed medications	False	5	C5944829;C5944830;C5944831
0521U					
0522U					
0523U					
0524U					
0525U					
0526U					
0527U					
0528U					
0529U					
0530U					
0531U					
0532U					
0533U					
0534U					
0535U					
0536U					
0537U					
0538U					
0539U					
0540U					
0541U					
0542U					
0543U					
0545U					
0546U					
0547U					
0548U					
0549U					
0552U					
0553U					
0554U					
0555U					
0556U					
0557U					
0558T	CPT	Computed tomography scan taken for the purpose of biomechanical computed tomography analysis	False	4	C5202482;C5202483
0558U					
0559U					
0560U					
0561U					
0562U					
0563U					
0564U					
0565U					
0566U					
0567U					
0568U					
0569U					
0570U					
0571U					
0572U					
0573U					
0574U					
0575U					
0576U					
0577U					
0578U					
0579U					
0580U					
0581U					
0582U					
0583U					
0584U					
0585U					
0586U					
0587U					
0588U					
0589U					
0590U					
0591U					
0592U					
0593U					
0594U					
0595U					
0596U					
0597U					
0598T	CPT	Noncontact real-time fluorescence wound imaging, for bacterial presence, location, and load, per session; first anatomic site (eg, lower extremity)	False	4	C5416636;C5416637
0598U					
0599T	CPT	Noncontact real-time fluorescence wound imaging, for bacterial presence, location, and load, per session; each additional anatomic site (eg, upper extremity) (List separately in addition to code for primary procedure)	False	4	C5416638;C5416639
0599U					
0600U					
0601U					
0602U					
0603U					
0604U					
0605U					
0606U					
0607U					
0608U					
0609U					
0610U					
0611U					
0612U					
0613U					
0633T	CPT	Computed tomography, breast, including 3D rendering, when performed, unilateral; without contrast material	False	4	C5416710;C5416711
0634T	CPT	Computed tomography, breast, including 3D rendering, when performed, unilateral; with contrast material(s)	False	4	C5416712;C5416713
0635T	CPT	Computed tomography, breast, including 3D rendering, when performed, unilateral; without contrast, followed by contrast material(s)	False	4	C5416714;C5416715
0636T	CPT	Computed tomography, breast, including 3D rendering, when performed, bilateral; without contrast material(s)	False	4	C5416717;C5416718
0637T	CPT	Computed tomography, breast, including 3D rendering, when performed, bilateral; with contrast material(s)	False	4	C5416720;C5416719
0638T	CPT	Computed tomography, breast, including 3D rendering, when performed, bilateral; without contrast, followed by contrast material(s)	False	4	C5416721;C5416722
0640T	CPT	Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; first anatomic site	False	4	C5852194;C5691575
0648T	CPT	Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session; single organ	False	4	C5691583;C5697442
0649T	CPT	Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure); single organ (List separately in addition to code for primary procedure)	False	4	C5691585;C5697444
0721T	CPT	Quantitative computed tomography (CT) tissue characterization, including interpretation and report, obtained without concurrent CT examination of any structure contained in previously acquired diagnostic imaging	False	4	C5702414;C5702413
0722T	CPT	Quantitative computed tomography (CT) tissue characterization, including interpretation and report, obtained with concurrent CT examination of any structure contained in the concurrently acquired diagnostic imaging dataset (List separately in addition to code for primary procedure)	False	4	C5702415
0723T	CPT	Quantitative magnetic resonance cholangiopancreatography (QMRCP), including data preparation and transmission, interpretation and report, obtained without diagnostic magnetic resonance imaging (MRI) examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session	False	4	C5702416;C5702417
0724T	CPT	Quantitative magnetic resonance cholangiopancreatography (QMRCP), including data preparation and transmission, interpretation and report, obtained with diagnostic magnetic resonance imaging (MRI) examination of the same anatomy (eg, organ, gland, tissue, target structure) (List separately in addition to code for primary procedure)	False	4	C5702418;C5702419
0807T	CPT	Pulmonary tissue ventilation analysis using software-based processing of data from separately captured cinefluorograph images; in combination with previously acquired computed tomography (CT) images, including data preparation and transmission, quantification of pulmonary tissue ventilation, data review, interpretation and report	False	4	C5852329;C5852330
0808T	CPT	Pulmonary tissue ventilation analysis using software-based processing of data from separately captured cinefluorograph images; in combination with computed tomography (CT) images taken for the purpose of pulmonary tissue ventilation analysis, including data preparation and transmission, quantification of pulmonary tissue ventilation, data review, interpretation and report	False	4	C5852331;C5852332
0815T	CPT	Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine	False	4	C5852344;C5852345
0857T	CPT	Opto-acoustic imaging, breast, unilateral, including axilla when performed, real-time with image documentation, augmentative analysis and report (List separately in addition to code for primary procedure)	False	4	C5852370;C5852371
0859T	CPT	Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; each additional anatomic site (List separately in addition to code for primary procedure)	False	4	C5852195;C5852196
0860T	CPT	Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), for screening for peripheral arterial disease, including provocative maneuvers, image acquisition, interpretation, and report, one or both lower extremities	False	4	C5852198;C5852197
0865T	CPT	Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion identification, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the brain during the same session	False	4	C5852376;C5852377
0866T	CPT	Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion detection, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the brain (List separately in addition to code for primary procedure)	False	4	C5852378;C5852379
0877T	CPT	Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; obtained without concurrent CT examination of any structure contained in previously acquired diagnostic imaging	False	4	C5944935
0878T	CPT	Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; obtained with concurrent CT examination of the same structure	False	4	C5944936
0879T	CPT	Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; radiological data preparation and transmission	False	4	C5944937
0880T	CPT	Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; physician or other qualified health care professional interpretation and report	False	4	C5944938
0889T	CPT	Personalized target development for accelerated, repetitive high-dose functional connectivity MRI-guided theta-burst stimulation derived from a structural and resting-state functional MRI, including data preparation and transmission, generation of the target, motor threshold-starting location, neuronavigation files and target report, review and interpretation	False	4	C5944948
0898T	CPT	Noninvasive prostate cancer estimation map, derived from augmentative analysis of image-guided fusion biopsy and pathology, including visualization of margin volume and location, with margin determination and physician interpretation and report	False	4	C5944961
0899T	CPT	Noninvasive determination of absolute quantitation of myocardial blood flow (AQMBF), derived from augmentative algorithmic analysis of the dataset acquired via contrast cardiac magnetic resonance (CMR), pharmacologic stress, with interpretation and report by a physician or other qualified health care professional (List separately in addition to code for primary procedure)	False	4	C5944962
0900T	CPT	Noninvasive estimate of absolute quantitation of myocardial blood flow (AQMBF), derived from assistive algorithmic analysis of the dataset acquired via contrast cardiac magnetic resonance (CMR), pharmacologic stress, with interpretation and report by a physician or other qualified health care professional (List separately in addition to code for primary procedure)	False	4	C5944963
0932T	CPT	Noninvasive detection of heart failure derived from augmentative analysis of an echocardiogram that demonstrated preserved ejection fraction, with interpretation and report by a physician or other qualified health care professional	False	4	C5945018;C5945019
0944T	CPT	3D contour simulation of target liver lesion(s) and margin(s) for image-guided percutaneous microwave ablation	False	4	C5945040
0946T	CPT	Orthopedic implant movement analysis using paired computed tomography (CT) examination of the target structure, including data acquisition, data preparation and transmission, interpretation and report (including CT scan of the joint or extremity performed with paired views)	False	4	C5945043;C5945044
0947T	CPT	Magnetic resonance image guided low intensity focused ultrasound (MRgFUS), stereotactic blood-brain barrier disruption using microbubble resonators to increase the concentration of blood-based biomarkers of target, intracranial, including stereotactic navigation and frame placement, when performed	False	4	C5945045;C5945046
0961T					
0972T					
0977T					
0984T					
0985T					
0986T					
0987T					
0992T					
0993T					
1010T					
1020T					
19296	CPT	Placement of radiotherapy afterloading expandable catheter (single or multichannel) into the breast for interstitial radioelement application following partial mastectomy, includes imaging guidance; on date separate from partial mastectomy	False	6	C3705628;C1504120;C3705629;C5692260
19297	CPT	Placement of radiotherapy afterloading expandable catheter (single or multichannel) into the breast for interstitial radioelement application following partial mastectomy, includes imaging guidance; concurrent with partial mastectomy (List separately in addition to code for primary procedure)	False	6	C3705630;C1504121;C5692261;C3705631
19298	CPT	Placement of radiotherapy after loading brachytherapy catheters (multiple tube and button type) into the breast for interstitial radioelement application following (at the time of or subsequent to) partial mastectomy, includes imaging guidance	False	7	C1504122;C3705633;C3705632;C5692262;C3518233
20555	CPT	Placement of needles or catheters into muscle and/or soft tissue for subsequent interstitial radioelement application (at the time of or subsequent to the procedure)	False	10	C1964173;C3518253;C3518252;C3518254;C5692289;C3518251;C3518249;C3518250
31643	CPT	Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with placement of catheter(s) for intracavitary radioelement application	False	8	C3520340;C5693551;C3520341;C3520339;C3520338;C0695022
32553	CPT	Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), percutaneous, intra-thoracic, single or multiple	False	6	C2724263;C5693598;C5406390;C5406389
32701	CPT	Thoracic target(s) delineation for stereotactic body radiation therapy (SRS/SBRT), (photon or particle beam), entire course of treatment	False	6	C5406403;C3511512;C5406404;C5693626
36415	CPT	Collection of venous blood by venipuncture	False	5	C1548758
41019	CPT	Placement of needles, catheters, or other device(s) into the head and/or neck region (percutaneous, transoral, or transnasal) for subsequent interstitial radioelement application	False	22	C1964203;C5694315;C5407940;C5407943;C3521364;C5407941;C3521352;C3521354;C3521366;C3521351;C3521357;C3521358;C3521363;C3521367;C3521355;C3521360;C3521361;C5407938;C5407939;C5407942
49327	CPT	Laparoscopy, surgical; with placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), intra-abdominal, intrapelvic, and/or retroperitoneum, including imaging guidance, if performed, single or multiple (List separately in addition to code for primary procedure)	False	16	C2939250;C5408704;C3522347;C3522339;C3522342;C3522348;C5694827;C3522341;C3522340;C5408700;C5408699;C5408703;C5408701;C5408702
49411	CPT	Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), percutaneous, intra-abdominal, intra-pelvic (except prostate), and/or retroperitoneum, single or multiple	False	12	C2724291;C5408709;C5694834;C5408711;C5408712;C5408713;C5408714;C5408715;C5408708;C5408710
49412	CPT	Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), open, intra-abdominal, intrapelvic, and/or retroperitoneum, including image guidance, if performed, single or multiple (List separately in addition to code for primary procedure)	False	16	C2939251;C3522363;C3522358;C3522359;C3522362;C3522364;C5694835;C3522356;C3522355;C3522360;C3522354;C3522357;C3522361;C3522365
51020	CPT	Cystotomy or cystostomy, with fulguration and/or insertion of radioactive material	False	10	C3522787;C2066271;C3514575;C3522789;C2066273;C3522788;C3522790;C0372359
51798	CPT	Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging	False	6	C5408997;C1144666;C3514616;C5408996
55875	CPT	Transperineal placement of needles or catheters into prostate for interstitial radioelement application, with or without cystoscopy	False	8	C3867541;C0372514;C3523188;C3867540;C5695224;C3523189
55876	CPT	Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), prostate (via needle, any approach), single or multiple	False	10	C5695225;C3867538;C3867535;C3867537;C3867539;C3523190;C1737192;C4052186
55920	CPT	Placement of needles or catheters into pelvic organs and/or genitalia (except prostate) for subsequent interstitial radioelement application	False	10	C1964220;C5409239;C5409235;C3523193;C5697563;C5409237;C5409238;C5409236
57155	CPT	Insertion of uterine tandem and/or vaginal ovoids for clinical brachytherapy	False	7	C0973318;C5697565;C3523208;C3523209;C3523210
57156	CPT	Insertion of a vaginal radiation afterloading apparatus for clinical brachytherapy	False	5	C2939256;C5695257
58346	CPT	Insertion of Heyman capsules for clinical brachytherapy	False	5	C5695321;C0973319
61715	CPT	Magnetic resonance image guided high intensity focused ultrasound (MRgFUS), stereotactic ablation of target, intracranial, including stereotactic navigation and frame placement, when performed	False	6	C5944453;C5944455;C5944452;C5944454
61770	CPT	Stereotactic localization, including burr hole(s), with insertion of catheter(s) or probe(s) for placement of radiation source	False	8	C5695555;C3524183;C3524181;C0196063;C3524180;C3524182
61796	CPT	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion	False	5	C2366674;C5695559;C5409641
61797	CPT	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional cranial lesion, simple (List separately in addition to code for primary procedure)	False	5	C2366675;C5695560;C5409643
61798	CPT	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 complex cranial lesion	False	5	C2366676;C5695561;C5409644
61799	CPT	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional cranial lesion, complex (List separately in addition to code for primary procedure)	False	5	C5695562;C5409646;C2366677
61800	CPT	Application of stereotactic headframe for stereotactic radiosurgery (List separately in addition to code for primary procedure)	False	5	C2366678;C5695563;C3515200
63620	CPT	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 spinal lesion	False	7	C3866866;C3866865;C3866867;C2366680;C5695709
63621	CPT	Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional spinal lesion (List separately in addition to code for primary procedure)	False	7	C5410310;C5410311;C2366681;C5695710;C5410309
70100	CPT	Radiologic examination, mandible; partial, less than 4 views	False	9	C0202719;C3866675;C3866678;C3866676;C3866677;C5696049
70110	CPT	Radiologic examination, mandible; complete, minimum of 4 views	False	6	C3866674;C0202720;C5696050
70120	CPT	Radiologic examination, mastoids; less than 3 views per side	False	11	C3866668;C3866671;C0202728;C3866669;C3866672;C3866670;C3866673;C5696051
70130	CPT	Radiologic examination, mastoids; complete, minimum of 3 views per side	False	6	C3866667;C0202729;C5696052
70134	CPT	Radiologic examination, internal auditory meati, complete	False	6	C3866666;C0202736;C5696053
70140	CPT	Radiologic examination, facial bones; less than 3 views	False	8	C0202710;C3866664;C3866665;C3866663;C5697548
70150	CPT	Radiologic examination, facial bones; complete, minimum of 3 views	False	6	C0202711;C3866661;C3527532
70160	CPT	Radiologic examination, nasal bones, complete, minimum of 3 views	False	6	C0202731;C3515732;C3866659
70190	CPT	Radiologic examination; optic foramina	False	5	C0202748;C5696055
70200	CPT	Radiologic examination; orbits, complete, minimum of 4 views	False	9	C0202747;C3866656;C3866654;C3866655;C3866657;C5696056;C2013765
70210	CPT	Radiologic examination, sinuses, paranasal, less than 3 views	False	6	C3866653;C0202733;C5697549
70220	CPT	Radiologic examination, sinuses, paranasal, complete, minimum of 3 views	False	7	C0202734;C3866650;C3866651;C5696057
70240	CPT	Radiologic examination, sella turcica	False	5	C0202686;C3515735
70250	CPT	Radiologic examination, skull; less than 4 views	False	7	C3866647;C3866649;C3866648;C5696058;C0373139
70260	CPT	Radiologic examination, skull; complete, minimum of 4 views	False	6	C3866646;C5696059;C0373140
70300	CPT	Radiologic examination, teeth; single view	False	10	C3866644;C0202775;C2586170;C3866645;C3866642;C3866643;C5697550
70310	CPT	Radiologic examination, teeth; partial examination, less than full mouth	False	5	C5410809;C0202776
70320	CPT	Radiologic examination, teeth; complete, full mouth	False	5	C0202777;C5410810
70328	CPT	Radiologic examination, temporomandibular joint, open and closed mouth; unilateral	False	5	C0202723;C5410811;C5696060
70330	CPT	Radiologic examination, temporomandibular joint, open and closed mouth; bilateral	False	6	C5416789;C0202724;C5410812;C5696061
70336	CPT	Magnetic resonance (eg, proton) imaging, temporomandibular joint(s)	False	6	C5410814;C0202726
70350	CPT	Cephalogram, orthodontic	False	5	C5696063;C0407698
70355	CPT	Orthopantogram (eg, panoramic x-ray)	False	5	C0034579;C5696064
70360	CPT	Radiologic examination; neck, soft tissue	False	5	C0373142
70370	CPT	Radiologic examination; pharynx or larynx, including fluoroscopy and/or magnification technique	False	10	C3866639;C0202769;C3525137;C3525140;C3527533;C3866638;C3525139;C3525136
70371	CPT	Complex dynamic pharyngeal and speech evaluation by cine or video recording	False	6	C0202770;C3866636;C3866637;C3515739
70380	CPT	Radiologic examination, salivary gland for calculus	False	6	C0202741;C1659593;C2121222;C5696065
70450	CPT	Computed tomography, head or brain; without contrast material	False	6	C5410817;C0202692;C5696067;C5410816
70460	CPT	Computed tomography, head or brain; with contrast material(s)	False	6	C3515742;C5410818;C5410819;C1275583
70470	CPT	Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections	False	6	C0202694;C3515743;C5410821;C5410820
70471					
70472					
70473					
70480	CPT	Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material	False	10	C5696068;C5410825;C5410822;C5410823;C5410826;C5410824;C5410827;C0373145
70481	CPT	Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; with contrast material(s)	False	10	C5410829;C5410831;C3515745;C5410828;C5410830;C5410832;C5410833;C0373146
70482	CPT	Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material, followed by contrast material(s) and further sections	False	10	C5410838;C5410834;C5410835;C3515746;C5410839;C5410836;C5410837;C0373147
70486	CPT	Computed tomography, maxillofacial area; without contrast material	False	5	C0202715;C5696069;C5410840
70487	CPT	Computed tomography, maxillofacial area; with contrast material(s)	False	5	C5410841;C0202716;C3515748
70488	CPT	Computed tomography, maxillofacial area; without contrast material, followed by contrast material(s) and further sections	False	5	C0202717;C3515749;C5410842
70490	CPT	Computed tomography, soft tissue neck; without contrast material	False	5	C0202758;C5410843
70491	CPT	Computed tomography, soft tissue neck; with contrast material(s)	False	5	C0202759;C5410844
70492	CPT	Computed tomography, soft tissue neck; without contrast material followed by contrast material(s) and further sections	False	5	C0202760;C5410845;C5696070
70496	CPT	Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C5410846;C3703790;C5410847;C0918137
70498	CPT	Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C5410849;C3703791;C5410848;C0918138
70540	CPT	Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)	False	11	C3495410;C5696071;C5410853;C5410854;C5410855;C5410856;C5410850;C5410851;C5410852
70542	CPT	Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; with contrast material(s)	False	11	C5410858;C5410863;C5410857;C5410860;C5410862;C5696072;C5410861;C5410859;C0918139
70543	CPT	Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences	False	11	C5410867;C5410870;C5410865;C5410868;C5696073;C5410866;C5410864;C5410869;C0918140
70544	CPT	Magnetic resonance angiography, head; without contrast material(s)	False	5	C4305213;C5696074;C5410871
70545	CPT	Magnetic resonance angiography, head; with contrast material(s)	False	5	C3839357;C5696075;C5410872
70546	CPT	Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) and further sequences	False	5	C5410873;C5696076;C0918143
70547	CPT	Magnetic resonance angiography, neck; without contrast material(s)	False	5	C5410874;C4305212;C5696077
70548	CPT	Magnetic resonance angiography, neck; with contrast material(s)	False	5	C5696078;C5410875;C0918145
70549	CPT	Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences	False	5	C5410876;C5696079;C0918146
70551	CPT	Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material	False	6	C0202699;C5410878;C5696080;C5410877
70552	CPT	Magnetic resonance (eg, proton) imaging, brain (including brain stem); with contrast material(s)	False	6	C3515757;C0202700;C5410880;C5410879
70553	CPT	Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences	False	6	C5410881;C3515758;C5410882;C0373149
70554	CPT	Magnetic resonance imaging, brain, functional MRI; including test selection and administration of repetitive body part movement and/or visual stimulation, not requiring physician or psychologist administration	False	7	C5410884;C1740478;C5410885;C3515759;C5410883
70555	CPT	Magnetic resonance imaging, brain, functional MRI; requiring physician or psychologist administration of entire neurofunctional testing	False	6	C1738519;C5696081;C5410886;C5410887
71045	CPT	Radiologic examination, chest; single view	False	5	C4523436
71046	CPT	Radiologic examination, chest; 2 views	False	5	C4523437
71047	CPT	Radiologic examination, chest; 3 views	False	5	C4523438
71048	CPT	Radiologic examination, chest; 4 or more views	False	5	C3515762;C4523439
71100	CPT	Radiologic examination, ribs, unilateral; 2 views	False	7	C0202814;C3866577;C3866578;C5696085
71101	CPT	Radiologic examination, ribs, unilateral; including posteroanterior chest, minimum of 3 views	False	7	C0202815;C3866576;C3866575;C5696086
71110	CPT	Radiologic examination, ribs, bilateral; 3 views	False	7	C3866573;C3866574;C0202817;C5696087
71111	CPT	Radiologic examination, ribs, bilateral; including posteroanterior chest, minimum of 4 views	False	7	C3866571;C0202818;C3866572;C5696088
71120	CPT	Radiologic examination; sternum, minimum of 2 views	False	6	C0202821;C3866570;C5696089
71130	CPT	Radiologic examination; sternoclavicular joint or joints, minimum of 3 views	False	6	C0202822;C3866569;C5696090
71250	CPT	Computed tomography, thorax, diagnostic; without contrast material	False	5	C1961126;C5410899;C2041475
71260	CPT	Computed tomography, thorax, diagnostic; with contrast material(s)	False	5	C0202824;C3515769;C5410901
71270	CPT	Computed tomography, thorax, diagnostic; without contrast material, followed by contrast material(s) and further sections	False	5	C5696091;C0202825;C5410902
71271	CPT	Computed tomography, thorax, low dose for lung cancer screening, without contrast material(s)	False	5	C5410903;C5410904;C5410905
71275	CPT	Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C5410907;C3703801;C5410906;C0918147
71550	CPT	Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s)	False	6	C5696092;C5410908;C0202826;C5410909
71551	CPT	Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); with contrast material(s)	False	6	C5410910;C5410911;C2316260;C0918148
71552	CPT	Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s), followed by contrast material(s) and further sequences	False	6	C5410913;C3515771;C5410912;C0918149
71555	CPT	Magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)	False	6	C5410914;C5410915;C3515772;C0373154
72020	CPT	Radiologic examination, spine, single view, specify level	False	12	C3866556;C3866559;C3866557;C3866561;C0373156;C3515774;C3866554;C3866555;C3866560;C3866558
72040	CPT	Radiologic examination, spine, cervical; 2 or 3 views	False	10	C3866548;C3866549;C3866551;C3866552;C3866553;C3866550;C3701998;C5696093
72050	CPT	Radiologic examination, spine, cervical; 4 or 5 views	False	8	C5696094;C3866544;C3511537;C3866545;C3866546;C3866547
72052	CPT	Radiologic examination, spine, cervical; 6 or more views	False	7	C5410918;C3515777;C5410916;C5410917;C0373157
72070	CPT	Radiologic examination, spine; thoracic, 2 views	False	6	C3853585;C2061525;C5410919
72072	CPT	Radiologic examination, spine; thoracic, 3 views	False	6	C0203159;C3866540;C3515779
72074	CPT	Radiologic examination, spine; thoracic, minimum of 4 views	False	7	C3866539;C0203160;C3866537;C3866538;C3515780
72080	CPT	Radiologic examination, spine; thoracolumbar junction, minimum of 2 views	False	6	C3853576;C2061523;C3515781;C5410920
72081	CPT	Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); one view	False	6	C4051877;C5696095;C5410922;C5410923
72082	CPT	Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); 2 or 3 views	False	8	C5410925;C4051876;C5696096;C5410927;C5410926;C5410928
72083	CPT	Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); 4 or 5 views	False	8	C5410930;C5410931;C4051875;C5696097;C5410933;C5410932
72084	CPT	Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); minimum of 6 views	False	6	C5410935;C5410934;C5696098;C4051874
72100	CPT	Radiologic examination, spine, lumbosacral; 2 or 3 views	False	8	C5696099;C3866532;C3515783;C3866534;C3866533;C2061524
72110	CPT	Radiologic examination, spine, lumbosacral; minimum of 4 views	False	6	C3866531;C3866530;C3515784
72114	CPT	Radiologic examination, spine, lumbosacral; complete, including bending views, minimum of 6 views	False	6	C5696100;C3866528;C3866529;C3853587
72120	CPT	Radiologic examination, spine, lumbosacral; bending views only, 2 or 3 views	False	8	C3866524;C3853588;C3866525;C5696101;C5410937;C5410936
72125	CPT	Computed tomography, cervical spine; without contrast material	False	5	C0203150;C5697551;C5410938
72126	CPT	Computed tomography, cervical spine; with contrast material	False	5	C0203151;C3515788;C5410939
72127	CPT	Computed tomography, cervical spine; without contrast material, followed by contrast material(s) and further sections	False	5	C0203152;C3515789;C5410940
72128	CPT	Computed tomography, thoracic spine; without contrast material	False	5	C5696102;C0203164;C5410941
72129	CPT	Computed tomography, thoracic spine; with contrast material	False	5	C0203165;C3515791;C5410942
72130	CPT	Computed tomography, thoracic spine; without contrast material, followed by contrast material(s) and further sections	False	5	C5410943;C0203166;C3515792
72131	CPT	Computed tomography, lumbar spine; without contrast material	False	5	C5416811;C0203173;C5696103
72132	CPT	Computed tomography, lumbar spine; with contrast material	False	5	C0203174;C5410944;C3515794
72133	CPT	Computed tomography, lumbar spine; without contrast material, followed by contrast material(s) and further sections	False	5	C0203175;C3515795;C5410945
72141	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; without contrast material	False	5	C0373158;C5696104;C5410946
72142	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; with contrast material(s)	False	5	C5410947;C3515797;C0373159
72146	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; without contrast material	False	5	C5696105;C5410948;C0373160
72147	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; with contrast material(s)	False	5	C3515799;C5410949;C0373161
72148	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material	False	5	C5696106;C5410950;C0373162
72149	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; with contrast material(s)	False	5	C0373163;C5410951;C3515801
72156	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical	False	5	C3515802;C5410952;C0373164
72157	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic	False	5	C3515803;C5410953;C0373165
72158	CPT	Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar	False	5	C0373166;C5410954;C3515804
72159	CPT	Magnetic resonance angiography, spinal canal and contents, with or without contrast material(s)	False	6	C5410955;C5696107;C5410956;C0373167
72170	CPT	Radiologic examination, pelvis; 1 or 2 views	False	11	C5696108;C5410957;C0203194;C3860868;C3860862;C3866518;C3866519;C4052149;C4052150
72190	CPT	Radiologic examination, pelvis; complete, minimum of 3 views	False	6	C0203195;C3866516;C3515806;C4052148
72191	CPT	Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C5410959;C5696109;C5410958;C0918150
72192	CPT	Computed tomography, pelvis; without contrast material	False	5	C0203198;C5410960
72193	CPT	Computed tomography, pelvis; with contrast material(s)	False	5	C0203199;C5410961
72194	CPT	Computed tomography, pelvis; without contrast material, followed by contrast material(s) and further sections	False	5	C0203200;C3515808;C5410962
72195	CPT	Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)	False	5	C5410963;C5696110;C0918151
72196	CPT	Magnetic resonance (eg, proton) imaging, pelvis; with contrast material(s)	False	5	C0203201;C2315896;C5410964
72197	CPT	Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences	False	5	C3515810;C5410965;C0918152
72198	CPT	Magnetic resonance angiography, pelvis, with or without contrast material(s)	False	6	C5696111;C0373168;C5410967;C5410966
72200	CPT	Radiologic examination, sacroiliac joints; less than 3 views	False	7	C3866511;C0373169;C3866512;C5696112
72202	CPT	Radiologic examination, sacroiliac joints; 3 or more views	False	6	C5696113;C0203187;C3866510
72220	CPT	Radiologic examination, sacrum and coccyx, minimum of 2 views	False	7	C0203189;C3866509;C3866508;C5696114
73000	CPT	Radiologic examination; clavicle, complete	False	8	C0203226;C3866501;C3515824;C3866502;C3866503;C2075294
73010	CPT	Radiologic examination; scapula, complete	False	7	C2121206;C3866500;C3866499;C3515825;C0373176
73020	CPT	Radiologic examination, shoulder; 1 view	False	9	C0203222;C3860528;C3866498;C2061623;C3866497;C3866496
73030	CPT	Radiologic examination, shoulder; complete, minimum of 2 views	False	7	C0373177;C3866494;C3866495;C3515826
73050	CPT	Radiologic examination; acromioclavicular joints, bilateral, with or without weighted distraction	False	10	C3866493;C3525206;C3866492;C5696122;C3525207;C5410979;C5410980;C0373179
73060	CPT	Radiologic examination; humerus, minimum of 2 views	False	7	C0203216;C3866488;C3866489;C3515828
73070	CPT	Radiologic examination, elbow; 2 views	False	7	C0203231;C3853590;C3866487
73080	CPT	Radiologic examination, elbow; complete, minimum of 3 views	False	8	C3866485;C0203232;C3866484;C3866486;C3515829
73090	CPT	Radiologic examination; forearm, 2 views	False	6	C0203237;C3515830
73092	CPT	Radiologic examination; upper extremity, infant, minimum of 2 views	False	6	C0203217;C3866483
73100	CPT	Radiologic examination, wrist; 2 views	False	7	C3853591;C3866482;C3865637
73110	CPT	Radiologic examination, wrist; complete, minimum of 3 views	False	8	C0203242;C3866479;C3866481;C3866480;C3515831
73120	CPT	Radiologic examination, hand; 2 views	False	7	C2028623;C0203246;C3866478;C3866477
73130	CPT	Radiologic examination, hand; minimum of 3 views	False	8	C3866475;C0203247;C3866476;C3866474
73140	CPT	Radiologic examination, finger(s), minimum of 2 views	False	12	C3866471;C0203250;C3866472;C3866470;C3866473
73200	CPT	Computed tomography, upper extremity; without contrast material	False	5	C5410983;C0203252;C5696125
73201	CPT	Computed tomography, upper extremity; with contrast material(s)	False	5	C0203253;C5410984
73202	CPT	Computed tomography, upper extremity; without contrast material, followed by contrast material(s) and further sections	False	5	C5410985;C0203254;C3515832
73206	CPT	Computed tomographic angiography, upper extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C5410987;C3703808;C5410986;C0918153
73218	CPT	Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; without contrast material(s)	False	5	C5696126;C5410988;C0918154
73219	CPT	Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; with contrast material(s)	False	7	C5410991;C3515835;C5410989;C5410990;C0918155
73220	CPT	Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; without contrast material(s), followed by contrast material(s) and further sequences	False	7	C0203255;C3515836;C5410994;C5410992;C5410993
73221	CPT	Magnetic resonance (eg, proton) imaging, any joint of upper extremity; without contrast material(s)	False	8	C5410996;C5696127;C5410995;C5410997;C5410998;C3853592
73222	CPT	Magnetic resonance (eg, proton) imaging, any joint of upper extremity; with contrast material(s)	False	8	C5411000;C5411002;C5411001;C5410999;C0918156
73223	CPT	Magnetic resonance (eg, proton) imaging, any joint of upper extremity; without contrast material(s), followed by contrast material(s) and further sequences	False	8	C5411004;C5411003;C3515837;C5411005;C5411006;C0918157
73225	CPT	Magnetic resonance angiography, upper extremity, with or without contrast material(s)	False	6	C5696128;C5411008;C5411007;C0373182
73501	CPT	Radiologic examination, hip, unilateral, with pelvis when performed; 1 view	False	6	C4052147;C5696129;C4051873;C4052146
73502	CPT	Radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views	False	6	C5411009;C5411010;C5696130;C4051872
73503	CPT	Radiologic examination, hip, unilateral, with pelvis when performed; minimum of 4 views	False	6	C5696131;C5411011;C4051871;C4052142
73521	CPT	Radiologic examination, hips, bilateral, with pelvis when performed; 2 views	False	6	C5696132;C4052141;C4051870
73522	CPT	Radiologic examination, hips, bilateral, with pelvis when performed; 3-4 views	False	8	C4052140;C5696133;C4052137;C4051869;C4052026;C4052138
73523	CPT	Radiologic examination, hips, bilateral, with pelvis when performed; minimum of 5 views	False	6	C4052135;C5696134;C4051868;C4052136
73551	CPT	Radiologic examination, femur; 1 view	False	5	C3861760;C5696136;C4051867
73552	CPT	Radiologic examination, femur; minimum 2 views	False	5	C4051866;C5696137;C4051980
73560	CPT	Radiologic examination, knee; 1 or 2 views	False	16	C3866437;C3866439;C5411013;C3866435;C3866438;C3866440;C3853674;C2061628;C3861157;C3861242;C3861291;C3865625;C3866436;C5696138
73562	CPT	Radiologic examination, knee; 3 views	False	8	C0203275;C3866434;C3866432;C3866433
73564	CPT	Radiologic examination, knee; complete, 4 or more views	False	6	C0373185;C3866431;C3515844
73565	CPT	Radiologic examination, knee; both knees, standing, anteroposterior	False	5	C0373186;C5696139;C5411014
73590	CPT	Radiologic examination; tibia and fibula, 2 views	False	6	C0203278;C2061914;C3515847
73592	CPT	Radiologic examination; lower extremity, infant, minimum of 2 views	False	6	C0203270;C3515848;C5411015
73600	CPT	Radiologic examination, ankle; 2 views	False	11	C3866425;C3866427;C3866429;C3515849;C2061515;C3866426;C3866428
73610	CPT	Radiologic examination, ankle; complete, minimum of 3 views	False	9	C3866421;C0373188;C3866422;C3866424;C3866423;C3515850
73620	CPT	Radiologic examination, foot; 2 views	False	8	C3866419;C3866420;C0203289;C3853595
73630	CPT	Radiologic examination, foot; complete, minimum of 3 views	False	6	C0203290;C3866418;C3515852
73650	CPT	Radiologic examination; calcaneus, minimum of 2 views	False	6	C0203292;C2322419;C3515853
73660	CPT	Radiologic examination; toe(s), minimum of 2 views	False	13	C3866414;C3866417;C0203294;C3866416;C3866415
73700	CPT	Computed tomography, lower extremity; without contrast material	False	5	C0203295;C5696142;C5411017
73701	CPT	Computed tomography, lower extremity; with contrast material(s)	False	5	C5696143;C5411018;C3840192
73702	CPT	Computed tomography, lower extremity; without contrast material, followed by contrast material(s) and further sections	False	5	C5696144;C0203297;C5411019
73706	CPT	Computed tomographic angiography, lower extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C5411021;C3703815;C5411020;C0918158
73718	CPT	Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s)	False	7	C5696145;C5411023;C5411024;C5411022;C0918159
73719	CPT	Magnetic resonance (eg, proton) imaging, lower extremity other than joint; with contrast material(s)	False	7	C3515858;C5411026;C5411027;C5411025;C0918160
73720	CPT	Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s), followed by contrast material(s) and further sequences	False	7	C0203299;C3515859;C5411028;C5411029;C5411030
73721	CPT	Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material	False	9	C5411035;C5696146;C5411032;C5411031;C5411033;C5411034;C0373190
73722	CPT	Magnetic resonance (eg, proton) imaging, any joint of lower extremity; with contrast material(s)	False	9	C5411039;C5411040;C5411036;C5411037;C3515861;C5411038;C0918161
73723	CPT	Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material(s), followed by contrast material(s) and further sequences	False	9	C5411041;C3527539;C5411042;C5411045;C5411043;C5411044;C0918162
73725	CPT	Magnetic resonance angiography, lower extremity, with or without contrast material(s)	False	6	C5696147;C5411046;C5411047;C0373191
74018	CPT	Radiologic examination, abdomen; 1 view	False	5	C3853584
74019	CPT	Radiologic examination, abdomen; 2 views	False	5	C4523441
74021	CPT	Radiologic examination, abdomen; 3 or more views	False	5	C4523442
74022	CPT	Radiologic examination, complete acute abdomen series, including 2 or more views of the abdomen (eg, supine, erect, decubitus), and a single view chest	False	12	C5696148;C3866381;C0373193;C3866382;C5201618;C5201619;C5201620;C5201621;C5201622;C5201623
74150	CPT	Computed tomography, abdomen; without contrast material	False	5	C0202838;C2041478;C5411048
74160	CPT	Computed tomography, abdomen; with contrast material(s)	False	5	C0202840;C5411049
74170	CPT	Computed tomography, abdomen; without contrast material, followed by contrast material(s) and further sections	False	5	C0202841;C3515864;C5411050
74174	CPT	Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C3248117;C5696149;C5411052;C5411051
74175	CPT	Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C5411054;C5696150;C5411053;C0918163
74176	CPT	Computed tomography, abdomen and pelvis; without contrast material	False	5	C2939268;C2957164;C5411055
74177	CPT	Computed tomography, abdomen and pelvis; with contrast material(s)	False	5	C5411056;C2315935;C3703818
74178	CPT	Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions	False	7	C3703819;C5411058;C2939270;C5411057;C5411059
74181	CPT	Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)	False	5	C5411060;C5696151;C0412693
74182	CPT	Magnetic resonance (eg, proton) imaging, abdomen; with contrast material(s)	False	5	C2314953;C5411061
74183	CPT	Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences	False	5	C3515867;C5411062;C0918165
74185	CPT	Magnetic resonance angiography, abdomen, with or without contrast material(s)	False	6	C3515868;C5411064;C5411063;C0373196
74210	CPT	Radiologic examination, pharynx and/or cervical esophagus, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study	False	13	C0373198;C5411070;C5411072;C5696153;C5411068;C5411071;C5411067;C5411069
74220	CPT	Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study	False	10	C5411074;C5201632;C5201635;C5201634;C5201633;C5411073
74221	CPT	Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; double-contrast (eg, high-density barium and effervescent agent) study	False	10	C5201638;C5201639;C5201641;C5201642;C5201643;C5201640
74230	CPT	Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study	False	10	C5411077;C5411075;C3515871;C5201644;C5201645;C5411076
74240	CPT	Radiologic examination, upper gastrointestinal tract, including scout abdominal radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study	False	10	C5201650;C5201651;C5201652;C5201654;C5201653;C0373200
74246	CPT	Radiologic examination, upper gastrointestinal tract, including scout abdominal radiograph(s) and delayed image(s), when performed; double-contrast (eg, high-density barium and effervescent agent) study, including glucagon, when administered	False	11	C5201659;C5201656;C5201657;C5201658;C5201660;C5201655;C0373202
74248	CPT	Radiologic small intestine follow-through study, including multiple serial images (List separately in addition to code for primary procedure for upper GI radiologic examination)	False	5	C5696155;C5201661;C5201663
74250	CPT	Radiologic examination, small intestine, including multiple serial images and scout abdominal radiograph(s), when performed; single-contrast (eg, barium) study	False	7	C5201669;C5696156;C5201665;C5201668
74251	CPT	Radiologic examination, small intestine, including multiple serial images and scout abdominal radiograph(s), when performed; double-contrast (eg, high-density barium and air via enteroclysis tube) study, including glucagon, when administered	False	13	C0373205;C5201671;C5201675;C5696157;C5201673;C5201672;C5201676;C5201674
74261	CPT	Computed tomographic (CT) colonography, diagnostic, including image postprocessing; without contrast material	False	5	C2724309;C5696158;C5411079
74262	CPT	Computed tomographic (CT) colonography, diagnostic, including image postprocessing; with contrast material(s) including non-contrast images, if performed	False	6	C5411080;C5411081;C2724310;C5696159
74263	CPT	Computed tomographic (CT) colonography, screening, including image postprocessing	False	5	C2724311;C5411082;C5696160
74270	CPT	Radiologic examination, colon, including scout abdominal radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study	False	10	C5411083;C5411084;C5696161;C5201679;C5201680;C0373206
74280	CPT	Radiologic examination, colon, including scout abdominal radiograph(s) and delayed image(s), when performed; double-contrast (eg, high density barium and air) study, including glucagon, when administered	False	11	C5696162;C5201684;C5201685;C5201686;C5201683;C5411085;C0373207
74290	CPT	Cholecystography, oral contrast	False	5	C0203079;C3515886
74712	CPT	Magnetic resonance (eg, proton) imaging, fetal, including placental and maternal pelvic imaging when performed; single or first gestation	False	6	C5411120;C5696183;C4051818;C5411121
75557	CPT	Cardiac magnetic resonance imaging for morphology and function without contrast material	False	5	C4545711;C5696187;C5411125
75559	CPT	Cardiac magnetic resonance imaging for morphology and function without contrast material; with stress imaging	False	5	C1964046;C5411126;C5696188
75561	CPT	Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences	False	5	C1964048;C5696189;C5411127
75563	CPT	Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences; with stress imaging	False	5	C1964050;C5696190;C5411128
75565	CPT	Cardiac magnetic resonance imaging for velocity flow mapping (List separately in addition to code for primary procedure)	False	5	C5411129;C5696191;C2724312
75571	CPT	Computed tomography, heart, without contrast material, with quantitative evaluation of coronary calcium	False	5	C2724313;C3515916;C5411130
75572	CPT	Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)	False	6	C5411132;C2724314;C3703843;C5411131
75573	CPT	Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology in the setting of congenital heart disease (including 3D image postprocessing, assessment of left ventricular [LV] cardiac function, right ventricular [RV] structure and function and evaluation of vascular structures, if performed)	False	6	C5411133;C5411134;C2724315;C5696192
75574	CPT	Computed tomographic angiography, heart, coronary arteries and bypass grafts (when present), with contrast material, including 3D image postprocessing (including evaluation of cardiac structure and morphology, assessment of cardiac function, and evaluation of venous structures, if performed)	False	8	C5411136;C2724316;C5411137;C5696193;C5411135;C5411138
75577					
75580	CPT	Noninvasive estimate of coronary fractional flow reserve (FFR) derived from augmentative software analysis of the data set from a coronary computed tomography angiography, with interpretation and report by a physician or other qualified health care professional	False	5	C4523769;C5850683
75635	CPT	Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing	False	6	C3703848;C5411144;C5411145;C0918166
76000	CPT	Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time	False	5	C5411254;C5696243;C0373311
76010	CPT	Radiologic examination from nose to rectum for foreign body, single view, child	False	6	C5696244;C0203055;C3866197
76100	CPT	Radiologic examination, single plane body section (eg, tomography), other than with urography	False	5	C5411257;C5696246;C0373324
76120	CPT	Cineradiography/videoradiography, except where specifically included	False	6	C0373325;C3515978;C3525383;C0008797
76125	CPT	Cineradiography/videoradiography to complement routine examination (List separately in addition to code for primary procedure)	False	6	C5411263;C0202611;C5411262
76376	CPT	3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; not requiring image postprocessing on an independent workstation	False	12	C5411267;C5411268;C1609547;C5411269;C5411274;C3515980;C5411273;C5411270;C5411271;C5411272
76377	CPT	3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstation	False	12	C1608996;C5411279;C5411280;C5411281;C5411278;C3515981;C5411275;C5411282;C5411277;C5411276
76380	CPT	Computed tomography, limited or localized follow-up study	False	6	C5411283;C0202657;C5696247;C5411284
76391	CPT	Magnetic resonance (eg, vibration) elastography	False	5	C1518156;C5696249;C5411285
76499	CPT	Unlisted diagnostic radiographic procedure	False	5	C5696251;C5411294;C0373327
76506	CPT	Echoencephalography, real time with image documentation (gray scale) (for determination of ventricular size, delineation of cerebral contents, and detection of fluid masses or other intracranial abnormalities), including A-mode encephalography as secondary component where indicated	False	6	C3866179;C0412508;C3866180;C0373328
76510	CPT	Ophthalmic ultrasound, diagnostic; B-scan and quantitative A-scan performed during the same patient encounter	False	5	C5697537;C1504143;C5411295
76511	CPT	Ophthalmic ultrasound, diagnostic; quantitative A-scan only	False	5	C5411296;C5696252;C0373329
76512	CPT	Ophthalmic ultrasound, diagnostic; B-scan (with or without superimposed non-quantitative A-scan)	False	6	C5411297;C0203446;C5696253;C5411298
76513	CPT	Ophthalmic ultrasound, diagnostic; anterior segment ultrasound, immersion (water bath) B-scan or high resolution biomicroscopy, unilateral or bilateral	False	9	C5696254;C5411300;C0373331;C5411299;C5411301;C5411303;C5411302
76514	CPT	Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness)	False	6	C5696255;C1314092;C3866173;C3525396
76516	CPT	Ophthalmic biometry by ultrasound echography, A-scan	False	5	C0412515;C5696256
76519	CPT	Ophthalmic biometry by ultrasound echography, A-scan; with intraocular lens power calculation	False	5	C5696257;C0203449
76536	CPT	Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation	False	5	C0203453;C3866171;C4510089
76604	CPT	Ultrasound, chest (includes mediastinum), real time with image documentation	False	6	C5411304;C5411305;C5696259;C0373332
76641	CPT	Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; complete	False	6	C3862147;C5411306;C3865382;C5696260
76642	CPT	Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited	False	6	C3865381;C5696261;C5411308;C5411309
76700	CPT	Ultrasound, abdominal, real time with image documentation; complete	False	5	C5696262;C5411311;C0373334
76705	CPT	Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)	False	12	C5411314;C5411317;C5411319;C5411320;C5696263;C5411313;C5411315;C5411316;C5411318;C0373335
76706	CPT	Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)	False	5	C0412525;C5411321;C4291772
76770	CPT	Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete	False	8	C5411322;C5411324;C5696264;C5411325;C5411323;C0373336
76775	CPT	Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited	False	8	C5411328;C3866152;C5696265;C5411326;C5411327;C0373337
76776	CPT	Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation	False	5	C1737169;C0412548
76800	CPT	Ultrasound, spinal canal and contents	False	5	C0203451;C5696266
76801	CPT	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation	False	6	C5411329;C1144704;C5696267;C5411330
76802	CPT	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; each additional gestation (List separately in addition to code for primary procedure)	False	5	C1144705;C5696268;C5411331
76805	CPT	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation	False	6	C0203421;C5696269;C5411333;C5411332
76810	CPT	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; each additional gestation (List separately in addition to code for primary procedure)	False	5	C5696270;C5411334;C0373339
76811	CPT	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation	False	6	C1144706;C5696271;C5411336;C5411335
76812	CPT	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; each additional gestation (List separately in addition to code for primary procedure)	False	5	C5411337;C5696272;C1144707
76815	CPT	Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses	False	9	C0203420;C5411344;C5411348;C5696275;C5411345;C5411346;C5411347
76816	CPT	Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus	False	8	C5411352;C5411351;C5696276;C5411349;C5411350;C0373340
76818	CPT	Fetal biophysical profile; with non-stress testing	False	5	C2243062;C3516004;C5411353
76819	CPT	Fetal biophysical profile; without non-stress testing	False	6	C5411354;C0203425;C0203428;C0918172
76820	CPT	Doppler velocimetry, fetal; umbilical artery	False	5	C1504144;C5696277
76821	CPT	Doppler velocimetry, fetal; middle cerebral artery	False	5	C1504145;C5696278
76825	CPT	Echocardiography, fetal, cardiovascular system, real time with image documentation (2D), with or without M-mode recording	False	6	C5411356;C5696279;C5411355;C0373341
76826	CPT	Echocardiography, fetal, cardiovascular system, real time with image documentation (2D), with or without M-mode recording; follow-up or repeat study	False	8	C5411358;C5411357;C5696280;C5411359;C5411360;C0373342
76827	CPT	Doppler echocardiography, fetal, pulsed wave and/or continuous wave with spectral display; complete	False	7	C0373343;C5696281;C5411361;C5411362;C5411363
76828	CPT	Doppler echocardiography, fetal, pulsed wave and/or continuous wave with spectral display; follow-up or repeat study	False	10	C5411369;C5696282;C5411368;C5411365;C5411367;C5411364;C5411366;C0373344
76856	CPT	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	False	6	C0203479;C3866110;C5696285;C5411373
76857	CPT	Ultrasound, pelvic (nonobstetric), real time with image documentation; limited or follow-up (eg, for follicles)	False	6	C0203480;C5411375;C5696286;C5411376
76870	CPT	Ultrasound, scrotum and contents	False	5	C0412550;C0845888
76881	CPT	Ultrasound, complete joint (ie, joint space and peri-articular soft-tissue structures), real-time with image documentation	False	5	C2939271;C5696289;C5411380
76882	CPT	Ultrasound, limited, joint or focal evaluation of other nonvascular extremity structure(s) (eg, joint space, peri-articular tendon[s], muscle[s], nerve[s], other soft-tissue structure[s], or soft-tissue mass[es]), real-time with image documentation	False	16	C5702006;C5411382;C5411387;C2939272;C5411388;C5702004;C5702007;C5702003;C5702005;C5411381;C5411386
76883	CPT	Ultrasound, nerve(s) and accompanying structures throughout their entire anatomic course in one extremity, comprehensive, including real-time cine imaging with image documentation, per extremity	False	6	C5702008;C5702010;C5702009
76885	CPT	Ultrasound, infant hips, real time with imaging documentation; dynamic (requiring physician or other qualified health care professional manipulation)	False	6	C5411389;C5411390;C5696291;C0519821
76886	CPT	Ultrasound, infant hips, real time with imaging documentation; limited, static (not requiring physician or other qualified health care professional manipulation)	False	7	C2122220;C5411391;C3866104;C5411392;C0520378
76977	CPT	Ultrasound bone density measurement and interpretation, peripheral site(s), any method	False	6	C3525424;C5696300;C0695041
76978	CPT	Ultrasound, targeted dynamic microbubble sonographic contrast characterization (non-cardiac); initial lesion	False	5	C5696301;C4732077;C5411396
76979	CPT	Ultrasound, targeted dynamic microbubble sonographic contrast characterization (non-cardiac); each additional lesion with separate injection (List separately in addition to code for primary procedure)	False	5	C4732080;C5696302;C5411397
76981	CPT	Ultrasound, elastography; parenchyma (eg, organ)	False	5	C5696303;C4732083;C4732085
76982	CPT	Ultrasound, elastography; first target lesion	False	5	C4732086;C5696304
76983	CPT	Ultrasound, elastography; each additional target lesion (List separately in addition to code for primary procedure)	False	5	C5696305;C4732090;C4732088
76984	CPT	Ultrasound, intraoperative thoracic aorta (eg, epiaortic), diagnostic	False	6	C5850684;C5850685;C5850686
76987	CPT	Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; including placement and manipulation of transducer, image acquisition, interpretation and report	False	6	C5850688;C5850689
76988	CPT	Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; placement, manipulation of transducer, and image acquisition only	False	6	C5850690;C5850691;C5850692
76989	CPT	Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; interpretation and report only	False	6	C5850693;C5850694
76999	CPT	Unlisted ultrasound procedure (eg, diagnostic, interventional)	False	7	C5411398;C5411400;C5696306;C0041618;C5411399
77046	CPT	Magnetic resonance imaging, breast, without contrast material; unilateral	False	5	C5696315;C4732092;C5411415
77047	CPT	Magnetic resonance imaging, breast, without contrast material; bilateral	False	5	C5696316;C4732094;C5411416
77048	CPT	Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; unilateral	False	6	C5411417;C5696317;C4732097;C5411418
77049	CPT	Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral	False	6	C4732101;C5411419;C5696318;C5411420
77061	CPT	Diagnostic digital breast tomosynthesis; unilateral	False	5	C3863722;C5696321
77062	CPT	Diagnostic digital breast tomosynthesis; bilateral	False	5	C5696322;C3863729
77065	CPT	Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral	False	6	C4292313;C5696324;C4292312;C0993890
77066	CPT	Diagnostic mammography, including computer-aided detection (CAD) when performed; bilateral	False	6	C0993888;C5416729;C4292314;C5411426
77071	CPT	Manual application of stress performed by physician or other qualified health care professional for joint radiography, including contralateral joint if indicated	False	6	C3866049;C3525438;C5696325;C0695040
77072	CPT	Bone age studies	False	7	C5696326;C3866047;C0411916;C3866048
77073	CPT	Bone length studies (orthoroentgenogram, scanogram)	False	6	C5696327;C3866046;C0373314
77074	CPT	Radiologic examination, osseous survey; limited (eg, for metastases)	False	6	C5696328;C0202617;C3866045;C3866044
77075	CPT	Radiologic examination, osseous survey; complete (axial and appendicular skeleton)	False	5	C5696329;C0202616;C3866043
77076	CPT	Radiologic examination, osseous survey, infant	False	5	C0202618;C5696330
77077	CPT	Joint survey, single view, 2 or more joints (specify)	False	5	C1736630;C5696331;C5411428
77078	CPT	Computed tomography, bone mineral density study, 1 or more sites, axial skeleton (eg, hips, pelvis, spine)	False	9	C5411429;C5411430;C1737711;C5696332;C5411431;C5411433;C5411432
77080	CPT	Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)	False	9	C5411434;C1740748;C5696333;C5411437;C5411435;C5411438;C5411436
77081	CPT	Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)	False	10	C5696334;C5411444;C1740480;C5411442;C5411440;C5411441;C5411445;C5411443
77084	CPT	Magnetic resonance (eg, proton) imaging, bone marrow blood supply	False	5	C0202674;C5411452
77085	CPT	Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment	False	9	C3865380;C5411447;C5411448;C5411450;C5696335;C5411451;C5411449
77086	CPT	Vertebral fracture assessment via dual-energy X-ray absorptiometry (DXA)	False	5	C5411453;C3865379;C5696336
77089	CPT	Trabecular bone score (TBS), structural condition of the bone microarchitecture; using dual X-ray absorptiometry (DXA) or other imaging data on gray-scale variogram, calculation, with interpretation and report on fracture-risk	False	6	C5697863;C5691479;C5696337;C5697862
77261	CPT	Therapeutic radiology treatment planning; simple	False	6	C0373358;C3866025;C5696341
77262	CPT	Therapeutic radiology treatment planning; intermediate	False	6	C5411454;C5696342;C0373359
77263	CPT	Therapeutic radiology treatment planning; complex	False	6	C0203502;C5411455;C5696343;C5411456
77280	CPT	Therapeutic radiology simulation-aided field setting; simple	False	6	C3866022;C5696344;C0373360
77285	CPT	Therapeutic radiology simulation-aided field setting; intermediate	False	6	C5411457;C5696345;C0373361
77290	CPT	Therapeutic radiology simulation-aided field setting; complex	False	6	C0373362;C5696346;C5411458
77295	CPT	3-dimensional radiotherapy plan, including dose-volume histograms	False	6	C3702030;C5411460;C5696349;C5411461
77299	CPT	Unlisted procedure, therapeutic radiology clinical treatment planning	False	5	C0203527;C5696348
77300	CPT	Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, only when prescribed by the treating physician	False	5	C3516053;C5411462;C0373364
77301	CPT	Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications	False	6	C5411463;C0973330;C5696350;C3525445
77306	CPT	Teletherapy isodose plan; simple (1 or 2 unmodified ports directed to a single area of interest), includes basic dosimetry calculation(s)	False	5	C5696351;C3865378;C0203516
77307	CPT	Teletherapy isodose plan; complex (multiple treatment areas, tangential ports, the use of wedges, blocking, rotational beam, or special beam considerations), includes basic dosimetry calculation(s)	False	5	C5696352;C3865377;C0203518
77316	CPT	Brachytherapy isodose plan; simple (calculation[s] made from 1 to 4 sources, or remote afterloading brachytherapy, 1 channel), includes basic dosimetry calculation(s)	False	6	C3865376;C5411468;C5696353;C5411467
77317	CPT	Brachytherapy isodose plan; intermediate (calculation[s] made from 5 to 10 sources, or remote afterloading brachytherapy, 2-12 channels), includes basic dosimetry calculation(s)	False	6	C3865375;C5411471;C5411470;C5696354
77318	CPT	Brachytherapy isodose plan; complex (calculation[s] made from over 10 sources, or remote afterloading brachytherapy, over 12 channels), includes basic dosimetry calculation(s)	False	6	C3865374;C5411474;C5696355;C5411473
77321	CPT	Special teletherapy port plan, particles, hemibody, total body	False	6	C5696356;C0203524;C3866017;C3866016
77331	CPT	Special dosimetry (eg, TLD, microdosimetry) (specify), only when prescribed by the treating physician	False	7	C3866015;C0203512;C3516061;C0039814;C0373365
77332	CPT	Treatment devices, design and construction; simple (simple block, simple bolus)	False	7	C0203528;C5411477;C3516062;C5411475;C5411476
77333	CPT	Treatment devices, design and construction; intermediate (multiple blocks, stents, bite blocks, special bolus)	False	9	C5411478;C5411481;C0203529;C3866011;C3516063;C5411479;C5411480
77334	CPT	Treatment devices, design and construction; complex (irregular blocks, special shields, compensators, wedges, molds or casts)	False	11	C3866005;C0203530;C3865999;C3866001;C3866002;C3866003;C3866004;C3866000;C2094482
77336	CPT	Continuing medical physics consultation, including assessment of treatment parameters, quality assurance of dose delivery, and review of patient treatment documentation in support of the radiation oncologist, reported per week of therapy	False	6	C5696357;C0373366;C5411482;C3525448
77338	CPT	Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan	False	5	C5696358;C2724318;C5411483
77370	CPT	Special medical radiation physics consultation	False	5	C0203493;C5696359
77371	CPT	Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; multi-source Cobalt 60 based	False	6	C1736900;C5696360;C5411484;C5411485
77372	CPT	Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; linear accelerator based	False	6	C3865994;C1736631;C5696361
77373	CPT	Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions	False	5	C1737712;C5411487;C5944543
77387	CPT	Guidance for localization of target volume for delivery of radiation treatment, includes intrafraction tracking, when performed	False	6	C3865371;C5696368;C5411493;C5411494
77399	CPT	Unlisted procedure, medical radiation physics, dosimetry and treatment devices, and special services	False	8	C0203495;C5411505;C5696363;C5411504;C5411502;C5411503
77402	CPT	Radiation treatment delivery, >=1 MeV; simple	False	5	C3853605;C5411497
77407	CPT	Radiation treatment delivery, >=1 MeV; intermediate	False	5	C0373371;C5411498
77412	CPT	Radiation treatment delivery, >=1 MeV; complex	False	5	C3853606;C5411499
77417	CPT	Therapeutic radiology port image(s)	False	6	C5696365;C4051864
77423	CPT	High energy neutron radiation treatment delivery, 1 or more isocenter(s) with coplanar or non-coplanar geometry with blocking and/or wedge, and/or compensator(s)	False	6	C3865982;C3865983;C1611757;C5696371
77427	CPT	Radiation treatment management, 5 treatments	False	5	C3865981;C5696372;C0812547
77431	CPT	Radiation therapy management with complete course of therapy consisting of 1 or 2 fractions only	False	6	C3865979;C3865980;C5696373;C0373384
77432	CPT	Stereotactic radiation treatment management of cranial lesion(s) (complete course of treatment consisting of 1 session)	False	6	C0373385;C3865978;C5696374
77435	CPT	Stereotactic body radiation therapy, treatment management, per treatment course, to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions	False	8	C5411506;C1742711;C3865976;C5696375;C3525466;C5411507
77436					
77437					
77438					
77439					
77470	CPT	Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)	False	9	C0206113;C1719237;C3865973;C3865974;C0043162
77499	CPT	Unlisted procedure, therapeutic radiology treatment management	False	5	C5697538;C0373387
77520	CPT	Proton treatment delivery; simple, without compensation	False	5	C5696376;C3516077;C0695042
77522	CPT	Proton treatment delivery; simple, with compensation	False	5	C5696377;C0918173
77523	CPT	Proton treatment delivery; intermediate	False	5	C5696378;C0812548
77525	CPT	Proton treatment delivery; complex	False	5	C5696379;C0918174
77600	CPT	Hyperthermia, externally generated; superficial (ie, heating to a depth of 4 cm or less)	False	5	C0373388;C5696380;C5411509
77605	CPT	Hyperthermia, externally generated; deep (ie, heating to depths greater than 4 cm)	False	5	C0373389;C5696381;C5411510
77610	CPT	Hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators	False	5	C0203601;C5696382;C5411511
77615	CPT	Hyperthermia generated by interstitial probe(s); more than 5 interstitial applicators	False	5	C5696383;C3865971;C0203602
77620	CPT	Hyperthermia generated by intracavitary probe(s)	False	6	C0203603;C5696384
77750	CPT	Infusion or instillation of radioelement solution (includes 3-month follow-up care)	False	6	C3865969;C0203631;C3665453;C3865970
77761	CPT	Intracavitary radiation source application; simple	False	6	C0203575;C5696385;C5411512;C5411513
77762	CPT	Intracavitary radiation source application; intermediate	False	6	C5696386;C3865967;C5411514;C0203576
77763	CPT	Intracavitary radiation source application; complex	False	6	C0203577;C3865966;C5411515;C5696387
77767	CPT	Remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter up to 2.0 cm or 1 channel	False	6	C4052120;C5411516;C4050034;C5696388
77768	CPT	Remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter over 2.0 cm and 2 or more channels, or multiple lesions	False	8	C5696389;C4050033;C5411518;C5411519;C5411517;C4052117
77770	CPT	Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 1 channel	False	8	C5411520;C4052114;C4050030;C5696390;C5411521;C4052113
77771	CPT	Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 2-12 channels	False	8	C5411522;C5696391;C4050032;C5411523;C4052111;C4052112
77772	CPT	Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; over 12 channels	False	8	C5411524;C4050031;C5696392;C5411525;C4052109;C4052110
77778	CPT	Interstitial radiation source application, complex, includes supervision, handling, loading of radiation source, when performed	False	6	C0203583;C5411526;C3865963
77789	CPT	Surface application of low dose rate radionuclide source	False	5	C5696393;C4051863
77790	CPT	Supervision, handling, loading of radiation source	False	5	C0203606
77799	CPT	Unlisted procedure, clinical brachytherapy	False	5	C0203596;C5696395
78012	CPT	Thyroid uptake, single or multiple quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)	False	6	C3865961;C3511538;C3865962;C5696396
78013	CPT	Thyroid imaging (including vascular flow, when performed)	False	6	C0203779;C0203785;C3865960;C5696397
78014	CPT	Thyroid imaging (including vascular flow, when performed); with single or multiple uptake(s) quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)	False	8	C3865959;C3865958;C3865957;C3865956;C5696398;C3496323
78015	CPT	Thyroid carcinoma metastases imaging; limited area (eg, neck and chest only)	False	6	C3865955;C0203786;C5696399;C5411527
78016	CPT	Thyroid carcinoma metastases imaging; with additional studies (eg, urinary recovery)	False	6	C5696400;C5411528;C0203791;C3865953
78018	CPT	Thyroid carcinoma metastases imaging; whole body	False	5	C0203790;C3865952;C3516087
78020	CPT	Thyroid carcinoma metastases uptake (List separately in addition to code for primary procedure)	False	5	C3865951;C5696401;C0695044
78070	CPT	Parathyroid planar imaging (including subtraction, when performed)	False	6	C3511539;C3865950;C5696402
78071	CPT	Parathyroid planar imaging (including subtraction, when performed); with tomographic (SPECT)	False	6	C5696403;C5411529;C3511540;C5411530
78072	CPT	Parathyroid planar imaging (including subtraction, when performed); with tomographic (SPECT), and concurrently acquired computed tomography (CT) for anatomical localization	False	6	C5411531;C5696404;C3511541;C5411532
78075	CPT	Adrenal imaging, cortex and/or medulla	False	7	C0373398;C2094532;C3865947;C2094533;C5696405
78099	CPT	Unlisted endocrine procedure, diagnostic nuclear medicine	False	5	C5411533;C3516092;C0373399
78102	CPT	Bone marrow imaging; limited area	False	5	C0203801;C3865946;C5696406
78103	CPT	Bone marrow imaging; multiple areas	False	5	C5696407;C0203802;C3865944
78104	CPT	Bone marrow imaging; whole body	False	5	C5411534;C0203803;C5696408
78110	CPT	Plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); single sampling	False	5	C3865942;C5696409;C0373400
78111	CPT	Plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); multiple samplings	False	5	C3865940;C0373401;C5696410
78120	CPT	Red cell volume determination (separate procedure); single sampling	False	5	C3865939;C0203809;C5696411
78121	CPT	Red cell volume determination (separate procedure); multiple samplings	False	5	C5696412;C3865937;C0203810
78122	CPT	Whole blood volume determination, including separate measurement of plasma volume and red cell volume (radiopharmaceutical volume-dilution technique)	False	6	C5411538;C0203805;C3865936;C5696413
78130	CPT	Red cell survival study	False	5	C0412489;C3865935;C5696414
78140	CPT	Labeled red cell sequestration, differential organ/tissue (eg, splenic and/or hepatic)	False	5	C3865933;C0373403;C5696415
78185	CPT	Spleen imaging only, with or without vascular flow	False	6	C3865932;C3865931;C5696416;C0373405
78191	CPT	Platelet survival study	False	5	C3865926;C5696417;C0412490
78195	CPT	Lymphatics and lymph nodes imaging	False	5	C0203827;C5696418
78199	CPT	Unlisted hematopoietic, reticuloendothelial and lymphatic procedure, diagnostic nuclear medicine	False	5	C5411542;C5411541;C0373407
78201	CPT	Liver imaging; static only	False	5	C0203759;C3865924;C3516100
78202	CPT	Liver imaging; with vascular flow	False	5	C3865923;C0203761;C3516101
78215	CPT	Liver and spleen imaging; static only	False	5	C3865920;C0203766;C5696419
78216	CPT	Liver and spleen imaging; with vascular flow	False	5	C0203767;C3865919;C5696420
78226	CPT	Hepatobiliary system imaging, including gallbladder when present	False	6	C3248121;C3865918;C5697539;C5411543
78227	CPT	Hepatobiliary system imaging, including gallbladder when present; with pharmacologic intervention, including quantitative measurement(s) when performed	False	8	C3248122;C3865913;C5411544;C3865914;C5696421;C5411545
78230	CPT	Salivary gland imaging	False	5	C3496536;C3865912;C3516105
78231	CPT	Salivary gland imaging; with serial images	False	5	C5696422;C3865911;C0373410
78232	CPT	Salivary gland function study	False	5	C0203772;C3865910;C5696423
78258	CPT	Esophageal motility	False	5	C5696424;C0700223;C3865909
78261	CPT	Gastric mucosa imaging	False	5	C0203748;C3865908;C5696425
78262	CPT	Gastroesophageal reflux study	False	5	C3865907;C0473905;C5696426
78264	CPT	Gastric emptying imaging study (eg, solid, liquid, or both)	False	5	C5696427;C0203071;C3865906
78265	CPT	Gastric emptying imaging study (eg, solid, liquid, or both); with small bowel transit	False	5	C5696428;C4050028;C4052108
78266	CPT	Gastric emptying imaging study (eg, solid, liquid, or both); with small bowel and colon transit, multiple days	False	5	C4050029;C5696429;C5411548
78267	CPT	Urea breath test, C-14 (isotopic); acquisition for analysis	False	5	C5411550;C5696430;C0812549
78268	CPT	Urea breath test, C-14 (isotopic); analysis	False	5	C5696431;C0812550;C5411552
78278	CPT	Acute gastrointestinal blood loss imaging	False	5	C0203751;C3865899;C5696432
78282	CPT	Gastrointestinal protein loss	False	5	C3865898;C0473916;C5696433
78290	CPT	Intestine imaging (eg, ectopic gastric mucosa, Meckel's localization, volvulus)	False	5	C5696434;C1278711;C3865897
78291	CPT	Peritoneal-venous shunt patency test (eg, for LeVeen, Denver shunt)	False	7	C5696435;C0203872;C3865896;C3865894;C3865895
78299	CPT	Unlisted gastrointestinal procedure, diagnostic nuclear medicine	False	5	C5411553;C3516109;C0373413
78300	CPT	Bone and/or joint imaging; limited area	False	7	C5696436;C3865891;C3865893;C3865892;C0373414
78305	CPT	Bone and/or joint imaging; multiple areas	False	7	C3865888;C3865889;C3865890;C5696437;C0373415
78306	CPT	Bone and/or joint imaging; whole body	False	7	C0373416;C5411554;C5696438;C5411555;C5411556
78315	CPT	Bone and/or joint imaging; 3 phase study	False	7	C3865882;C3865883;C3865884;C5696439;C0373417
78399	CPT	Unlisted musculoskeletal procedure, diagnostic nuclear medicine	False	5	C5696442;C5411557;C0373419
78428	CPT	Cardiac shunt detection	False	5	C0203739;C5696444
78429	CPT	Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single study; with concurrently acquired computed tomography transmission scan	False	8	C5696452;C5411564;C5411565;C5201688;C5411566;C5411567
78430	CPT	Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scan	False	16	C5411572;C5411574;C5411580;C5411582;C5411573;C5411577;C5696459;C5201700;C5411575;C5411576;C5411578;C5411583;C5411579;C5411581
78431	CPT	Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scan	False	16	C5411584;C5411590;C5411595;C5411587;C5411594;C5201714;C5696459;C5411586;C5411589;C5411591;C5411593;C5411585;C5411588;C5411592
78432	CPT	Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability)	False	8	C5411615;C5696460;C5201746;C5411614;C5411616;C5411617
78433	CPT	Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability); with concurrently acquired computed tomography transmission scan	False	8	C5411618;C5201751;C5696461;C5411619;C5411620;C5411621
78434	CPT	Absolute quantitation of myocardial blood flow (AQMBF), positron emission tomography (PET), rest and pharmacologic stress (List separately in addition to code for primary procedure)	False	5	C5696462;C5411622;C5201757
78445	CPT	Non-cardiac vascular flow imaging (ie, angiography, venography)	False	7	C3865861;C3865859;C5696445;C0519146;C5411623
78451	CPT	Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic)	False	8	C2724319;C5411625;C5696446;C5411626;C5411627;C5411624
78452	CPT	Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection	False	8	C5411628;C2724320;C5696446;C5411630;C5411629;C5411631
78453	CPT	Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic)	False	8	C2724321;C4052106;C5696447;C4052104;C4052105;C4052103
78454	CPT	Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection	False	8	C3865840;C3865842;C2724322;C3865839;C3865841;C5696447
78456	CPT	Acute venous thrombosis imaging, peptide	False	5	C5696448;C0812551
78457	CPT	Venous thrombosis imaging, venogram; unilateral	False	5	C3865838;C0203737;C5696449
78458	CPT	Venous thrombosis imaging, venogram; bilateral	False	6	C0203738;C5696450;C5411632;C5411633
78459	CPT	Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single study	False	8	C5411569;C5411571;C5411568;C5696451;C5411570;C0373423
78466	CPT	Myocardial imaging, infarct avid, planar; qualitative or quantitative	False	6	C3865836;C3865837;C3516129;C0373427
78468	CPT	Myocardial imaging, infarct avid, planar; with ejection fraction by first pass technique	False	5	C5696453;C0373428
78469	CPT	Myocardial imaging, infarct avid, planar; tomographic SPECT with or without quantification	False	8	C5696454;C5411635;C5411638;C5411637;C5411636;C0373429
78472	CPT	Cardiac blood pool imaging, gated equilibrium; planar, single study at rest or stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without additional quantitative processing	False	14	C5696455;C3865834;C3865828;C3865831;C3865833;C3865829;C3865827;C3865830;C3865832;C3525524;C3525527;C0373430
78473	CPT	Cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fraction, at rest and stress (exercise and/or pharmacologic), with or without additional quantification	False	14	C3865822;C3865833;C3865834;C0373431;C3865823;C3865826;C3865832;C3865825;C3865824;C3525527;C5696455;C3525526
78481	CPT	Cardiac blood pool imaging (planar), first pass technique; single study, at rest or with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification	False	14	C5696456;C5411642;C5411644;C5411648;C5411640;C5411641;C5411643;C5411646;C5411647;C5411649;C0519149;C5411645
78483	CPT	Cardiac blood pool imaging (planar), first pass technique; multiple studies, at rest and with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification	False	14	C5411650;C5411652;C5411656;C5411658;C5696457;C5411654;C5411651;C5411653;C5411655;C5411659;C5411657;C0519150
78491	CPT	Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic)	False	16	C5411600;C5411601;C5411602;C5411604;C5411596;C5411607;C5696458;C5411605;C5411599;C5411606;C5411597;C5411598;C5411603;C0519151
78492	CPT	Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic)	False	10	C5411608;C5411610;C5696458;C5411611;C5411613;C5411609;C5411612;C0519152
78494	CPT	Cardiac blood pool imaging, gated equilibrium, SPECT, at rest, wall motion study plus ejection fraction, with or without quantitative processing	False	6	C5696463;C0695046;C5411661;C5411660
78496	CPT	Cardiac blood pool imaging, gated equilibrium, single study, at rest, with right ventricular ejection fraction by first pass technique (List separately in addition to code for primary procedure)	False	5	C3865803;C5696464;C0695047
78499	CPT	Unlisted cardiovascular procedure, diagnostic nuclear medicine	False	5	C5411662;C0373434;C5696465
78579	CPT	Pulmonary ventilation imaging (eg, aerosol or gas)	False	7	C3248123;C3865801;C3865802;C3516138
78580	CPT	Pulmonary perfusion imaging (eg, particulate)	False	6	C0203685;C3865800;C3525539;C5696466
78582	CPT	Pulmonary ventilation (eg, aerosol or gas) and perfusion imaging	False	7	C3248124;C5696467;C3865798;C3865799
78597	CPT	Quantitative differential pulmonary perfusion, including imaging when performed	False	6	C3248125;C5696468;C3525540;C5411663
78598	CPT	Quantitative differential pulmonary perfusion and ventilation (eg, aerosol or gas), including imaging when performed	False	10	C5696469;C3865794;C3248126;C3865796;C3525541;C5411666;C5411664;C5411665
78599	CPT	Unlisted respiratory procedure, diagnostic nuclear medicine	False	5	C5696470;C5411667;C0373436
78600	CPT	Brain imaging, less than 4 static views	False	5	C0203861;C5696471
78601	CPT	Brain imaging, less than 4 static views; with vascular flow	False	5	C0203864;C5696472
78605	CPT	Brain imaging, minimum 4 static views	False	5	C5696473;C0203862
78606	CPT	Brain imaging, minimum 4 static views; with vascular flow	False	5	C0203865;C5411669;C5696474
78608	CPT	Brain imaging, positron emission tomography (PET); metabolic evaluation	False	5	C3516146;C5411670;C0373437
78610	CPT	Brain imaging, vascular flow only	False	5	C0203863;C5696472;C0373439
78630	CPT	Cerebrospinal fluid flow, imaging (not including introduction of material); cisternography	False	5	C5696476;C0412343;C0373441
78635	CPT	Cerebrospinal fluid flow, imaging (not including introduction of material); ventriculography	False	5	C0203870;C0373442;C5696477
78645	CPT	Cerebrospinal fluid flow, imaging (not including introduction of material); shunt evaluation	False	5	C0412344;C5696478;C0373443
78650	CPT	Cerebrospinal fluid leakage detection and localization	False	5	C3865791;C5696479;C0203874
78660	CPT	Radiopharmaceutical dacryocystography	False	5	C0412346;C5696480
78699	CPT	Unlisted nervous system procedure, diagnostic nuclear medicine	False	5	C0373445;C5696481;C5411672
78700	CPT	Kidney imaging morphology	False	5	C3865790;C3665455;C3516158
78701	CPT	Kidney imaging morphology; with vascular flow	False	5	C0203845;C3865789;C5696482
78707	CPT	Kidney imaging morphology; with vascular flow and function, single study without pharmacological intervention	False	5	C5696483;C0519153;C5411674
78708	CPT	Kidney imaging morphology; with vascular flow and function, single study, with pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)	False	8	C5411678;C5696484;C0520383;C5411676;C5411677;C5411679
78709	CPT	Kidney imaging morphology; with vascular flow and function, multiple studies, with and without pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)	False	8	C5696483;C5411680;C5411681;C5411682;C5411683;C0520384
78725	CPT	Kidney function study, non-imaging radioisotopic study	False	5	C0373448;C3516159;C5411684
78730	CPT	Urinary bladder residual study (List separately in addition to code for primary procedure)	False	5	C0203852;C3865780;C3516160
78740	CPT	Ureteral reflux study (radiopharmaceutical voiding cystogram)	False	5	C0203853;C5696485;C3525551
78761	CPT	Testicular imaging with vascular flow	False	5	C5696486;C0203855;C3865779
78799	CPT	Unlisted genitourinary procedure, diagnostic nuclear medicine	False	5	C5696487;C5411685;C0373449
78800	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, single area (eg, head, neck, chest, pelvis), single day imaging	False	44	C5696488;C5411696;C5411695;C5201768;C5201771;C5201776;C5201780;C5201782;C5201788;C5201765;C5201769;C5201767;C5201770;C5201778;C5201779;C5201785;C5201789;C5201766;C5201772;C5201784;C5201786;C5201787;C5201790;C5201762;C5201764
78801	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, 2 or more areas (eg, abdomen and pelvis, head and chest), 1 or more days imaging or single area imaging over 2 or more days	False	7	C3865776;C2094655;C5696489;C5201801
78802	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, whole body, single day imaging	False	12	C5411697;C5411698;C5696490;C5201806;C5201809;C5201810;C5201803;C5201807;C5201808;C5201805
78803	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT), single area (eg, head, neck, chest, pelvis) or acquisition, single day imaging	False	50	C5702011;C5702012;C5702013;C5411699;C5411701;C5411703;C5411704;C5411705;C5411714;C5411719;C5411721;C5411724;C5411700;C5411702;C5411708;C5411716;C5411717;C5411718;C5411722;C5702014;C5702016;C5702015;C5702017;C5411706;C5411707
78804	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, whole body, requiring 2 or more days imaging	False	12	C1314095;C5696491;C5201854;C5201852;C5201856;C5201851;C5201855;C5411729;C5411730
78811	CPT	Positron emission tomography (PET) imaging; limited area (eg, chest, head/neck)	False	9	C1504146;C3516172;C5411810;C5411808;C5411809;C5411811;C5411812
78812	CPT	Positron emission tomography (PET) imaging; skull base to mid-thigh	False	5	C1504147;C5696498;C5411813
78813	CPT	Positron emission tomography (PET) imaging; whole body	False	5	C1504148;C5696490;C5411814
78814	CPT	Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; limited area (eg, chest, head/neck)	False	13	C5411815;C5411819;C5411820;C1504149;C5411816;C5411823;C5696499;C5411822;C5411821;C5411817;C5411818
78815	CPT	Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh	False	5	C1504150;C5411824;C5696500
78816	CPT	Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body	False	6	C1504151;C5696501;C5411826;C5411825
78830	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, single area (eg, head, neck, chest, pelvis) or acquisition, single day imaging	False	47	C5702019;C5702020;C5411731;C5411732;C5411733;C5411735;C5411737;C5411738;C5411741;C5411746;C5411754;C5411744;C5411747;C5411748;C5411752;C5411753;C5411758;C5411759;C5201859;C5702021;C5702022;C5702018;C5411736;C5411740;C5411757
78831	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT), minimum 2 areas (eg, pelvis and knees, chest and abdomen) or separate acquisitions (eg, lung ventilation and perfusion), single day imaging, or single area or acquisition over 2 or more days	False	43	C5702023;C5702033;C5702035;C5702036;C5702038;C5702039;C5411769;C5411772;C5411774;C5411776;C5411777;C5411767;C5411768;C5411773;C5411775;C5411781;C5411782;C5411783;C5411785;C5702025;C5702027;C5201895;C5702024;C5702026;C5702028
78832	CPT	Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, minimum 2 areas (eg, pelvis and knees, chest and abdomen) or separate acquisitions (eg, lung ventilation and perfusion), single day imaging, or single area or acquisition over 2 or more days	False	32	C5702041;C5702045;C5702046;C5411788;C5411791;C5411798;C5411802;C5411804;C5411790;C5411797;C5411799;C5702042;C5702043;C5201927;C5702040;C5702044;C5411789;C5411794;C5411795;C5411792;C5411796;C5411793;C5411803;C5411805;C5411806
78835	CPT	Radiopharmaceutical quantification measurement(s) single area (List separately in addition to code for primary procedure)	False	6	C5696496;C5201958;C5201956
78999	CPT	Unlisted miscellaneous procedure, diagnostic nuclear medicine	False	5	C0373458;C5696502;C5411827
79005	CPT	Radiopharmaceutical therapy, by oral administration	False	5	C2169312;C5696503;C1504152
79101	CPT	Radiopharmaceutical therapy, by intravenous administration	False	5	C2169305;C1504153;C5696504
79200	CPT	Radiopharmaceutical therapy, by intracavitary administration	False	5	C0203614;C5696505;C3525561
79300	CPT	Radiopharmaceutical therapy, by interstitial radioactive colloid administration	False	5	C5696506;C0203615;C3525562
79403	CPT	Radiopharmaceutical therapy, radiolabeled monoclonal antibody by intravenous infusion	False	5	C5696507;C1314096
79440	CPT	Radiopharmaceutical therapy, by intra-articular administration	False	5	C2094671;C5696508;C0373463
79445	CPT	Radiopharmaceutical therapy, by intra-arterial particulate administration	False	5	C1504154;C3865755;C5696509
79999	CPT	Radiopharmaceutical therapy, unlisted procedure	False	5	C0203608;C5411829;C0373465
80061	CPT	Lipid panel This panel must include the following: Cholesterol, serum, total (82465) Lipoprotein, direct measurement, high density cholesterol (HDL cholesterol) (83718) Triglycerides (84478)	False	8	C5411876;C0200382;C5574763;C5411875;C5411874
81528	CPT	Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result	False	5	C5413264;C4051849;C4051914
82270	CPT	Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)	False	5	C5413325;C0519828;C3516305
82465	CPT	Cholesterol, serum or whole blood, total	False	6	C0201950;C0373576;C1445957;C3525706
82947	CPT	Glucose; quantitative, blood (except reagent strip)	False	5	C5413394;C0392201;C0523658
82950	CPT	Glucose; post glucose dose (includes glucose)	False	5	C0373621
82951	CPT	Glucose; tolerance test (GTT), 3 specimens (includes glucose)	False	5	C5413396;C5413395;C0373622
83718	CPT	Lipoprotein, direct measurement; high density cholesterol (HDL cholesterol)	False	5	C0392885
84478	CPT	Triglycerides	False	5	C0202236
86890	CPT	Autologous blood or component, collection processing and storage; predeposited	False	6	C5413704;C3525871;C0398307;C0373961
86891	CPT	Autologous blood or component, collection processing and storage; intra- or postoperative salvage	False	8	C5413705;C5413706;C5413707;C5413708;C3516487;C0373962
86927	CPT	Fresh frozen plasma, thawing, each unit	False	5	C3516492;C5413723;C0373972
86930	CPT	Frozen blood, each unit; freezing (includes preparation)	False	5	C3516493;C5413724;C0373973
86931	CPT	Frozen blood, each unit; thawing	False	5	C5413725;C3516494;C0373974
86932	CPT	Frozen blood, each unit; freezing (includes preparation) and thawing	False	5	C3516495;C5413726;C0373975
86945	CPT	Irradiation of blood product, each unit	False	5	C0200620
86950	CPT	Leukocyte transfusion	False	5	C0086548
86960	CPT	Volume reduction of blood or blood product (eg, red blood cells or platelets), each unit	False	6	C1609549;C3516497;C5413729;C5413728
86965	CPT	Pooling of platelets or other blood products	False	6	C0373978;C3525890;C2097072
86985	CPT	Splitting of blood or blood products, each unit	False	6	C5413762;C0373984;C3516500;C5413763
90612					
90613					
90635					
90637	CPT	Influenza virus vaccine, quadrivalent (qIRV), mRNA; 30 mcg/0.5 mL dosage, for intramuscular use	False	5	C5944836
90638	CPT	Influenza virus vaccine, quadrivalent (qIRV), mRNA; 60 mcg/0.5 mL dosage, for intramuscular use	False	5	C5944837
90653	CPT	Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use	False	5	C3511580;C5696648;C5414799
90655	CPT	Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use	False	5	C4291797;C5696650
90656	CPT	Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use	False	5	C4291798;C5696651
90657	CPT	Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use	False	5	C4291799;C5696652
90658	CPT	Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use	False	5	C5696653;C4291800
90660	CPT	Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use	False	5	C4051836;C5696654
90661	CPT	Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use	False	5	C1964063;C5944832
90662	CPT	Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use	False	5	C1964064;C5696659
90670	CPT	Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use	False	5	C2724349;C5700427
90671	CPT	Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use	False	5	C5691554
90672	CPT	Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use	False	5	C4051835;C5414818
90673	CPT	Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use	False	5	C3702513;C5414820;C5696658
90674	CPT	Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use	False	5	C4291801;C5696656
90677	CPT	Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use	False	5	C5691555
90682	CPT	Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use	False	5	C4301942;C5696666
90684	CPT	Pneumococcal conjugate vaccine, 21 valent (PCV21), for intramuscular use	False	5	C5944834
90685	CPT	Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use	False	5	C4291802;C5696667
90686	CPT	Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use	False	5	C4291803;C5696668
90687	CPT	Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use	False	5	C4291804;C5696669
90688	CPT	Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use	False	5	C4291805;C5696670
90689	CPT	Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use	False	5	C5696671;C4732390
90694	CPT	Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use	False	5	C5202239;C5696672
90695	CPT	Influenza virus vaccine, H5N8, derived from cell cultures, adjuvanted, for intramuscular use	False	5	C5944833
90732	CPT	Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or intramuscular use	False	6	C5696683;C5414851;C5414850;C0374122
90739	CPT	Hepatitis B vaccine (HepB), CpG-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use	False	6	C5702325;C3511582;C5702326
90740	CPT	Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use	False	6	C5696691;C5414858;C5414857;C0918229
90743	CPT	Hepatitis B vaccine (HepB), adolescent, 2 dose schedule, for intramuscular use	False	5	C5696692;C0918230
90744	CPT	Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use	False	6	C5696693;C0374127;C5414860;C5414861
90746	CPT	Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use	False	5	C5696694;C0374129
90747	CPT	Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use	False	6	C5696696;C5414864;C5414863;C0374130
90749	CPT	Unlisted vaccine/toxoid	False	6	C5696699;C5414866;C5414867;C0374131
90756	CPT	Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use	False	5	C4523607;C5696657
90759	CPT	Hepatitis B vaccine (HepB), 3-antigen (S, Pre-S1, Pre-S2), 10 mcg dosage, 3 dose schedule, for intramuscular use	False	5	C5696695;C5691558
90901	CPT	Biofeedback training by any modality	False	5	C0204634;C0871664
90912	CPT	Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; initial 15 minutes of one-on-one physician or other qualified health care professional contact with the patient	False	28	C5414898;C5414901;C5414903;C5414889;C5414902;C5202244;C5202243;C5414883;C5414884;C5414886;C5414893;C5414896;C5414906;C5414885;C5414888;C5414891;C5414894;C5414895;C5414897;C5414899;C5414904;C5414905;C5414887;C5414890;C5414892
90913	CPT	Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; each additional 15 minutes of one-on-one physician or other qualified health care professional contact with the patient (List separately in addition to code for primary procedure)	False	16	C5414908;C5414909;C5414911;C5414917;C5414912;C5414915;C5414918;C5696716;C5202257;C5414910;C5414913;C5414907;C5414914;C5414916
91110	CPT	Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report	False	5	C1314125;C3704003;C5414957
91111	CPT	Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus with interpretation and report	False	5	C5414958;C3704004;C1740482
91304	CPT	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, 5 mcg/0.5 mL dosage, for intramuscular use	False	5	C5691553;C5696640
91318	CPT	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 3 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use	False	5	C5852108
91319	CPT	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 10 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use	False	5	C5852109
91320	CPT	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use	False	5	C5852110
91321	CPT	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25 mL dosage, for intramuscular use	False	5	C5852111
91322	CPT	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use	False	5	C5852112
91323					
92132	CPT	Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), anterior segment, with interpretation and report, unilateral or bilateral	False	8	C2939303;C5696778;C5944842;C5944839;C5944840;C5944841
92133	CPT	Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve	False	8	C2939304;C5696779;C5944844;C5944847;C5944846;C5944845
92134	CPT	Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina	False	8	C5696780;C2939305;C5944851;C5944848;C5944849;C5944850
92137	CPT	Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina, including OCT angiography	False	8	C5944854;C5944856;C5944852;C5944857;C5944853;C5944855
92227	CPT	Imaging of retina for detection or monitoring of disease; with remote clinical staff review and report, unilateral or bilateral	False	8	C5414991;C2939306;C5414989;C5696784;C5414990;C5414988
92228	CPT	Imaging of retina for detection or monitoring of disease; with remote physician or other qualified health care professional interpretation and report, unilateral or bilateral	False	8	C2939307;C5414993;C5414994;C5414995;C5696785;C5414996
92229	CPT	Imaging of retina for detection or monitoring of disease; point-of-care autonomous analysis and report, unilateral or bilateral	False	8	C5702333;C5702334;C5702336;C5702335;C5414997;C5414998
92507	CPT	Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual	False	7	C5415038;C0374250;C3516880;C5415040;C5415039
92508	CPT	Treatment of speech, language, voice, communication, and/or auditory processing disorder; group, 2 or more individuals	False	7	C5696813;C5415041;C5415042;C5415043;C0374251
92520	CPT	Laryngeal function studies (ie, aerodynamic testing and acoustic testing)	False	5	C5696815;C0199432
92521	CPT	Evaluation of speech fluency (eg, stuttering, cluttering)	False	5	C5696816;C3702514
92522	CPT	Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria)	False	5	C3702515
92523	CPT	Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)	False	5	C3702516;C3709158
92524	CPT	Behavioral and qualitative analysis of voice and resonance	False	5	C5696817;C3702517
92526	CPT	Treatment of swallowing dysfunction and/or oral function for feeding	False	7	C5696818;C3526665;C2121152;C3526664;C0374254
92597	CPT	Evaluation for use and/or fitting of voice prosthetic device to supplement oral speech	False	7	C5696867;C3526674;C3526676;C3526675;C0374267
92607	CPT	Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; first hour	False	5	C1144725;C5696871;C5415092
92608	CPT	Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; each additional 30 minutes (List separately in addition to code for primary procedure)	False	5	C1144726;C5696872;C5415093
92609	CPT	Therapeutic services for the use of speech-generating device, including programming and modification	False	5	C1144727;C5696873;C5415094
92610	CPT	Evaluation of oral and pharyngeal swallowing function	False	5	C1144728;C3516936
92611	CPT	Motion fluoroscopic evaluation of swallowing function by cine or video recording	False	6	C1144729;C3526680;C5696874;C3516937
92612	CPT	Flexible endoscopic evaluation of swallowing by cine or video recording	False	6	C5415095;C1144730;C3704010;C5415096
92614	CPT	Flexible endoscopic evaluation, laryngeal sensory testing by cine or video recording	False	6	C5415099;C1144780;C3516940;C5415100
92616	CPT	Flexible endoscopic evaluation of swallowing and laryngeal sensory testing by cine or video recording	False	6	C3516942;C1144732;C5415104;C5415103
92974	CPT	Transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy (List separately in addition to code for primary procedure)	False	5	C5696904;C0973347;C3526708
93303	CPT	Transthoracic echocardiography for congenital cardiac anomalies; complete	False	5	C5696954;C0519171
93304	CPT	Transthoracic echocardiography for congenital cardiac anomalies; follow-up or limited study	False	6	C5696955;C5415324;C5415325;C0519172
93306	CPT	Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography	False	6	C5415326;C5415327;C2366742;C5696956
93307	CPT	Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, without spectral or color Doppler echocardiography	False	6	C0519173;C5415329;C5415328;C0013516
93308	CPT	Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study	False	8	C5696957;C0519174;C5415330;C5415332;C5415331;C5415333
93320	CPT	Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete	False	7	C5415345;C5696966;C0520400;C5415343;C5415344
93321	CPT	Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)	False	10	C5415348;C5415351;C5696967;C5415347;C5415349;C5415350;C5415346;C0520401
93325	CPT	Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)	False	5	C2022193;C0474781;C5696968
93356	CPT	Myocardial strain imaging using speckle tracking-derived assessment of myocardial mechanics (List separately in addition to codes for echocardiography imaging)	False	5	C5202292;C5202294;C5202293
93797	CPT	Physician or other qualified health care professional services for outpatient cardiac rehabilitation; without continuous ECG monitoring (per session)	False	6	C5697041;C3526866;C5415490;C0199540
93798	CPT	Physician or other qualified health care professional services for outpatient cardiac rehabilitation; with continuous ECG monitoring (per session)	False	6	C5415492;C5697042;C5415491;C0199541
93880	CPT	Duplex scan of extracranial arteries; complete bilateral study	False	5	C5415495;C5697044;C0374346
93882	CPT	Duplex scan of extracranial arteries; unilateral or limited study	False	6	C3526869;C3526868;C5697045;C0374347
93886	CPT	Transcranial Doppler study of the intracranial arteries; complete study	False	5	C0203387;C5697046;C5415496
93888	CPT	Transcranial Doppler study of the intracranial arteries; limited study	False	5	C0203388;C2061932;C5697047
93892	CPT	Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection	False	5	C5697049;C1504189;C2145231
93893	CPT	Transcranial Doppler study of the intracranial arteries; venous-arterial shunt detection with intravenous microbubble injection	False	5	C1504190;C5944859
93896	CPT	Vasoreactivity study performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)	False	5	C5944860;C5944861
93897	CPT	Emboli detection without intravenous microbubble injection performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)	False	5	C5944862;C5944863
93898	CPT	Venous-arterial shunt detection with intravenous microbubble injection performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)	False	5	C5944864;C5944865
93922	CPT	Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels)	False	6	C2939333;C3526871;C5697052;C3526872
93923	CPT	Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure measurements with bidirectional Doppler waveform recording and analysis, at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental volume plethysmography at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental transcutaneous oxygen tension measurements at 3 or more levels), or single level study with provocative functional maneuvers (eg, measurements with postural provocative tests, or measurements with reactive hyperemia)	False	6	C2939334;C5415500;C5697053;C5415499
93924	CPT	Noninvasive physiologic studies of lower extremity arteries, at rest and following treadmill stress testing, (ie, bidirectional Doppler waveform or volume plethysmography recording and analysis at rest with ankle/brachial indices immediately after and at timed intervals following performance of a standardized protocol on a motorized treadmill plus recording of time of onset of claudication or other symptoms, maximal walking time, and time to recovery) complete bilateral study	False	5	C5415501;C2939335;C5697054
93925	CPT	Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study	False	6	C0374351;C5697055;C5415503;C5415502
93926	CPT	Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study	False	8	C5697056;C3526879;C3526878;C5415505;C5415504;C0374352
93930	CPT	Duplex scan of upper extremity arteries or arterial bypass grafts; complete bilateral study	False	6	C0374353;C5415507;C5697057;C5415506
93931	CPT	Duplex scan of upper extremity arteries or arterial bypass grafts; unilateral or limited study	False	8	C0374354;C3526883;C5697058;C3526882;C5415508;C5415509
93970	CPT	Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study	False	5	C0374356;C5415510;C5697059
93971	CPT	Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study	False	6	C5697060;C0374357;C5415512;C5415511
93975	CPT	Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study	False	9	C5415514;C5415513;C5697061;C5415515;C5415516;C5415517;C0519183
93976	CPT	Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study	False	9	C5415519;C5415521;C5697062;C5415520;C5415518;C5415522;C0519184
93978	CPT	Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study	False	8	C5415525;C5697063;C5415526;C5415523;C5415524;C0374360
93979	CPT	Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study	False	12	C5697064;C5415528;C5415529;C3526898;C5415530;C3526896;C3526899;C3526897;C5415527;C0374361
93980	CPT	Duplex scan of arterial inflow and venous outflow of penile vessels; complete study	False	5	C5697065;C5415531;C0374362
93981	CPT	Duplex scan of arterial inflow and venous outflow of penile vessels; follow-up or limited study	False	6	C0374363;C5697066;C5415532;C5415533
93990	CPT	Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)	False	5	C0374364;C5697069;C5415536
93998	CPT	Unlisted noninvasive vascular diagnostic study	False	5	C3248239;C3248364
95851	CPT	Range of motion measurements and report (separate procedure); each extremity (excluding hand) or each trunk section (spine)	False	6	C3526977;C5697175;C3526978;C0374431
95852	CPT	Range of motion measurements and report (separate procedure); hand, with or without comparison with normal side	False	6	C5415715;C0204063;C5415714;C5697176
95992	CPT	Canalith repositioning procedure(s) (eg, Epley maneuver, Semont maneuver), per day	False	5	C5697251;C1096698;C5415840
96000	CPT	Comprehensive computer-based motion analysis by video-taping and 3D kinematics	False	5	C0973355;C5697253;C5415843
96001	CPT	Comprehensive computer-based motion analysis by video-taping and 3D kinematics; with dynamic plantar pressure measurements during walking	False	5	C0973356;C5697254;C5415844
96002	CPT	Dynamic surface electromyography, during walking or other functional activities, 1-12 muscles	False	6	C5415845;C0973357;C5697255;C5415846
96105	CPT	Assessment of aphasia (includes assessment of expressive and receptive speech and language function, language comprehension, speech production ability, reading, spelling, writing, eg, by Boston Diagnostic Aphasia Examination) with interpretation and report, per hour	False	5	C5415852;C5697267;C0374463
96125	CPT	Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report	False	5	C1964073;C5697268;C5415853
97010	CPT	Application of a modality to 1 or more areas; hot or cold packs	False	8	C5415987;C0374482;C5697342;C5415985;C5415988;C5415986
97012	CPT	Application of a modality to 1 or more areas; traction, mechanical	False	6	C5415990;C0553622;C5415989;C0374483
97016	CPT	Application of a modality to 1 or more areas; vasopneumatic devices	False	6	C5697344;C5415993;C0374485;C5415994
97018	CPT	Application of a modality to 1 or more areas; paraffin bath	False	6	C5415995;C5415996;C5697345;C0374486
97022	CPT	Application of a modality to 1 or more areas; whirlpool	False	6	C5697346;C5416764;C5415997;C0374488
97024	CPT	Application of a modality to 1 or more areas; diathermy (eg, microwave)	False	6	C5697347;C5415998;C5415999;C0374489
97026	CPT	Application of a modality to 1 or more areas; infrared	False	6	C5697348;C0374490;C5416001;C5416000
97028	CPT	Application of a modality to 1 or more areas; ultraviolet	False	6	C5416003;C5697349;C5416002;C0374491
97032	CPT	Application of a modality to 1 or more areas; electrical stimulation (manual), each 15 minutes	False	6	C0374492;C5416004;C5697350;C5416005
97033	CPT	Application of a modality to 1 or more areas; iontophoresis, each 15 minutes	False	6	C5697351;C5416006;C5416007;C0374493
97034	CPT	Application of a modality to 1 or more areas; contrast baths, each 15 minutes	False	6	C5697352;C0374494;C5416008;C5416009
97035	CPT	Application of a modality to 1 or more areas; ultrasound, each 15 minutes	False	6	C5416011;C5697353;C5416010;C0374495
97036	CPT	Application of a modality to 1 or more areas; Hubbard tank, each 15 minutes	False	6	C5697354;C0374496;C5416013;C5416012
97039	CPT	Unlisted modality (specify type and time if constant attendance)	False	5	C5697355;C5416014;C0374497
97110	CPT	Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility	False	5	C0374498;C3517306;C5697356
97112	CPT	Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities	False	6	C0374499;C5697357;C5416015;C5416016
97113	CPT	Therapeutic procedure, 1 or more areas, each 15 minutes; aquatic therapy with therapeutic exercises	False	6	C0374500;C5697358;C5416017;C5416018
97116	CPT	Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)	False	6	C5697359;C5416019;C5416020;C0374501
97124	CPT	Therapeutic procedure, 1 or more areas, each 15 minutes; massage, including effleurage, petrissage and/or tapotement (stroking, compression, percussion)	False	12	C5697360;C5416023;C5416024;C5416028;C5416022;C5416021;C5416026;C5416025;C5416027;C0374503
97129	CPT	Therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing, and sequencing tasks), direct (one-on-one) patient contact; initial 15 minutes	False	5	C5697361;C5202410;C5202411
97130	CPT	Therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing, and sequencing tasks), direct (one-on-one) patient contact; each additional 15 minutes (List separately in addition to code for primary procedure)	False	5	C5697362;C5202412;C5202414
97139	CPT	Unlisted therapeutic procedure (specify)	False	5	C0393107;C5416029;C0374504
97140	CPT	Manual therapy techniques (eg, mobilization/ manipulation, manual lymphatic drainage, manual traction), 1 or more regions, each 15 minutes	False	6	C5416030;C5697363;C0695171;C5416031
97150	CPT	Therapeutic procedure(s), group (2 or more individuals)	False	5	C0374505;C5697364
97161	CPT	Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; A clinical presentation with stable and/or uncomplicated characteristics; and Clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 20 minutes are spent face-to-face with the patient and/or family.	False	5	C4292027;C4291816;C5416042
97162	CPT	Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in addressing a total of 3 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; An evolving clinical presentation with changing characteristics; and Clinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 30 minutes are spent face-to-face with the patient and/or family.	False	7	C5416044;C5416043;C4291817;C4292028;C5416045
97163	CPT	Physical therapy evaluation: high complexity, requiring these components: A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; A clinical presentation with unstable and unpredictable characteristics; and Clinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 45 minutes are spent face-to-face with the patient and/or family.	False	7	C5416048;C5416047;C4292029;C4291818;C5416046
97164	CPT	Re-evaluation of physical therapy established plan of care, requiring these components: An examination including a review of history and use of standardized tests and measures is required; and Revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome Typically, 20 minutes are spent face-to-face with the patient and/or family.	False	7	C4292030;C5416050;C4291819;C5416049;C5416051
97165	CPT	Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An assessment(s) that identifies 1-3 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of low complexity, which includes an analysis of the occupational profile, analysis of data from problem-focused assessment(s), and consideration of a limited number of treatment options. Patient presents with no comorbidities that affect occupational performance. Modification of tasks or assistance (eg, physical or verbal) with assessment(s) is not necessary to enable completion of evaluation component. Typically, 30 minutes are spent face-to-face with the patient and/or family.	False	7	C4291820;C4292031;C5416053;C5416054;C5416052
97166	CPT	Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 3-5 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of moderate analytic complexity, which includes an analysis of the occupational profile, analysis of data from detailed assessment(s), and consideration of several treatment options. Patient may present with comorbidities that affect occupational performance. Minimal to moderate modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 45 minutes are spent face-to-face with the patient and/or family.	False	7	C4291821;C4292032;C5416056;C5416055;C5416057
97167	CPT	Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 5 or more performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of high analytic complexity, which includes an analysis of the patient profile, analysis of data from comprehensive assessment(s), and consideration of multiple treatment options. Patient presents with comorbidities that affect occupational performance. Significant modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 60 minutes are spent face-to-face with the patient and/or family.	False	7	C4291822;C5416059;C5697340;C5416058;C5416060
97168	CPT	Re-evaluation of occupational therapy established plan of care, requiring these components: An assessment of changes in patient functional or medical status with revised plan of care; An update to the initial occupational profile to reflect changes in condition or environment that affect future interventions and/or goals; and A revised plan of care. A formal reevaluation is performed when there is a documented change in functional status or a significant change to the plan of care is required. Typically, 30 minutes are spent face-to-face with the patient and/or family.	False	7	C4291823;C5416061;C5416063;C5697341;C5416062
97530	CPT	Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes	False	5	C5416032;C0374514;C5697365
97533	CPT	Sensory integrative techniques to enhance sensory processing and promote adaptive responses to environmental demands, direct (one-on-one) patient contact, each 15 minutes	False	5	C5697366;C5416033;C0918239
97535	CPT	Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes	False	6	C5416035;C0374515;C3517314;C5416034
97537	CPT	Community/work reintegration training (eg, shopping, transportation, money management, avocational activities and/or work environment/modification analysis, work task analysis, use of assistive technology device/adaptive equipment), direct one-on-one contact, each 15 minutes	False	6	C3517315;C5416036;C5416037;C0374516
97542	CPT	Wheelchair management (eg, assessment, fitting, training), each 15 minutes	False	5	C5697367;C0374517
97545	CPT	Work hardening/conditioning; initial 2 hours	False	6	C5697368;C5416039;C5416038;C0374518
97546	CPT	Work hardening/conditioning; each additional hour (List separately in addition to code for primary procedure)	False	6	C5697369;C5416041;C5416040;C0374519
97550	CPT	Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; initial 30 minutes	False	13	C5852161;C5852160;C5852165;C5852163;C5852166;C5852167;C5852164;C5852168;C5852169;C5852162;C5852170
97551	CPT	Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; each additional 15 minutes (List separately in addition to code for primary service)	False	13	C5852171;C5852172;C5852179;C5852175;C5852176;C5852177;C5852181;C5852173;C5852174;C5852180;C5852178
97552	CPT	Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face with multiple sets of caregivers	False	13	C5852190;C5852191;C5852192;C5852182;C5852184;C5852185;C5852186;C5852189;C5852183;C5852187;C5852188
97597	CPT	Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less	False	6	C2939339;C5416078;C5697370;C5416077
97598	CPT	Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)	False	6	C5416081;C2939340;C5697371;C5416080
97602	CPT	Removal of devitalized tissue from wound(s), non-selective debridement, without anesthesia (eg, wet-to-moist dressings, enzymatic, abrasion, larval therapy), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session	False	5	C5697372;C5416082;C0918241
97605	CPT	Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters	False	5	C1504199;C5697373;C5416083
97606	CPT	Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters	False	5	C5416084;C1504200;C5697374
97607	CPT	Negative pressure wound therapy, (eg, vacuum assisted drainage collection), utilizing disposable, non-durable medical equipment including provision of exudate management collection system, topical application(s), wound assessment, and instructions for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters	False	5	C5416085;C3865293;C5697375
97608	CPT	Negative pressure wound therapy, (eg, vacuum assisted drainage collection), utilizing disposable, non-durable medical equipment including provision of exudate management collection system, topical application(s), wound assessment, and instructions for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters	False	5	C5697376;C5416086;C3854210
97610	CPT	Low frequency, non-contact, non-thermal ultrasound, including topical application(s), when performed, wound assessment, and instruction(s) for ongoing care, per day	False	6	C1964170;C5416087;C5697377;C5416088
97750	CPT	Physical performance test or measurement (eg, musculoskeletal, functional capacity), with written report, each 15 minutes	False	6	C5416089;C0374521;C5697378;C5416090
97755	CPT	Assistive technology assessment (eg, to restore, augment or compensate for existing function, optimize functional tasks and/or maximize environmental accessibility), direct one-on-one contact, with written report, each 15 minutes	False	5	C5697379;C1314127;C5416091
97760	CPT	Orthotic(s) management and training (including assessment and fitting when not otherwise reported), upper extremity(ies), lower extremity(ies) and/or trunk, initial orthotic(s) encounter, each 15 minutes	False	14	C5416092;C5416094;C5416098;C1609004;C5416093;C5697380;C5416095;C5416096;C5416097;C5416099
97761	CPT	Prosthetic(s) training, upper and/or lower extremity(ies), initial prosthetic(s) encounter, each 15 minutes	False	9	C5697381;C4523647;C4523648;C4523649;C0519195
97763	CPT	Orthotic(s)/prosthetic(s) management and/or training, upper extremity(ies), lower extremity(ies), and/or trunk, subsequent orthotic(s)/prosthetic(s) encounter, each 15 minutes	False	58	C4523650;C4523655;C4523660;C4523668;C4523671;C4523674;C4523677;C4523665;C4523667;C4523669;C4523670;C4523679;C5697382;C4523652;C4523656;C4523657;C4523658;C4523661;C4523662;C4523664;C4523678;C4523653;C4523659;C4523666;C4523672
97799	CPT	Unlisted physical medicine/rehabilitation service or procedure	False	8	C5697383;C5416102;C5416104;C5416105;C5416103;C0374523
98966	CPT	Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	False	5	C1964074;C5944874;C5944873
98967	CPT	Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion	False	5	C1964075;C5944876;C5944875
98968	CPT	Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion	False	5	C1964076;C5944878;C5944877
98970	CPT	Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes	False	5	C5416150;C5416151;C5944879
98971	CPT	Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes	False	5	C5944880;C5202419;C5416152
98972	CPT	Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes	False	5	C5416153;C5416154
98975	CPT	Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); initial set-up and patient education on use of equipment	False	7	C5691569;C5944882;C5944883;C5944884;C5944885
98976	CPT	Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); device(s) supply for data access or data transmissions to support monitoring of respiratory system, each 30 days	False	13	C5944892;C5691570;C5944886;C5944887;C5944891;C5944894;C5944895;C5944888;C5944890;C5944893;C5944889
98977	CPT	Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); device(s) supply for data access or data transmissions to support monitoring of musculoskeletal system, each 30 days	False	13	C5944896;C5944899;C5944901;C5944902;C5691571;C5944897;C5944898;C5944903;C5944905;C5944900;C5944904
98979					
98980	CPT	Remote therapeutic monitoring treatment management services, physician or other qualified health care professional time in a calendar month requiring at least one interactive communication with the patient or caregiver during the calendar month; first 20 minutes	False	5	C5691572;C5697399;C5698309
98981	CPT	Remote therapeutic monitoring treatment management services, physician or other qualified health care professional time in a calendar month requiring at least one interactive communication with the patient or caregiver during the calendar month; each additional 20 minutes (List separately in addition to code for primary procedure)	False	5	C5697400;C5698310;C5691573
98984					
98985					
A4641					
A4642					
A4650					
A9500					
A9501					
A9502					
A9503					
A9504					
A9505					
A9506					
A9507					
A9508					
A9509					
A9510					
A9512					
A9513					
A9515					
A9516					
A9517					
A9520					
A9521					
A9524					
A9526					
A9527					
A9528					
A9529					
A9530					
A9531					
A9532					
A9536					
A9537					
A9538					
A9539					
A9540					
A9541					
A9542					
A9543					
A9546					
A9547					
A9548					
A9550					
A9551					
A9552					
A9553					
A9554					
A9555					
A9556					
A9557					
A9558					
A9559					
A9560					
A9561					
A9562					
A9563					
A9564					
A9566					
A9567					
A9568					
A9569					
A9570					
A9571					
A9572					
A9573					
A9576					
A9577					
A9578					
A9579					
A9580					
A9584					
A9586					
A9587					
A9588					
A9590					
A9591					
A9592					
A9593					
A9594					
A9595					
A9596					
A9597					
A9598					
A9600					
A9601					
A9602					
A9604					
A9606					
A9607					
A9608					
A9609					
A9610					
A9611					
A9612					
A9616					
A9697					
A9699					
A9700					
A9800					
C1716					
C1717					
C1719					
C2616					
C2634					
C2635					
C2636					
C2638					
C2639					
C2640					
C2641					
C2642					
C2643					
C2644					
C2645					
C2698					
C2699					
C8001					
C8004					
C8937					
C9067					
C9176					
C9762					
C9763					
C9791					
C9793					
G0027					
G0103					
G0118					
G0123					
G0124					
G0130					
G0141					
G0143					
G0144					
G0145					
G0147					
G0148					
G0183					
G0279					
G0281					
G0283					
G0288					
G0306					
G0307					
G0327					
G0328					
G0329					
G0339					
G0340					
G0416					
G0432					
G0433					
G0435					
G0451					
G0471					
G0472					
G0475					
G0476					
G0480					
G0481					
G0482					
G0483					
G0499					
G0541					
G0542					
G0543					
G0562					
G0563					
G0566					
G0567					
G0659					
G2250					
G2251					
G9143					
P2028					
P2029					
P2031					
P2033					
P2038					
P3000					
P3001					
P9612					
P9615					
Q0092					
Q0111					
Q0112					
Q0113					
Q0114					
Q0115					
Q0224					
Q0235					
Q0237					
Q0249					
Q2034					
Q2035					
Q2036					
Q2037					
Q2038					
Q2039					
Q3001					
Q9950					
Q9951					
Q9953					
Q9954					
Q9955					
Q9956					
Q9957					
Q9958					
Q9959					
Q9960					
Q9961					
Q9962					
Q9963					
Q9964					
Q9965					
Q9966					
Q9967					
Q9982					
Q9983					
R0070					
R0075					
U0001					
U0002					